Pathways Knowlegdes

Biological pathway database


Pathway DOIs Note
Proton-coupled monocarboxylate transport

Accession ID: Reactome:R-RNO-433692
  • 10.1074/jbc.m411950200
  • 10.1208/s12248-008-9035-6
  • 10.14670/hh-24.243
Merezhinskaya N, Fishbein WN. Monocarboxylate transporters: past, present, and future. Histol Histopathol. 2009 Feb;24(2):243–64. doi: 10.14670/hh-24.243. PMID: 19085840.; Morris ME, Felmlee MA. Overview of the Proton-coupled MCT (SLC16A) Family of Transporters: Characterization, Function and Role in the Transport of the Drug of Abuse ?-Hydroxybutyric Acid. The AAPS Journal. 2008 Jun 04;10(2):311. doi: 10.1208/s12248-008-9035-6.; Wilson MC, Meredith D, Fox JE, Manoharan C, Davies AJ, Halestrap AP. Basigin (CD147) is the target for organomercurial inhibition of monocarboxylate transporter isoforms 1 and 4: the ancillary protein for the insensitive MCT2 is EMBIGIN (gp70). J Biol Chem. 2005 Jul 22;280(29):27213–21. doi: 10.1074/jbc.m411950200. PMID: 15917240.
Metabolism

Accession ID: Reactome:R-XTR-1430728
-
Pyruvate metabolism

Accession ID: Reactome:R-XTR-70268
  • 10.1016/s0021-9258(19)38795-2
  • 10.3390/cells10040762
Prochownik EV, Wang H. The Metabolic Fates of Pyruvate in Normal and Neoplastic Cells. Cells. 2021 Mar 30;10(4). PMID: 33808495; PMCID: PMC8066905.; Reed LJ, Hackert ML. Structure-function relationships in dihydrolipoamide acyltransferases. Journal of Biological Chemistry. 1990 Jun;265(16):8971–4. doi: 10.1016/s0021-9258(19)38795-2.; Cori CF. The glucose-lactic acid cycle and gluconeogenesis. Curr Top Cell Regul. 1981;18():377–87. PMID: 7273846.
Transport of small molecules

Accession ID: Reactome:R-XTR-382551
-
SLC-mediated transmembrane transport

Accession ID: Reactome:R-XTR-425407
  • 10.1006/abbi.1999.1213
  • 10.1007/s00424-003-1064-5
  • 10.1007/s00424-003-1089-9
  • 10.1007/s00424-003-1168-y
  • 10.1007/s00424-003-1192-y
  • 10.1007/s00424-005-1487-2
  • 10.1016/j.febslet.2015.03.012
  • 10.1016/j.mam.2012.07.010
  • 10.1016/s0021-9258(18)31744-7
  • 10.1073/pnas.94.7.2897
  • 10.1079/bjn2002763
  • 10.1097/mnh.0b013e3282e7d7d0
  • 10.1111/j.1471-4159.2004.02962.x
  • 10.1152/physiol.00037.2007
  • 10.1152/physrev.00044.2006
  • 10.1177/0960327107070573
  • 10.1186/1479-7364-3-2-195
  • 10.1208/s12248-008-9035-6
  • 10.1590/s0100-879x2006000900002
Schneider S. Inositol transport proteins. FEBS Lett. 2015 Apr 28;589(10):1049–58. doi: 10.1016/j.febslet.2015.03.012. PMID: 25819438.; Anderson CM, Stahl A. SLC27 fatty acid transport proteins. Molecular Aspects of Medicine. 2013 Apr;34(2-3):516–28. doi: 10.1016/j.mam.2012.07.010.; He L, Vasiliou K, Nebert DW. Analysis and update of the human solute carrier (SLC) gene superfamily. Hum Genomics. 2009 Jan;3(2):195–206. PMID: 19164095; PMCID: PMC2752037.; Morris ME, Felmlee MA. Overview of the Proton-coupled MCT (SLC16A) Family of Transporters: Characterization, Function and Role in the Transport of the Drug of Abuse ?-Hydroxybutyric Acid. The AAPS Journal. 2008 Jun 04;10(2):311. doi: 10.1208/s12248-008-9035-6.; Dorwart MR, Shcheynikov N, Yang D, Muallem S. The solute carrier 26 family of proteins in epithelial ion transport. Physiology (Bethesda). 2008 Apr;23():104–14. doi: 10.1152/physiol.00037.2007. PMID: 18400693.; Ashmore J. Cochlear outer hair cell motility. Physiol Rev. 2008 Jan;88(1):173–210. doi: 10.1152/physrev.00044.2006. PMID: 18195086.; Sindic A, Chang MH, Mount DB, Romero MF. Renal physiology of SLC26 anion exchangers. Curr Opin Nephrol Hypertens. 2007 Sep;16(5):484–90. doi: 10.1097/mnh.0b013e3282e7d7d0. PMID: 17693766.; Bressler JP, Olivi L, Cheong JH, Kim Y, Maerten A, Bannon D. Metal transporters in intestine and brain: their involvement in metal-associated neurotoxicities. Hum Exp Toxicol. 2007 Mar;26(3):221–9. doi: 10.1177/0960327107070573. PMID: 17439925.; Handford M, Rodriguez-Furlán C, Orellana A. Nucleotide-sugar transporters: structure, function and roles in vivo. Braz J Med Biol Res. 2006 Sep;39(9):1149–58. doi: 10.1590/s0100-879x2006000900002. PMID: 16981043.; Pajor AM. Molecular properties of the SLC13 family of dicarboxylate and sulfate transporters. Pflügers Archiv - European Journal of Physiology. 2005 Oct 07;451(5):597–605. doi: 10.1007/s00424-005-1487-2.; Traiffort E, Ruat M, O'Regan S, Meunier FM. Molecular characterization of the family of choline transporter-like proteins and their splice variants. Journal of Neurochemistry. 2005 Feb 04;92(5):1116–25. doi: 10.1111/j.1471-4159.2004.02962.x.; Koepsell H, Endou H. The SLC22 drug transporter family. Pflügers Archiv - European Journal of Physiology. 2003 Jul 19;447(5):666–76. doi: 10.1007/s00424-003-1089-9.; Hediger MA, Romero MF, Peng J, Rolfs A, Takanaga H, Bruford EA. The ABCs of solute carriers: physiological, pathological and therapeutic implications of human membrane transport proteins. Pflügers Archiv - European Journal of Physiology. 2003 Nov 18;447(5):465–8. doi: 10.1007/s00424-003-1192-y.; Hagenbuch B, Meier PJ. Organic anion transporting polypeptides of the OATP/ SLC21 family: phylogenetic classification as OATP/ SLCO superfamily, new nomenclature and molecular/functional properties. Pfl?gers Archiv European Journal of Physiology. 2004 Feb 01;447(5):653–65. doi: 10.1007/s00424-003-1168-y.; Chen N, Reith MEA, Quick MW. Synaptic uptake and beyond: the sodium- and chloride-dependent neurotransmitter transporter family SLC6. Pflügers Archiv - European Journal of Physiology. 2003 Apr 29;447(5):519–31. doi: 10.1007/s00424-003-1064-5.; Wood IS, Trayhurn P. Glucose transporters (GLUT and SGLT): expanded families of sugar transport proteins. Br J Nutr. 2003 Jan;89(1):3–9. doi: 10.1079/bjn2002763. PMID: 12568659.; Prasad PD, Wang H, Huang W, Fei YJ, Leibach FH, Devoe LD, Ganapathy V. Molecular and functional characterization of the intestinal Na+-dependent multivitamin transporter. Arch Biochem Biophys. 1999 Jun 01;366(1):95–106. doi: 10.1006/abbi.1999.1213. PMID: 10334869.; Kanamori A, Nakayama J, Fukuda MN, Stallcup WB, Sasaki K, Fukuda M, Hirabayashi Y. Expression cloning and characterization of a cDNA encoding a novel membrane protein required for the formation of O -acetylated ganglioside: A putative acetyl-CoA transporter. Proc. Natl. Acad. Sci. U.S.A. 1997 Apr;94(7):2897–902. doi: 10.1073/pnas.94.7.2897.; Olives B, Neau P, Bailly P, Hediger MA, Rousselet G, Cartron JP, Ripoche P. Cloning and functional expression of a urea transporter from human bone marrow cells. Journal of Biological Chemistry. 1994 Dec;269(50):31649–52. doi: 10.1016/s0021-9258(18)31744-7.
Metabolism

Accession ID: Reactome:R-CEL-1430728
-
Signaling by GPCR

Accession ID: Reactome:R-CFA-372790
  • 10.1002/cmdc.200600134
  • 10.1038/nrm2299
  • 10.1093/emboj/18.7.1723
Oldham WM, Hamm HE. Heterotrimeric G protein activation by G-protein-coupled receptors. Nature Reviews Molecular Cell Biology. 2008 Jan;9(1):60–71. doi: 10.1038/nrm2299.; Jacoby E, Bouhelal R, Gerspacher M, Seuwen K. The 7 TM G-protein-coupled receptor target family. ChemMedChem. 2006 Aug;1(8):761–82. doi: 10.1002/cmdc.200600134. PMID: 16902930.; Bockaert J, Pin JP. Molecular tinkering of G protein-coupled receptors: an evolutionary success. EMBO J. 1999 Apr 01;18(7):1723–9. PMID: 10202136; PMCID: PMC1171258.
Pyruvate metabolism

Accession ID: Reactome:R-CFA-70268
  • 10.1016/s0021-9258(19)38795-2
  • 10.3390/cells10040762
Prochownik EV, Wang H. The Metabolic Fates of Pyruvate in Normal and Neoplastic Cells. Cells. 2021 Mar 30;10(4). PMID: 33808495; PMCID: PMC8066905.; Reed LJ, Hackert ML. Structure-function relationships in dihydrolipoamide acyltransferases. Journal of Biological Chemistry. 1990 Jun;265(16):8971–4. doi: 10.1016/s0021-9258(19)38795-2.; Cori CF. The glucose-lactic acid cycle and gluconeogenesis. Curr Top Cell Regul. 1981;18():377–87. PMID: 7273846.
Class A/1 (Rhodopsin-like receptors)

Accession ID: Reactome:R-DRE-373076
  • 10.1002/cmdc.200600134
  • 10.1186/gb-2002-3-11-research0063
Jacoby E, Bouhelal R, Gerspacher M, Seuwen K. The 7 TM G-protein-coupled receptor target family. ChemMedChem. 2006 Aug;1(8):761–82. doi: 10.1002/cmdc.200600134. PMID: 16902930.; Joost P, Methner A. Phylogenetic analysis of 277 human G-protein-coupled receptors as a tool for the prediction of orphan receptor ligands. Genome Biology. 2002 Oct 17;3(11):research0063.1. doi: 10.1186/gb-2002-3-11-research0063.
Organic anion transport by SLC22 transporters

Accession ID: Reactome:R-DRE-561048
  • 10.1007/s00424-003-1089-9
  • 10.1007/s11095-006-9181-4
  • 10.1097/mnh.0b013e32830b5d5d
Ahn S, Bhatnagar V. Update on the molecular physiology of organic anion transporters. Current Opinion in Nephrology and Hypertension. 2008 Sep;17(5):499–505. doi: 10.1097/mnh.0b013e32830b5d5d.; Rizwan AN, Burckhardt G. Organic Anion Transporters of the SLC22 Family: Biopharmaceutical, Physiological, and Pathological Roles. Pharmaceutical Research. 2007 Jan 24;24(3):450–70. doi: 10.1007/s11095-006-9181-4.; Koepsell H, Endou H. The SLC22 drug transporter family. Pflügers Archiv - European Journal of Physiology. 2003 Jul 19;447(5):666–76. doi: 10.1007/s00424-003-1089-9.
Pyruvate metabolism

Accession ID: Reactome:R-DME-70268
  • 10.1016/s0021-9258(19)38795-2
  • 10.3390/cells10040762
Prochownik EV, Wang H. The Metabolic Fates of Pyruvate in Normal and Neoplastic Cells. Cells. 2021 Mar 30;10(4). PMID: 33808495; PMCID: PMC8066905.; Reed LJ, Hackert ML. Structure-function relationships in dihydrolipoamide acyltransferases. Journal of Biological Chemistry. 1990 Jun;265(16):8971–4. doi: 10.1016/s0021-9258(19)38795-2.; Cori CF. The glucose-lactic acid cycle and gluconeogenesis. Curr Top Cell Regul. 1981;18():377–87. PMID: 7273846.
Proton-coupled monocarboxylate transport

Accession ID: Reactome:R-GGA-433692
  • 10.1074/jbc.m411950200
  • 10.1208/s12248-008-9035-6
  • 10.14670/hh-24.243
Merezhinskaya N, Fishbein WN. Monocarboxylate transporters: past, present, and future. Histol Histopathol. 2009 Feb;24(2):243–64. doi: 10.14670/hh-24.243. PMID: 19085840.; Morris ME, Felmlee MA. Overview of the Proton-coupled MCT (SLC16A) Family of Transporters: Characterization, Function and Role in the Transport of the Drug of Abuse ?-Hydroxybutyric Acid. The AAPS Journal. 2008 Jun 04;10(2):311. doi: 10.1208/s12248-008-9035-6.; Wilson MC, Meredith D, Fox JE, Manoharan C, Davies AJ, Halestrap AP. Basigin (CD147) is the target for organomercurial inhibition of monocarboxylate transporter isoforms 1 and 4: the ancillary protein for the insensitive MCT2 is EMBIGIN (gp70). J Biol Chem. 2005 Jul 22;280(29):27213–21. doi: 10.1074/jbc.m411950200. PMID: 15917240.
Transport of small molecules

Accession ID: Reactome:R-HSA-382551
-
SLC-mediated transmembrane transport

Accession ID: Reactome:R-HSA-425407
  • 10.1006/abbi.1999.1213
  • 10.1007/s00424-003-1064-5
  • 10.1007/s00424-003-1089-9
  • 10.1007/s00424-003-1168-y
  • 10.1007/s00424-003-1192-y
  • 10.1007/s00424-005-1487-2
  • 10.1016/j.febslet.2015.03.012
  • 10.1016/j.mam.2012.07.010
  • 10.1016/s0021-9258(18)31744-7
  • 10.1073/pnas.94.7.2897
  • 10.1079/bjn2002763
  • 10.1097/mnh.0b013e3282e7d7d0
  • 10.1111/j.1471-4159.2004.02962.x
  • 10.1152/physiol.00037.2007
  • 10.1152/physrev.00044.2006
  • 10.1177/0960327107070573
  • 10.1186/1479-7364-3-2-195
  • 10.1208/s12248-008-9035-6
  • 10.1590/s0100-879x2006000900002
Schneider S. Inositol transport proteins. FEBS Lett. 2015 Apr 28;589(10):1049–58. doi: 10.1016/j.febslet.2015.03.012. PMID: 25819438.; Anderson CM, Stahl A. SLC27 fatty acid transport proteins. Molecular Aspects of Medicine. 2013 Apr;34(2-3):516–28. doi: 10.1016/j.mam.2012.07.010.; He L, Vasiliou K, Nebert DW. Analysis and update of the human solute carrier (SLC) gene superfamily. Hum Genomics. 2009 Jan;3(2):195–206. PMID: 19164095; PMCID: PMC2752037.; Morris ME, Felmlee MA. Overview of the Proton-coupled MCT (SLC16A) Family of Transporters: Characterization, Function and Role in the Transport of the Drug of Abuse ?-Hydroxybutyric Acid. The AAPS Journal. 2008 Jun 04;10(2):311. doi: 10.1208/s12248-008-9035-6.; Dorwart MR, Shcheynikov N, Yang D, Muallem S. The solute carrier 26 family of proteins in epithelial ion transport. Physiology (Bethesda). 2008 Apr;23():104–14. doi: 10.1152/physiol.00037.2007. PMID: 18400693.; Ashmore J. Cochlear outer hair cell motility. Physiol Rev. 2008 Jan;88(1):173–210. doi: 10.1152/physrev.00044.2006. PMID: 18195086.; Sindic A, Chang MH, Mount DB, Romero MF. Renal physiology of SLC26 anion exchangers. Curr Opin Nephrol Hypertens. 2007 Sep;16(5):484–90. doi: 10.1097/mnh.0b013e3282e7d7d0. PMID: 17693766.; Bressler JP, Olivi L, Cheong JH, Kim Y, Maerten A, Bannon D. Metal transporters in intestine and brain: their involvement in metal-associated neurotoxicities. Hum Exp Toxicol. 2007 Mar;26(3):221–9. doi: 10.1177/0960327107070573. PMID: 17439925.; Handford M, Rodriguez-Furlán C, Orellana A. Nucleotide-sugar transporters: structure, function and roles in vivo. Braz J Med Biol Res. 2006 Sep;39(9):1149–58. doi: 10.1590/s0100-879x2006000900002. PMID: 16981043.; Pajor AM. Molecular properties of the SLC13 family of dicarboxylate and sulfate transporters. Pflügers Archiv - European Journal of Physiology. 2005 Oct 07;451(5):597–605. doi: 10.1007/s00424-005-1487-2.; Traiffort E, Ruat M, O'Regan S, Meunier FM. Molecular characterization of the family of choline transporter-like proteins and their splice variants. Journal of Neurochemistry. 2005 Feb 04;92(5):1116–25. doi: 10.1111/j.1471-4159.2004.02962.x.; Koepsell H, Endou H. The SLC22 drug transporter family. Pflügers Archiv - European Journal of Physiology. 2003 Jul 19;447(5):666–76. doi: 10.1007/s00424-003-1089-9.; Hediger MA, Romero MF, Peng J, Rolfs A, Takanaga H, Bruford EA. The ABCs of solute carriers: physiological, pathological and therapeutic implications of human membrane transport proteins. Pflügers Archiv - European Journal of Physiology. 2003 Nov 18;447(5):465–8. doi: 10.1007/s00424-003-1192-y.; Hagenbuch B, Meier PJ. Organic anion transporting polypeptides of the OATP/ SLC21 family: phylogenetic classification as OATP/ SLCO superfamily, new nomenclature and molecular/functional properties. Pfl?gers Archiv European Journal of Physiology. 2004 Feb 01;447(5):653–65. doi: 10.1007/s00424-003-1168-y.; Chen N, Reith MEA, Quick MW. Synaptic uptake and beyond: the sodium- and chloride-dependent neurotransmitter transporter family SLC6. Pflügers Archiv - European Journal of Physiology. 2003 Apr 29;447(5):519–31. doi: 10.1007/s00424-003-1064-5.; Wood IS, Trayhurn P. Glucose transporters (GLUT and SGLT): expanded families of sugar transport proteins. Br J Nutr. 2003 Jan;89(1):3–9. doi: 10.1079/bjn2002763. PMID: 12568659.; Prasad PD, Wang H, Huang W, Fei YJ, Leibach FH, Devoe LD, Ganapathy V. Molecular and functional characterization of the intestinal Na+-dependent multivitamin transporter. Arch Biochem Biophys. 1999 Jun 01;366(1):95–106. doi: 10.1006/abbi.1999.1213. PMID: 10334869.; Kanamori A, Nakayama J, Fukuda MN, Stallcup WB, Sasaki K, Fukuda M, Hirabayashi Y. Expression cloning and characterization of a cDNA encoding a novel membrane protein required for the formation of O -acetylated ganglioside: A putative acetyl-CoA transporter. Proc. Natl. Acad. Sci. U.S.A. 1997 Apr;94(7):2897–902. doi: 10.1073/pnas.94.7.2897.; Olives B, Neau P, Bailly P, Hediger MA, Rousselet G, Cartron JP, Ripoche P. Cloning and functional expression of a urea transporter from human bone marrow cells. Journal of Biological Chemistry. 1994 Dec;269(50):31649–52. doi: 10.1016/s0021-9258(18)31744-7.
Metabolism

Accession ID: Reactome:R-HSA-1430728
  • 10.1002/jcph.371
  • 10.1006/geno.1998.5606
  • 10.1006/jmbi.2001.4680
  • 10.1016/j.addr.2008.02.014
  • 10.1016/j.bbagen.2016.01.024
  • 10.1016/j.bbalip.2010.01.013
  • 10.1016/j.bbalip.2010.08.002
  • 10.1016/j.bbrc.2012.05.094
  • 10.1016/j.molcel.2021.06.027
  • 10.1016/j.pharmthera.2016.10.018
  • 10.1016/s0006-291x(02)00623-x
  • 10.1016/s0021-9258(18)90095-5
  • 10.1016/s0021-9258(19)36611-6
  • 10.1016/s0021-9258(19)77281-0
  • 10.1021/bi002249z
  • 10.1021/tx980144f
  • 10.1073/pnas.1607003113
  • 10.1073/pnas.79.2.325
  • 10.1073/pnas.92.21.9475
  • 10.1073/pnas.93.16.8612
  • 10.1074/jbc.273.40.26138
  • 10.1074/jbc.274.52.37125
  • 10.1074/jbc.m002863200
  • 10.1074/jbc.m112.355206
  • 10.1074/jbc.m700915200
  • 10.1083/jcb.201211110
  • 10.1084/jem.20081880
  • 10.1091/mbc.e03-06-0385
  • 10.1096/fj.14-268441
  • 10.1107/s2053230x13033591
  • 10.1111/j.1432-1033.1996.0132u.x
  • 10.1124/jpet.107.134593
  • 10.1124/jpet.110.173195
  • 10.1128/mcb.01636-07
  • 10.1152/physiolgenomics.90211.2008
  • 10.1159/000134427
  • 10.1172/jci117597
  • 10.1172/jci2890
  • 10.1177/0091270011405664
  • 10.1371/journal.pgen.1000133
  • 10.3109/03602539808996323
  • 10.3109/10409238909082552
  • 10.3389/fimmu.2015.00043
  • 10.3390/biology12050686
Gao J, Shen W. Sirtuin-3-Mediated Cellular Metabolism Links Cardiovascular Remodeling with Hypertension. Biology (Basel). 2023 May 06;12(5). PMID: 37237500; PMCID: PMC10215109.; Chen D, Xia S, Zhang R, Li Y, Famulare CA, Fan H, Wu R, Wang M, Zhu AC, Elf SE, Su R, Dong L, Arellano M, Blum WG, Mao H, Lonial S, Stock W, Odenike O, Le Beau M, Boggon TJ, He C, Chen J, Gao X, Levine RL, Chen J. Lysine acetylation restricts mutant IDH2 activity to optimize transformation in AML cells. Molecular Cell. 2021 Sep;81(18):3833–3847.e11. doi: 10.1016/j.molcel.2021.06.027.; James MO, Jahn SC, Zhong G, Smeltz MG, Hu Z, Stacpoole PW. Therapeutic applications of dichloroacetate and the role of glutathione transferase zeta-1. Pharmacology & Therapeutics. 2017 Feb;170():166–80. doi: 10.1016/j.pharmthera.2016.10.018.; Dalli J, Vlasakov I, Riley IR, Rodriguez AR, Spur BW, Petasis NA, Chiang N, Serhan CN. Maresin conjugates in tissue regeneration biosynthesis enzymes in human macrophages. Proc Natl Acad Sci U S A. 2016 Oct 25;113(43):12232–7. PMID: 27791009; PMCID: PMC5087052.; Jahn SC, Solayman MHM, Lorenzo RJ, Langaee T, Stacpoole PW, James MO. GSTZ1 expression and chloride concentrations modulate sensitivity of cancer cells to dichloroacetate. Biochimica et Biophysica Acta (BBA) - General Subjects. 2016 Jun;1860(6):1202–10. doi: 10.1016/j.bbagen.2016.01.024.; Dalli J, Ramon S, Norris PC, Colas RA, Serhan CN. Novel proresolving and tissue-regenerative resolvin and protectin sulfido-conjugated pathways. The FASEB Journal. 2015 Feb 20;29(5):2120–36. doi: 10.1096/fj.14-268441.; Siiskonen H, Oikari S, Pasonen-Seppänen S, Rilla K. Hyaluronan Synthase 1: A Mysterious Enzyme with Unexpected Functions. Front. Immunol. 2015 Feb 05;6(). doi: 10.3389/fimmu.2015.00043.; Shroads AL, Coats BS, McDonough CW, Langaee T, Stacpoole PW. Haplotype variations in glutathione transferase zeta 1 influence the kinetics and dynamics of chronic dichloroacetate in children. The Journal of Clinical Pharma. 2014 Aug 06;55(1):50–5. doi: 10.1002/jcph.371.; Boone CD, Zhong G, Smeltz M, James MO, McKenna R. Preliminary X-ray crystallographic analysis of glutathione transferase zeta 1 (GSTZ1a-1a). Acta Crystallogr F Struct Biol Commun. 2014 Feb;70(Pt 2):187–9. PMID: 24637752; PMCID: PMC3936459.; Shah M, Baterina OY, Taupin V, Farquhar MG. ARH directs megalin to the endocytic recycling compartment to regulate its proteolysis and gene expression. J Cell Biol. 2013 Jul 08;202(1):113–27. PMID: 23836931; PMCID: PMC3704979.; Harada N, Fujimoto E, Okuyama M, Sakaue H, Nakaya Y. Identification and functional characterization of human glycerol-3-phosphate acyltransferase 1 gene promoters. Biochemical and Biophysical Research Communications. 2012 Jun;423(1):128–33. doi: 10.1016/j.bbrc.2012.05.094.; Shroads AL, Langaee T, Coats BS, Kurtz TL, Bullock JR, Weithorn D, Gong Y, Wagner DA, Ostrov DA, Johnson JA, Stacpoole PW. Human Polymorphisms in the Glutathione Transferase Zeta 1/Maleylacetoacetate Isomerase Gene Influence the Toxicokinetics of Dichloroacetate. The Journal of Clinical Pharma. 2012 Jun;52(6):837–49. doi: 10.1177/0091270011405664.; Yu W, Dittenhafer-Reed KE, Denu JM. SIRT3 Protein Deacetylates Isocitrate Dehydrogenase 2 (IDH2) and Regulates Mitochondrial Redox Status. Journal of Biological Chemistry. 2012 Apr;287(17):14078–86. doi: 10.1074/jbc.m112.355206.; Li W, James MO, McKenzie SC, Calcutt NA, Liu C, Stacpoole PW. Mitochondrion as a Novel Site of Dichloroacetate Biotransformation by Glutathione Transferase ?1. The Journal of Pharmacology and Experimental Therapeutics. 2011 Jan;336(1):87–94. doi: 10.1124/jpet.110.173195.; Bannenberg G, Serhan CN. Specialized pro-resolving lipid mediators in the inflammatory response: An update. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 2010 Dec;1801(12):1260–73. doi: 10.1016/j.bbalip.2010.08.002.; Schiavoni G, Bennati AM, Castelli M, Fazia MAD, Beccari T, Servillo G, Roberti R. Activation of TM7SF2 promoter by SREBP-2 depends on a new sterol regulatory element, a GC-box, and an inverted CCAAT-box. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 2010 May;1801(5):587–92. doi: 10.1016/j.bbalip.2010.01.013.; Serhan CN, Yang R, Martinod K, Kasuga K, Pillai PS, Porter TF, Oh SF, Spite M. Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions. J Exp Med. 2009 Jan 16;206(1):15–23. PMID: 19103881; PMCID: PMC2626672.; Stacpoole PW, Kurtz TL, Han Z, Langaee T. Role of dichloroacetate in the treatment of genetic mitochondrial diseases. Advanced Drug Delivery Reviews. 2008 Oct;60(13-14):1478–87. doi: 10.1016/j.addr.2008.02.014.; Rome S, Lecomte V, Meugnier E, Rieusset J, Debard C, Euthine V, Vidal H, Lefai E. Microarray analyses of SREBP-1a and SREBP-1c target genes identify new regulatory pathways in muscle. Physiol Genomics. 2008 Aug 15;34(3):327–37. doi: 10.1152/physiolgenomics.90211.2008. PMID: 18559965.; Reed BD, Charos AE, Szekely AM, Weissman SM, Snyder M. Genome-Wide Occupancy of SREBP1 and Its Partners NFY and SP1 Reveals Novel Functional Roles and Combinatorial Regulation of Distinct Classes of Genes. PLoS Genet. 2008 Jul 25;4(7):e1000133. doi: 10.1371/journal.pgen.1000133.; Shroads AL, Guo X, Dixit V, Liu H, James MO, Stacpoole PW. Age-Dependent Kinetics and Metabolism of Dichloroacetate: Possible Relevance to Toxicity. The Journal of Pharmacology and Experimental Therapeutics. 2008 Mar;324(3):1163–71. doi: 10.1124/jpet.107.134593.; Lombard DB, Alt FW, Cheng H, Bunkenborg J, Streeper RS, Mostoslavsky R, Kim J, Yancopoulos G, Valenzuela D, Murphy A, Yang Y, Chen Y, Hirschey MD, Bronson RT, Haigis M, Guarente LP, Farese RV, Weissman S, Verdin E, Schwer B. Mammalian Sir2 Homolog SIRT3 Regulates Global Mitochondrial Lysine Acetylation. Molecular and Cellular Biology. 2007 Dec 01;27(24):8807–14. doi: 10.1128/mcb.01636-07.; Schulz T, Schumacher U, Prehm P: Hyaluronan export by the ABC transporter MRP5 and its modulation by intracellular cGMP. J Biol Chem. 2007 Jul 20;282(29):20999-1004. doi: 10.1074/jbc.M700915200. Epub 2007 May 31.; Nagai M, Meerloo T, Takeda T, Farquhar MG. The adaptor protein ARH escorts megalin to and through endosomes. Mol Biol Cell. 2003 Dec;14(12):4984–96. PMID: 14528014; PMCID: PMC284800.; Nagai M, Sakakibara J, Nakamura Y, Gejyo F, Ono T. SREBP-2 and NF-Y are involved in the transcriptional regulation of squalene epoxidase. Biochemical and Biophysical Research Communications. 2002 Jul;295(1):74–80. doi: 10.1016/s0006-291x(02)00623-x.; Read J, Pearce J, Li X, Muirhead H, Chirgwin J, Davies C. The crystal structure of human phosphoglucose isomerase at 1.6 A resolution: implications for catalytic mechanism, cytokine activity and haemolytic anaemia. J Mol Biol. 2001 Jun 01;309(2):447–63. doi: 10.1006/jmbi.2001.4680. PMID: 11371164.; Polekhina G, Board PG, Blackburn AC, Parker MW. Crystal structure of maleylacetoacetate isomerase/glutathione transferase zeta reveals the molecular basis for its remarkable catalytic promiscuity. Biochemistry. 2001 Feb 13;40(6):1567–76. doi: 10.1021/bi002249z. PMID: 11327815.; Clish CB, Levy BD, Chiang N, Tai HH, Serhan CN. Oxidoreductases in lipoxin A4 metabolic inactivation: a novel role for 15-onoprostaglandin 13-reductase/leukotriene B4 12-hydroxydehydrogenase in inflammation. J Biol Chem. 2000 Aug 18;275(33):25372–80. doi: 10.1074/jbc.m002863200. PMID: 10837478.; Shiota C, Coffey J, Grimsby J, Grippo JF, Magnuson MA. Nuclear Import of Hepatic Glucokinase Depends upon Glucokinase Regulatory Protein, whereas Export Is Due to a Nuclear Export Signal Sequence in Glucokinase. Journal of Biological Chemistry. 1999 Dec;274(52):37125–30. doi: 10.1074/jbc.274.52.37125.; Gåfvels M, Olin M, Chowdhary BP, Raudsepp T, Andersson U, Persson B, Jansson M, Björkhem I, Eggertsen G. Structure and chromosomal assignment of the sterol 12alpha-hydroxylase gene (CYP8B1) in human and mouse: eukaryotic cytochrome P-450 gene devoid of introns. Genomics. 1999 Mar 01;56(2):184–96. doi: 10.1006/geno.1998.5606. PMID: 10051404.; Tong Z, Board PG, Anders MW. Glutathione transferase zeta-catalyzed biotransformation of dichloroacetic acid and other alpha-haloacids. Chem Res Toxicol. 1998 Nov;11(11):1332–8. doi: 10.1021/tx980144f. PMID: 9815194.; Pai J, Guryev O, Brown MS, Goldstein JL. Differential Stimulation of Cholesterol and Unsaturated Fatty Acid Biosynthesis in Cells Expressing Individual Nuclear Sterol Regulatory Element-binding Proteins. Journal of Biological Chemistry. 1998 Oct;273(40):26138–48. doi: 10.1074/jbc.273.40.26138.; Orho M, Bosshard NU, Buist NR, Gitzelmann R, Aynsley-Green A, Blümel P, Gannon MC, Nuttall FQ, Groop LC. Mutations in the liver glycogen synthase gene in children with hypoglycemia due to glycogen storage disease type 0. J Clin Invest. 1998 Aug 01;102(3):507–15. PMID: 9691087; PMCID: PMC508911.; Stacpoole PW, Henderson GN, Yan Z, Cornett R, James MO. Pharmacokinetics, metabolism and toxicology of dichloroacetate. Drug Metab Rev. 1998 Aug;30(3):499–539. doi: 10.3109/03602539808996323. PMID: 9710704.; Moestrup SK, Birn H, Fischer PB, Petersen CM, Verroust PJ, Sim RB, Christensen EI, Nexø E. Megalin-mediated endocytosis of transcobalamin-vitamin-B12 complexes suggests a role of the receptor in vitamin-B12 homeostasis. Proc. Natl. Acad. Sci. U.S.A. 1996 Aug 06;93(16):8612–7. doi: 10.1073/pnas.93.16.8612.; Hjälm G, Murray E, Crumley G, Harazim W, Lundgren S, Onyango I, Ek B, Larsson M, Juhlin C, Hellman P, Davis H, Åkerström G, Rask L, Morse B. Cloning and Sequencing of Human gp330, a Ca2+-Binding Receptor with Potential Intracellular Signaling Properties. European Journal of Biochemistry. 1996 Jul;239(1):132–7. doi: 10.1111/j.1432-1033.1996.0132u.x.; Matsushima M, Inazawa J, Takahashi E, Suzumori K, Nakamura Y. Molecular cloning and mapping of a human cDNA (SC5DL) encoding a protein homologous to fungal sterol-C5-desaturase. Cytogenet Cell Genet. 1996;74(4):252–4. doi: 10.1159/000134427. PMID: 8976377.; Clària J, Serhan CN. Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions. Proc. Natl. Acad. Sci. U.S.A. 1995 Oct 10;92(21):9475–9. doi: 10.1073/pnas.92.21.9475.; Kounnas MZ, Loukinova EB, Stefansson S, Harmony JAK, Brewer BH, Strickland DK, Argraves WS. Identification of glycoprotein 330 as an endocytic receptor for apolipoprotein J/clusterin. Journal of Biological Chemistry. 1995 Sep;270(39):23234a. doi: 10.1016/s0021-9258(18)90095-5.; Xu W, Beutler E. The characterization of gene mutations for human glucose phosphate isomerase deficiency associated with chronic hemolytic anemia. J Clin Invest. 1994 Dec;94(6):2326–9. PMID: 7989588; PMCID: PMC330061.; Ishida H, Noshiro M, Okuda K, Coon MJ. Purification and characterization of 7 alpha-hydroxy-4-cholesten-3-one 12 alpha-hydroxylase. Journal of Biological Chemistry. 1992 Oct;267(30):21319–23. doi: 10.1016/s0021-9258(19)36611-6.; Newgard CB, Hwang PK, Fletterick RJ. The Family of Glycogen Phosphorylases: Structure and Functio. Critical Reviews in Biochemistry and Molecular Biology. 1989 Jan;24(1):69–99. doi: 10.3109/10409238909082552.; Chen YT, He JK, Ding JH, Brown BI. Glycogen debranching enzyme: purification, antibody characterization, and immunoblot analyses of type III glycogen storage disease. Am J Hum Genet. 1987 Dec;41(6):1002–15. PMID: 2961257; PMCID: PMC1684360.; Furuya E, Yokoyama M, Uyeda K. Regulation of fructose-6-phosphate 2-kinase by phosphorylation and dephosphorylation: possible mechanism for coordinated control of glycolysis and glycogenolysis. Proc Natl Acad Sci U S A. 1982 Jan;79(2):325–9. PMID: 6281764; PMCID: PMC345719.; TSUBOI KK, ESTRADA J, HUDSON PB. Enzymes of the human erythrocyte. IV. Phosphoglucose isomerase, purification and properties. J Biol Chem. 1958 Mar;231(1):19–29. PMID: 13538944.
Signaling Pathways

Accession ID: Reactome:R-HSA-162582
  • 10.1001/jamaneurol.2017.3859
  • 10.1002/(sici)1096-8628(19991229)89:4<218::aid-ajmg6>3.0.co;2-e
  • 10.1002/(sici)1096-9136(199706)14:2+3.0.co;2-4
  • 10.1002/(sici)1097-0215(19991126)83:5<640::aid-ijc13>3.0.co;2-d
  • 10.1002/(sici)1098-2396(200002)35:2<79::aid-syn1>3.0.co;2-x
  • 10.1002/1097-0169(200011)47:3<174::aid-cm2>3.0.co;2-n
  • 10.1002/1097-4652(200101)186:1<35::aid-jcp1003>3.0.co;2-x
  • 10.1002/14651858.cd001750.pub4
  • 10.1002/14651858.cd002095.pub5
  • 10.1002/14651858.cd005262.pub3
  • 10.1002/14651858.cd007990.pub3
  • 10.1002/1521-1878(200101)23:1<3::aid-bies1001>3.0.co;2-f
  • 10.1002/ajmg.a.32944
  • 10.1002/ajmg.a.37781
  • 10.1002/anie.201102965
  • 10.1002/anie.201102967
  • 10.1002/ardp.200800174
  • 10.1002/bies.20757
  • 10.1002/bies.20822
  • 10.1002/bip.20420
  • 10.1002/cam4.2455
  • 10.1002/cam4.3627
  • 10.1002/clc.4960131104
  • 10.1002/clc.4960150109
  • 10.1002/cm.20342
  • 10.1002/cm.20472
  • 10.1002/cm.21560
  • 10.1002/cne.10532
  • 10.1002/cphy.c140007
  • 10.1002/dneu.22427
  • 10.1002/dvdy.20037
  • 10.1002/dvdy.21246
  • 10.1002/dvdy.21991
  • 10.1002/dvdy.22046
  • 10.1002/dvdy.22130
  • 10.1002/dvdy.22199
  • 10.1002/dvdy.602
  • 10.1002/dvg.20299
  • 10.1002/eji.200323787
  • 10.1002/eji.200324772
  • 10.1002/eji.200535716
  • 10.1002/embj.201386399
  • 10.1002/gcc.2870080408
  • 10.1002/hep.21259
  • 10.1002/hep.22293
  • 10.1002/hep.28507
  • 10.1002/humu.22688
  • 10.1002/ibd.20225
  • 10.1002/ibd.23023
  • 10.1002/ijc.23131
  • 10.1002/iub.1078
  • 10.1002/j.1460-2075.1984.tb01904.x
  • 10.1002/j.1460-2075.1987.tb02733.x
  • 10.1002/j.1460-2075.1988.tb03042.x
  • 10.1002/j.1460-2075.1990.tb07454.x
  • 10.1002/j.1460-2075.1991.tb07784.x
  • 10.1002/j.1460-2075.1992.tb05182.x
  • 10.1002/j.1460-2075.1992.tb05484.x
  • 10.1002/j.1460-2075.1993.tb05879.x
  • 10.1002/j.1460-2075.1993.tb06225.x
  • 10.1002/j.1460-2075.1994.tb06361.x
  • 10.1002/j.1460-2075.1994.tb06424.x
  • 10.1002/j.1460-2075.1994.tb06577.x
  • 10.1002/j.1460-2075.1995.tb00101.x
  • 10.1002/j.1460-2075.1995.tb00173.x
  • 10.1002/j.1460-2075.1995.tb00245.x
  • 10.1002/j.1460-2075.1995.tb00280.x
  • 10.1002/j.1460-2075.1995.tb07002.x
  • 10.1002/j.1460-2075.1995.tb07076.x
  • 10.1002/j.1460-2075.1995.tb07279.x
  • 10.1002/j.1460-2075.1995.tb07316.x
  • 10.1002/j.1460-2075.1996.tb00356.x
  • 10.1002/j.1460-2075.1996.tb00471.x
  • 10.1002/j.1460-2075.1996.tb00539.x
  • 10.1002/j.1460-2075.1996.tb00571.x
  • 10.1002/j.1460-2075.1996.tb00602.x
  • 10.1002/j.1460-2075.1996.tb00603.x
  • 10.1002/j.1460-2075.1996.tb00663.x
  • 10.1002/j.1460-2075.1996.tb01013.x
  • 10.1002/j.1875-9114.1982.tb04521.x
  • 10.1002/j.1875-9114.1983.tb03252.x
  • 10.1002/j.1875-9114.1988.tb03543.x
  • 10.1002/jbmr.282
  • 10.1002/jcb.10140
  • 10.1002/jcb.20257
  • 10.1002/jcb.20344
  • 10.1002/jcb.20459
  • 10.1002/jcb.22690
  • 10.1002/jcb.24635
  • 10.1002/jcp.10279
  • 10.1002/jcp.1116
  • 10.1002/jcp.20839
  • 10.1002/jcp.21560
  • 10.1002/jcp.22335
  • 10.1002/jcp.24531
  • 10.1002/jcp.24596
  • 10.1002/jcp.31265
  • 10.1002/jlb.66.3.521
  • 10.1002/jnr.1175
  • 10.1002/mc.20087
  • 10.1002/mc.20389
  • 10.1002/mds.27740
  • 10.1002/mrd.10066
  • 10.1002/path.4123
  • 10.1002/pro.5560060704
  • 10.1002/pros.22974
  • 10.1002/prot.24523
  • 10.1002/prp2.356
  • 10.1002/prp2.631
  • 10.1002/psc.747
  • 10.1002/rcm.2783
  • 10.1002/stem.561
  • 10.1006/abio.1997.2208
  • 10.1006/abio.2000.4795
  • 10.1006/bbrc.1993.1403
  • 10.1006/bbrc.1993.1451
  • 10.1006/bbrc.1993.1610
  • 10.1006/bbrc.1993.1658
  • 10.1006/bbrc.1993.2027
  • 10.1006/bbrc.1993.2122
  • 10.1006/bbrc.1993.2130
  • 10.1006/bbrc.1993.2423
  • 10.1006/bbrc.1993.2662
  • 10.1006/bbrc.1994.1142
  • 10.1006/bbrc.1994.1349
  • 10.1006/bbrc.1994.1613
  • 10.1006/bbrc.1994.2049
  • 10.1006/bbrc.1994.2726
  • 10.1006/bbrc.1994.2852
  • 10.1006/bbrc.1996.0739
  • 10.1006/bbrc.1996.0959
  • 10.1006/bbrc.1996.1132
  • 10.1006/bbrc.1996.1288
  • 10.1006/bbrc.1996.1553
  • 10.1006/bbrc.1996.6039
  • 10.1006/bbrc.1997.6150
  • 10.1006/bbrc.1997.6161
  • 10.1006/bbrc.1997.6895
  • 10.1006/bbrc.1997.7272
  • 10.1006/bbrc.1997.7719
  • 10.1006/bbrc.1997.7982
  • 10.1006/bbrc.1998.9489
  • 10.1006/bbrc.1999.0379
  • 10.1006/bbrc.1999.1760
  • 10.1006/bbrc.2000.2223
  • 10.1006/bbrc.2000.2610
  • 10.1006/bbrc.2000.2920
  • 10.1006/bbrc.2000.3225
  • 10.1006/bbrc.2000.3275
  • 10.1006/bbrc.2000.3354
  • 10.1006/bbrc.2000.3469
  • 10.1006/bbrc.2000.3760
  • 10.1006/bbrc.2000.4008
  • 10.1006/bbrc.2000.4089
  • 10.1006/bbrc.2000.4160
  • 10.1006/bbrc.2001.4521
  • 10.1006/bbrc.2001.5022
  • 10.1006/bbrc.2001.5102
  • 10.1006/bbrc.2001.5307
  • 10.1006/bbrc.2001.5512
  • 10.1006/bbrc.2001.5791
  • 10.1006/bbrc.2001.5939
  • 10.1006/bbrc.2002.6406
  • 10.1006/bbrc.2002.6528
  • 10.1006/cimm.1997.1208
  • 10.1006/cimm.2001.1851
  • 10.1006/cyto.2001.0871
  • 10.1006/dbio.1996.8463
  • 10.1006/dbio.1999.9335
  • 10.1006/excr.1996.0045
  • 10.1006/excr.1999.4671
  • 10.1006/excr.2000.5046
  • 10.1006/excr.2000.5076
  • 10.1006/excr.2001.5295
  • 10.1006/excr.2002.5576
  • 10.1006/exnr.1999.7148
  • 10.1006/frne.1995.1013
  • 10.1006/geno.1993.1141
  • 10.1006/geno.1993.1345
  • 10.1006/geno.1994.1553
  • 10.1006/geno.1994.1613
  • 10.1006/geno.1995.1109
  • 10.1006/geno.1995.1180
  • 10.1006/geno.1995.9996
  • 10.1006/geno.1997.4713
  • 10.1006/geno.1997.5069
  • 10.1006/geno.1998.5655
  • 10.1006/geno.1999.5758
  • 10.1006/geno.1999.5992
  • 10.1006/geno.2000.6212
  • 10.1006/geno.2001.6650
  • 10.1006/geno.2002.6771
  • 10.1006/jmbi.1999.3318
  • 10.1006/mcne.1995.1015
  • 10.1006/mcne.1996.0052
  • 10.1006/mcne.1999.0799
  • 10.1006/mgme.1999.2840
  • 10.1006/mvre.1999.2144
  • 10.1006/prep.1995.1062
  • 10.1007/82_2010_40
  • 10.1007/978-1-4419-1145-2_2
  • 10.1007/978-1-4615-2904-0_5
  • 10.1007/978-1-60761-738-9_7
  • 10.1007/978-3-642-23274-9_13
  • 10.1007/978-3-642-23274-9_15
  • 10.1007/978-3-642-25761-2_3
  • 10.1007/bf00542125
  • 10.1007/bf00849254
  • 10.1007/bf00928361
  • 10.1007/bf02245606
  • 10.1007/bf03259892
  • 10.1007/pl00005000
  • 10.1007/pl00005139
  • 10.1007/pl00005159
  • 10.1007/s00018-003-3165-x
  • 10.1007/s00018-004-4189-6
  • 10.1007/s00018-005-4533-5
  • 10.1007/s00018-008-8006-5
  • 10.1007/s00018-009-0086-3
  • 10.1007/s00018-010-0496-2
  • 10.1007/s00018-010-0520-6
  • 10.1007/s00018-012-1186-z
  • 10.1007/s00018-012-1189-9
  • 10.1007/s00134-004-2417-z
  • 10.1007/s00210-006-0083-0
  • 10.1007/s00210-007-0131-4
  • 10.1007/s002130100844
  • 10.1007/s00251-003-0625-2
  • 10.1007/s00408-004-2518-z
  • 10.1007/s00412-012-0392-7
  • 10.1007/s00418-002-0440-0
  • 10.1007/s004240000462
  • 10.1007/s00431-021-04022-1
  • 10.1007/s00439-011-1078-6
  • 10.1007/s00439-019-02018-4
  • 10.1007/s00441-009-0822-x
  • 10.1007/s00441-017-2641-9
  • 10.1007/s00520-006-0180-0
  • 10.1007/s00702-011-0763-x
  • 10.1007/s100380070012
  • 10.1007/s10059-010-0004-4
  • 10.1007/s10254-005-0004-0
  • 10.1007/s10286-011-0118-6
  • 10.1007/s10439-015-1442-0
  • 10.1007/s10456-009-9141-9
  • 10.1007/s10456-012-9275-z
  • 10.1007/s10540-004-7191-1
  • 10.1007/s10549-005-1483-4
  • 10.1007/s10637-015-0205-y
  • 10.1007/s10822-015-9858-z
  • 10.1007/s11010-012-1438-0
  • 10.1007/s11064-005-6868-6
  • 10.1007/s11064-017-2274-0
  • 10.1007/s11154-006-9000-6
  • 10.1007/s11596-007-0328-2
  • 10.1007/s11892-019-1188-4
  • 10.1007/s12022-015-9388-1
  • 10.1007/s12035-015-9164-8
  • 10.1007/s13148-010-0018-y
  • 10.1007/s13277-015-4502-z
  • 10.1007/s40120-017-0078-4
  • 10.1007/s40123-018-0128-8
  • 10.1007/s40256-014-0081-4
  • 10.1007/s40261-015-0311-9
  • 10.1007/s40263-019-00665-9
  • 10.1007/s40265-014-0333-2
  • 10.1007/s40265-018-0928-0
  • 10.1007/s40265-018-0977-4
  • 10.1007/s40265-020-01300-4
  • 10.1016/0002-8703(85)90702-1
  • 10.1016/0002-8703(85)90709-4
  • 10.1016/0002-9149(85)91036-7
  • 10.1016/0002-9149(89)91203-4
  • 10.1016/0002-9378(94)90415-4
  • 10.1016/0003-9861(91)90593-8
  • 10.1016/0005-2736(96)00039-9
  • 10.1016/0006-291x(84)90278-x
  • 10.1016/0006-291x(89)92727-7
  • 10.1016/0006-291x(90)91143-g
  • 10.1016/0006-291x(90)91552-4
  • 10.1016/0006-291x(91)91047-g
  • 10.1016/0006-291x(91)91682-3
  • 10.1016/0006-291x(91)91704-g
  • 10.1016/0006-291x(91)91944-8
  • 10.1016/0006-291x(92)90483-2
  • 10.1016/0006-291x(92)90629-y
  • 10.1016/0006-291x(92)90654-4
  • 10.1016/0006-291x(92)90685-e
  • 10.1016/0006-291x(92)91187-u
  • 10.1016/0006-291x(92)91285-x
  • 10.1016/0006-291x(92)91556-6
  • 10.1016/0006-291x(92)91557-7
  • 10.1016/0006-2952(91)90502-v
  • 10.1016/0006-8993(82)91048-4
  • 10.1016/0014-2999(95)00639-7
  • 10.1016/0014-5793(81)80952-0
  • 10.1016/0014-5793(84)81114-x
  • 10.1016/0014-5793(85)80069-7
  • 10.1016/0014-5793(85)80820-6
  • 10.1016/0014-5793(86)81534-4
  • 10.1016/0014-5793(88)80427-7
  • 10.1016/0014-5793(91)80585-q
  • 10.1016/0014-5793(93)81509-x
  • 10.1016/0014-5793(94)00475-7
  • 10.1016/0014-5793(94)00878-7
  • 10.1016/0014-5793(94)80235-1
  • 10.1016/0014-5793(94)80368-4
  • 10.1016/0014-5793(94)80590-3
  • 10.1016/0014-5793(95)00093-o
  • 10.1016/0014-5793(95)01006-z
  • 10.1016/0014-5793(95)01207-u
  • 10.1016/0014-5793(95)01351-2
  • 10.1016/0014-5793(95)01368-7
  • 10.1016/0014-5793(96)00368-7
  • 10.1016/0014-5793(96)01004-6
  • 10.1016/0024-3205(82)90374-5
  • 10.1016/0024-3205(94)90138-4
  • 10.1016/0024-3205(96)00423-7
  • 10.1016/0028-3908(94)00129-g
  • 10.1016/0028-3908(94)00149-m
  • 10.1016/0028-3908(96)84622-3
  • 10.1016/0031-9384(94)90369-7
  • 10.1016/0049-3848(90)90148-6
  • 10.1016/0076-6879(95)56011-4
  • 10.1016/0090-6980(90)90078-a
  • 10.1016/0092-8674(86)90783-x
  • 10.1016/0092-8674(88)90017-7
  • 10.1016/0092-8674(88)90485-0
  • 10.1016/0092-8674(89)90048-2
  • 10.1016/0092-8674(89)90054-8
  • 10.1016/0092-8674(90)90150-d
  • 10.1016/0092-8674(90)90294-o
  • 10.1016/0092-8674(90)90657-z
  • 10.1016/0092-8674(90)90697-d
  • 10.1016/0092-8674(91)90111-b
  • 10.1016/0092-8674(91)90124-h
  • 10.1016/0092-8674(91)90396-g
  • 10.1016/0092-8674(91)90419-y
  • 10.1016/0092-8674(91)90442-2
  • 10.1016/0092-8674(91)90556-e
  • 10.1016/0092-8674(91)90628-c
  • 10.1016/0092-8674(92)90165-9
  • 10.1016/0092-8674(92)90395-s
  • 10.1016/0092-8674(92)90444-h
  • 10.1016/0092-8674(93)90118-a
  • 10.1016/0092-8674(93)90132-a
  • 10.1016/0092-8674(93)90237-k
  • 10.1016/0092-8674(93)90368-z
  • 10.1016/0092-8674(93)90390-c
  • 10.1016/0092-8674(93)90489-d
  • 10.1016/0092-8674(93)90666-e
  • 10.1016/0092-8674(94)90070-1
  • 10.1016/0092-8674(94)90112-0
  • 10.1016/0092-8674(94)90259-3
  • 10.1016/0092-8674(94)90318-2
  • 10.1016/0092-8674(94)90400-6
  • 10.1016/0092-8674(94)90425-1
  • 10.1016/0092-8674(95)90070-5
  • 10.1016/0092-8674(95)90192-2
  • 10.1016/0092-8674(95)90204-x
  • 10.1016/0092-8674(95)90205-8
  • 10.1016/0092-8674(95)90206-6
  • 10.1016/0092-8674(95)90455-7
  • 10.1016/0167-4889(94)00198-n
  • 10.1016/0169-328x(94)90047-7
  • 10.1016/0197-0186(94)90079-5
  • 10.1016/0303-7207(96)03814-2
  • 10.1016/0304-3940(90)90832-t
  • 10.1016/0378-1119(93)90495-o
  • 10.1016/0888-7543(95)80009-b
  • 10.1016/0896-6273(88)90190-0
  • 10.1016/0896-6273(89)90261-4
  • 10.1016/0896-6273(92)90209-v
  • 10.1016/0896-6273(93)90306-c
  • 10.1016/0896-6273(94)90027-2
  • 10.1016/0896-6273(94)90055-8
  • 10.1016/0896-6273(95)90299-6
  • 10.1016/0898-6568(95)00017-j
  • 10.1016/0898-6568(95)02056-x
  • 10.1016/0922-4106(92)90123-d
  • 10.1016/0922-4106(93)90092-n
  • 10.1016/0922-4106(94)90042-6
  • 10.1016/0950-3528(93)90030-v
  • 10.1016/0960-0760(91)90199-f
  • 10.1016/0960-0760(94)90197-x
  • 10.1016/1043-2760(95)00179-4
  • 10.1016/b978-0-12-381298-8.00007-1
  • 10.1016/b978-0-12-394592-1.00006-5
  • 10.1016/b978-0-12-394592-1.00008-9
  • 10.1016/b978-0-12-394622-5.00004-3
  • 10.1016/b978-0-12-394622-5.00005-5
  • 10.1016/b978-0-12-405943-6.00005-1
  • 10.1016/j.ab.2004.01.022
  • 10.1016/j.abb.2006.06.011
  • 10.1016/j.abb.2010.06.004
  • 10.1016/j.abb.2010.07.014
  • 10.1016/j.ajhg.2011.07.001
  • 10.1016/j.ajo.2006.06.068
  • 10.1016/j.ajo.2012.09.032
  • 10.1016/j.ajpath.2013.02.043
  • 10.1016/j.amjmed.2020.01.031
  • 10.1016/j.anclin.2017.01.009
  • 10.1016/j.atherosclerosis.2006.04.018
  • 10.1016/j.atherosclerosis.2010.04.025
  • 10.1016/j.atherosclerosis.2017.10.025
  • 10.1016/j.bbadis.2012.11.010
  • 10.1016/j.bbagen.2005.04.002
  • 10.1016/j.bbagrm.2012.08.011
  • 10.1016/j.bbagrm.2014.12.011
  • 10.1016/j.bbalip.2006.05.001
  • 10.1016/j.bbalip.2011.05.004
  • 10.1016/j.bbalip.2011.06.013
  • 10.1016/j.bbalip.2012.02.004
  • 10.1016/j.bbalip.2012.08.010
  • 10.1016/j.bbalip.2014.02.006
  • 10.1016/j.bbamcr.2006.02.009
  • 10.1016/j.bbamcr.2006.11.001
  • 10.1016/j.bbamcr.2006.12.002
  • 10.1016/j.bbamcr.2007.06.008
  • 10.1016/j.bbamcr.2007.11.015
  • 10.1016/j.bbamcr.2009.06.002
  • 10.1016/j.bbamcr.2013.01.015
  • 10.1016/j.bbamcr.2014.09.004
  • 10.1016/j.bbamcr.2016.06.004
  • 10.1016/j.bbamem.2006.09.020
  • 10.1016/j.bbapap.2013.06.004
  • 10.1016/j.bbcan.2006.09.001
  • 10.1016/j.bbrc.2003.09.102
  • 10.1016/j.bbrc.2003.11.124
  • 10.1016/j.bbrc.2004.02.014
  • 10.1016/j.bbrc.2004.02.129
  • 10.1016/j.bbrc.2004.06.037
  • 10.1016/j.bbrc.2004.09.153
  • 10.1016/j.bbrc.2005.08.025
  • 10.1016/j.bbrc.2005.08.055
  • 10.1016/j.bbrc.2005.11.108
  • 10.1016/j.bbrc.2005.12.003
  • 10.1016/j.bbrc.2006.03.163
  • 10.1016/j.bbrc.2006.06.175
  • 10.1016/j.bbrc.2006.09.172
  • 10.1016/j.bbrc.2007.02.156
  • 10.1016/j.bbrc.2007.04.069
  • 10.1016/j.bbrc.2007.10.052
  • 10.1016/j.bbrc.2008.01.069
  • 10.1016/j.bbrc.2008.04.145
  • 10.1016/j.bbrc.2008.08.099
  • 10.1016/j.bbrc.2008.10.074
  • 10.1016/j.bbrc.2008.10.088
  • 10.1016/j.bbrc.2009.04.076
  • 10.1016/j.bbrc.2009.04.109
  • 10.1016/j.bbrc.2009.06.139
  • 10.1016/j.bbrc.2009.07.087
  • 10.1016/j.bbrc.2010.07.092
  • 10.1016/j.bbrc.2010.08.111
  • 10.1016/j.bbrc.2011.04.116
  • 10.1016/j.bbrc.2011.11.145
  • 10.1016/j.bbrc.2012.12.024
  • 10.1016/j.bbrc.2013.01.046
  • 10.1016/j.bcp.2004.01.002
  • 10.1016/j.bcp.2006.09.010
  • 10.1016/j.bcp.2010.04.016
  • 10.1016/j.bcp.2012.12.024
  • 10.1016/j.bcp.2024.116480
  • 10.1016/j.biocel.2005.10.017
  • 10.1016/j.biocel.2006.07.005
  • 10.1016/j.biocel.2006.12.005
  • 10.1016/j.biocel.2008.06.006
  • 10.1016/j.biocel.2009.07.006
  • 10.1016/j.biocel.2009.10.017
  • 10.1016/j.biocel.2012.01.019
  • 10.1016/j.biocel.2012.07.026
  • 10.1016/j.biocel.2013.11.004
  • 10.1016/j.biocel.2015.08.005
  • 10.1016/j.biochi.2007.05.003
  • 10.1016/j.bioorg.2014.09.003
  • 10.1016/j.bios.2015.12.066
  • 10.1016/j.bmc.2013.05.021
  • 10.1016/j.bmcl.2004.06.078
  • 10.1016/j.bmcl.2016.03.104
  • 10.1016/j.bpj.2016.05.042
  • 10.1016/j.canlet.2005.06.007
  • 10.1016/j.canlet.2008.11.014
  • 10.1016/j.canlet.2012.12.013
  • 10.1016/j.canlet.2017.09.020
  • 10.1016/j.cardiores.2006.04.015
  • 10.1016/j.carrev.2016.10.005
  • 10.1016/j.cbi.2012.11.019
  • 10.1016/j.cca.2010.02.074
  • 10.1016/j.cca.2013.11.010
  • 10.1016/j.ccell.2015.08.002
  • 10.1016/j.ccell.2016.02.012
  • 10.1016/j.ccell.2019.04.006
  • 10.1016/j.ccr.2004.07.008
  • 10.1016/j.ccr.2008.08.004
  • 10.1016/j.ccr.2009.02.012
  • 10.1016/j.ccr.2009.03.020
  • 10.1016/j.ccr.2009.05.009
  • 10.1016/j.ccr.2011.08.016
  • 10.1016/j.ccr.2012.02.010
  • 10.1016/j.ccr.2014.03.011
  • 10.1016/j.ceb.2005.09.009
  • 10.1016/j.ceb.2008.01.009
  • 10.1016/j.ceb.2008.12.012
  • 10.1016/j.ceb.2009.02.002
  • 10.1016/j.ceb.2009.03.007
  • 10.1016/j.ceb.2010.10.007
  • 10.1016/j.cell.2004.06.027
  • 10.1016/j.cell.2004.09.019
  • 10.1016/j.cell.2004.09.039
  • 10.1016/j.cell.2004.10.012
  • 10.1016/j.cell.2004.10.032
  • 10.1016/j.cell.2005.01.033
  • 10.1016/j.cell.2005.05.008
  • 10.1016/j.cell.2005.11.038
  • 10.1016/j.cell.2005.12.037
  • 10.1016/j.cell.2006.01.053
  • 10.1016/j.cell.2006.02.040
  • 10.1016/j.cell.2006.02.049
  • 10.1016/j.cell.2006.03.028
  • 10.1016/j.cell.2006.03.044
  • 10.1016/j.cell.2006.03.045
  • 10.1016/j.cell.2006.04.009
  • 10.1016/j.cell.2006.07.037
  • 10.1016/j.cell.2006.09.039
  • 10.1016/j.cell.2006.11.039
  • 10.1016/j.cell.2006.11.040
  • 10.1016/j.cell.2006.11.047
  • 10.1016/j.cell.2006.11.050
  • 10.1016/j.cell.2007.05.028
  • 10.1016/j.cell.2007.05.041
  • 10.1016/j.cell.2007.05.055
  • 10.1016/j.cell.2007.06.009
  • 10.1016/j.cell.2008.01.052
  • 10.1016/j.cell.2008.02.047
  • 10.1016/j.cell.2008.05.034
  • 10.1016/j.cell.2008.09.002
  • 10.1016/j.cell.2008.10.051
  • 10.1016/j.cell.2008.11.044
  • 10.1016/j.cell.2009.01.042
  • 10.1016/j.cell.2009.02.025
  • 10.1016/j.cell.2009.03.025
  • 10.1016/j.cell.2009.03.043
  • 10.1016/j.cell.2009.03.045
  • 10.1016/j.cell.2009.07.051
  • 10.1016/j.cell.2009.09.035
  • 10.1016/j.cell.2010.02.024
  • 10.1016/j.cell.2010.04.007
  • 10.1016/j.cell.2010.07.041
  • 10.1016/j.cell.2010.11.034
  • 10.1016/j.cell.2010.12.003
  • 10.1016/j.cell.2011.02.003
  • 10.1016/j.cell.2011.07.008
  • 10.1016/j.cell.2011.09.029
  • 10.1016/j.cell.2011.12.014
  • 10.1016/j.cell.2012.07.032
  • 10.1016/j.cell.2012.11.024
  • 10.1016/j.cell.2012.12.026
  • 10.1016/j.cell.2013.07.046
  • 10.1016/j.cell.2013.11.049
  • 10.1016/j.cell.2014.02.051
  • 10.1016/j.cell.2014.08.027
  • 10.1016/j.cell.2014.09.019
  • 10.1016/j.cell.2014.09.051
  • 10.1016/j.cell.2015.10.041
  • 10.1016/j.cell.2016.02.067
  • 10.1016/j.cell.2017.06.009
  • 10.1016/j.cell.2018.03.051
  • 10.1016/j.cell.2018.03.067
  • 10.1016/j.cellsig.2004.09.012
  • 10.1016/j.cellsig.2005.08.004
  • 10.1016/j.cellsig.2006.04.002
  • 10.1016/j.cellsig.2006.07.020
  • 10.1016/j.cellsig.2007.03.009
  • 10.1016/j.cellsig.2007.07.016
  • 10.1016/j.cellsig.2007.10.002
  • 10.1016/j.cellsig.2007.12.015
  • 10.1016/j.cellsig.2008.01.012
  • 10.1016/j.cellsig.2008.11.013
  • 10.1016/j.cellsig.2009.01.009
  • 10.1016/j.cellsig.2009.02.024
  • 10.1016/j.cellsig.2009.04.008
  • 10.1016/j.cellsig.2009.11.021
  • 10.1016/j.cellsig.2010.02.005
  • 10.1016/j.cellsig.2010.05.010
  • 10.1016/j.cellsig.2010.09.009
  • 10.1016/j.cellsig.2010.12.003
  • 10.1016/j.cellsig.2011.05.006
  • 10.1016/j.cellsig.2011.12.027
  • 10.1016/j.cellsig.2013.03.003
  • 10.1016/j.cellsig.2013.04.009
  • 10.1016/j.cellsig.2013.05.011
  • 10.1016/j.cellsig.2013.11.023
  • 10.1016/j.cellsig.2016.04.008
  • 10.1016/j.cellsig.2016.05.002
  • 10.1016/j.cellsig.2016.07.001
  • 10.1016/j.cellsig.2018.03.009
  • 10.1016/j.cellsig.2019.05.004
  • 10.1016/j.celrep.2012.07.010
  • 10.1016/j.celrep.2013.01.004
  • 10.1016/j.celrep.2013.01.010
  • 10.1016/j.celrep.2015.08.050
  • 10.1016/j.celrep.2016.10.021
  • 10.1016/j.celrep.2018.03.098
  • 10.1016/j.celrep.2024.114942
  • 10.1016/j.chembiol.2008.07.006
  • 10.1016/j.chom.2013.06.006
  • 10.1016/j.cmet.2004.12.003
  • 10.1016/j.cmet.2005.01.002
  • 10.1016/j.cmet.2006.04.008
  • 10.1016/j.coph.2011.09.015
  • 10.1016/j.critrevonc.2003.09.003
  • 10.1016/j.ctrv.2012.12.003
  • 10.1016/j.cub.2003.10.004
  • 10.1016/j.cub.2003.10.031
  • 10.1016/j.cub.2004.06.054
  • 10.1016/j.cub.2004.11.011
  • 10.1016/j.cub.2005.02.053
  • 10.1016/j.cub.2005.04.062
  • 10.1016/j.cub.2005.05.054
  • 10.1016/j.cub.2005.09.014
  • 10.1016/j.cub.2005.09.050
  • 10.1016/j.cub.2006.07.066
  • 10.1016/j.cub.2007.11.068
  • 10.1016/j.cub.2008.02.006
  • 10.1016/j.cub.2009.06.046
  • 10.1016/j.cub.2012.01.014
  • 10.1016/j.cub.2012.03.064
  • 10.1016/j.cub.2015.07.045
  • 10.1016/j.cub.2020.03.042
  • 10.1016/j.cytogfr.2004.03.007
  • 10.1016/j.cytogfr.2004.03.011
  • 10.1016/j.cytogfr.2004.04.003
  • 10.1016/j.cytogfr.2005.01.001
  • 10.1016/j.cytogfr.2005.01.008
  • 10.1016/j.cytogfr.2006.04.004
  • 10.1016/j.cytogfr.2006.09.009
  • 10.1016/j.devcel.2004.05.019
  • 10.1016/j.devcel.2004.08.022
  • 10.1016/j.devcel.2005.01.001
  • 10.1016/j.devcel.2005.09.008
  • 10.1016/j.devcel.2005.09.010
  • 10.1016/j.devcel.2005.12.013
  • 10.1016/j.devcel.2005.12.014
  • 10.1016/j.devcel.2006.04.004
  • 10.1016/j.devcel.2006.05.004
  • 10.1016/j.devcel.2006.07.003
  • 10.1016/j.devcel.2006.10.003
  • 10.1016/j.devcel.2006.10.015
  • 10.1016/j.devcel.2007.04.019
  • 10.1016/j.devcel.2007.08.004
  • 10.1016/j.devcel.2007.12.003
  • 10.1016/j.devcel.2007.12.004
  • 10.1016/j.devcel.2008.03.006
  • 10.1016/j.devcel.2008.04.015
  • 10.1016/j.devcel.2008.10.004
  • 10.1016/j.devcel.2009.06.016
  • 10.1016/j.devcel.2010.02.015
  • 10.1016/j.devcel.2010.03.007
  • 10.1016/j.devcel.2011.01.001
  • 10.1016/j.devcel.2011.01.008
  • 10.1016/j.devcel.2011.04.017
  • 10.1016/j.devcel.2011.04.018
  • 10.1016/j.devcel.2011.05.007
  • 10.1016/j.devcel.2011.05.010
  • 10.1016/j.devcel.2011.09.003
  • 10.1016/j.devcel.2011.09.007
  • 10.1016/j.devcel.2011.11.002
  • 10.1016/j.devcel.2012.04.005
  • 10.1016/j.devcel.2012.04.007
  • 10.1016/j.devcel.2012.07.004
  • 10.1016/j.devcel.2014.01.021
  • 10.1016/j.devcel.2014.03.024
  • 10.1016/j.devcel.2014.05.011
  • 10.1016/j.devcel.2017.04.010
  • 10.1016/j.devcel.2019.04.031
  • 10.1016/j.diff.2012.06.004
  • 10.1016/j.ebiom.2019.08.001
  • 10.1016/j.ejca.2005.08.008
  • 10.1016/j.ejcb.2018.05.003
  • 10.1016/j.ejmech.2013.02.007
  • 10.1016/j.ejphar.2004.07.014
  • 10.1016/j.ejphar.2004.08.025
  • 10.1016/j.ejphar.2005.12.067
  • 10.1016/j.ejphar.2010.10.033
  • 10.1016/j.eururo.2017.12.022
  • 10.1016/j.exer.2008.02.011
  • 10.1016/j.exer.2010.08.013
  • 10.1016/j.exer.2011.03.001
  • 10.1016/j.exphem.2004.11.002
  • 10.1016/j.exphem.2015.12.002
  • 10.1016/j.febslet.2004.03.101
  • 10.1016/j.febslet.2004.04.048
  • 10.1016/j.febslet.2004.06.095
  • 10.1016/j.febslet.2004.09.081
  • 10.1016/j.febslet.2005.01.006
  • 10.1016/j.febslet.2005.01.040
  • 10.1016/j.febslet.2005.01.085
  • 10.1016/j.febslet.2006.05.008
  • 10.1016/j.febslet.2006.06.041
  • 10.1016/j.febslet.2006.10.054
  • 10.1016/j.febslet.2007.01.039
  • 10.1016/j.febslet.2008.06.030
  • 10.1016/j.febslet.2009.01.042
  • 10.1016/j.febslet.2010.09.020
  • 10.1016/j.febslet.2011.07.048
  • 10.1016/j.febslet.2012.03.068
  • 10.1016/j.febslet.2014.06.025
  • 10.1016/j.fertnstert.2020.02.114
  • 10.1016/j.fertnstert.2020.04.017
  • 10.1016/j.freeradbiomed.2009.07.023
  • 10.1016/j.gde.2005.12.006
  • 10.1016/j.gde.2006.12.011
  • 10.1016/j.gde.2012.04.003
  • 10.1016/j.gde.2013.04.008
  • 10.1016/j.gene.2004.01.010
  • 10.1016/j.gene.2004.03.003
  • 10.1016/j.gene.2004.05.007
  • 10.1016/j.gene.2015.05.074
  • 10.1016/j.humpath.2005.07.011
  • 10.1016/j.ijdevneu.2014.01.005
  • 10.1016/j.immuni.2007.12.003
  • 10.1016/j.intimp.2006.01.013
  • 10.1016/j.jaad.2019.06.1288
  • 10.1016/j.jacc.2008.03.055
  • 10.1016/j.jacc.2009.05.056
  • 10.1016/j.jaut.2011.05.013
  • 10.1016/j.jbior.2014.04.002
  • 10.1016/j.jbior.2016.05.001
  • 10.1016/j.jbiotec.2016.07.007
  • 10.1016/j.jclinane.2018.06.045
  • 10.1016/j.jhep.2005.10.031
  • 10.1016/j.jhep.2006.09.014
  • 10.1016/j.jhep.2010.11.035
  • 10.1016/j.jmb.2004.08.056
  • 10.1016/j.jmb.2004.12.048
  • 10.1016/j.jmb.2006.04.009
  • 10.1016/j.jmb.2006.04.064
  • 10.1016/j.jmb.2007.04.065
  • 10.1016/j.jmb.2007.10.050
  • 10.1016/j.jmb.2012.06.016
  • 10.1016/j.jns.2016.11.029
  • 10.1016/j.jns.2017.03.025
  • 10.1016/j.jnutbio.2011.07.007
  • 10.1016/j.jpurol.2019.12.012
  • 10.1016/j.jsb.2008.09.007
  • 10.1016/j.jsbmb.2017.05.005
  • 10.1016/j.juro.2013.02.104
  • 10.1016/j.lfs.2005.10.026
  • 10.1016/j.mam.2017.11.007
  • 10.1016/j.mce.2003.09.012
  • 10.1016/j.mce.2006.04.021
  • 10.1016/j.mce.2008.10.052
  • 10.1016/j.mce.2010.02.003
  • 10.1016/j.mce.2013.04.026
  • 10.1016/j.mce.2013.06.021
  • 10.1016/j.mce.2013.09.019
  • 10.1016/j.mce.2014.02.002
  • 10.1016/j.mce.2015.01.016
  • 10.1016/j.mce.2015.07.016
  • 10.1016/j.mcn.2003.10.024
  • 10.1016/j.mcn.2005.08.019
  • 10.1016/j.mcn.2007.07.004
  • 10.1016/j.mcn.2008.10.016
  • 10.1016/j.mehy.2020.109988
  • 10.1016/j.metabol.2020.154282
  • 10.1016/j.mod.2005.07.004
  • 10.1016/j.mod.2009.02.002
  • 10.1016/j.mod.2009.04.003
  • 10.1016/j.modgep.2004.05.004
  • 10.1016/j.molbrainres.2003.11.017
  • 10.1016/j.molcel.2004.07.003
  • 10.1016/j.molcel.2004.07.016
  • 10.1016/j.molcel.2004.08.001
  • 10.1016/j.molcel.2004.08.010
  • 10.1016/j.molcel.2004.10.014
  • 10.1016/j.molcel.2004.11.055
  • 10.1016/j.molcel.2005.03.008
  • 10.1016/j.molcel.2005.03.026
  • 10.1016/j.molcel.2005.04.002
  • 10.1016/j.molcel.2005.06.028
  • 10.1016/j.molcel.2005.10.022
  • 10.1016/j.molcel.2006.01.012
  • 10.1016/j.molcel.2006.01.022
  • 10.1016/j.molcel.2006.03.026
  • 10.1016/j.molcel.2006.03.027
  • 10.1016/j.molcel.2006.09.001
  • 10.1016/j.molcel.2007.02.017
  • 10.1016/j.molcel.2007.03.003
  • 10.1016/j.molcel.2007.05.010
  • 10.1016/j.molcel.2007.05.017
  • 10.1016/j.molcel.2008.01.020
  • 10.1016/j.molcel.2008.03.003
  • 10.1016/j.molcel.2008.03.011
  • 10.1016/j.molcel.2008.05.014
  • 10.1016/j.molcel.2008.05.025
  • 10.1016/j.molcel.2008.07.024
  • 10.1016/j.molcel.2008.10.023
  • 10.1016/j.molcel.2008.10.025
  • 10.1016/j.molcel.2009.01.025
  • 10.1016/j.molcel.2009.05.006
  • 10.1016/j.molcel.2009.09.022
  • 10.1016/j.molcel.2009.09.043
  • 10.1016/j.molcel.2009.10.013
  • 10.1016/j.molcel.2009.10.024
  • 10.1016/j.molcel.2009.10.028
  • 10.1016/j.molcel.2010.01.035
  • 10.1016/j.molcel.2010.03.009
  • 10.1016/j.molcel.2011.01.023
  • 10.1016/j.molcel.2011.01.028
  • 10.1016/j.molcel.2011.02.031
  • 10.1016/j.molcel.2011.05.014
  • 10.1016/j.molcel.2011.07.014
  • 10.1016/j.molcel.2011.10.020
  • 10.1016/j.molcel.2011.12.032
  • 10.1016/j.molcel.2012.12.002
  • 10.1016/j.molcel.2013.06.007
  • 10.1016/j.molcel.2013.08.021
  • 10.1016/j.molcel.2013.10.004
  • 10.1016/j.molcel.2015.01.025
  • 10.1016/j.molcel.2017.02.005
  • 10.1016/j.molcel.2020.08.006
  • 10.1016/j.molimm.2009.04.027
  • 10.1016/j.molonc.2008.05.004
  • 10.1016/j.molonc.2014.05.013
  • 10.1016/j.nbd.2012.11.004
  • 10.1016/j.neuint.2019.02.019
  • 10.1016/j.neulet.2015.02.010
  • 10.1016/j.neulet.2017.08.067
  • 10.1016/j.neures.2006.08.003
  • 10.1016/j.neuron.2004.08.005
  • 10.1016/j.neuron.2006.08.024
  • 10.1016/j.neuron.2006.08.033
  • 10.1016/j.neuron.2006.09.031
  • 10.1016/j.neuron.2007.10.005
  • 10.1016/j.neuron.2010.12.024
  • 10.1016/j.neuropharm.2016.07.003
  • 10.1016/j.ophtha.2018.04.040
  • 10.1016/j.pain.2011.02.044
  • 10.1016/j.pharmthera.2005.09.008
  • 10.1016/j.pharmthera.2005.12.002
  • 10.1016/j.pharmthera.2008.01.001
  • 10.1016/j.pharmthera.2018.06.016
  • 10.1016/j.phrs.2012.04.005
  • 10.1016/j.phrs.2012.11.007
  • 10.1016/j.phrs.2016.12.029
  • 10.1016/j.phrs.2018.01.021
  • 10.1016/j.phrs.2018.04.020
  • 10.1016/j.phrs.2019.01.039
  • 10.1016/j.placenta.2005.10.003
  • 10.1016/j.placenta.2007.04.006
  • 10.1016/j.pupt.2010.03.011
  • 10.1016/j.sbi.2013.04.002
  • 10.1016/j.semcdb.2014.05.002
  • 10.1016/j.semcdb.2017.09.023
  • 10.1016/j.steroids.2005.09.011
  • 10.1016/j.steroids.2007.12.003
  • 10.1016/j.steroids.2008.11.020
  • 10.1016/j.steroids.2009.10.007
  • 10.1016/j.steroids.2009.11.005
  • 10.1016/j.str.2005.07.019
  • 10.1016/j.str.2010.07.010
  • 10.1016/j.str.2011.06.003
  • 10.1016/j.str.2011.07.005
  • 10.1016/j.str.2013.05.006
  • 10.1016/j.str.2016.03.002
  • 10.1016/j.str.2019.02.001
  • 10.1016/j.tcb.2004.10.003
  • 10.1016/j.tcb.2009.05.008
  • 10.1016/j.tcb.2010.02.002
  • 10.1016/j.tcb.2010.12.005
  • 10.1016/j.tcb.2012.04.005
  • 10.1016/j.tcb.2015.02.004
  • 10.1016/j.tem.2010.01.004
  • 10.1016/j.tibs.2005.10.005
  • 10.1016/j.tibs.2011.07.001
  • 10.1016/j.tins.2009.11.005
  • 10.1016/j.tips.2005.01.007
  • 10.1016/j.tips.2006.04.003
  • 10.1016/j.tips.2010.12.006
  • 10.1016/j.tips.2012.03.013
  • 10.1016/j.visres.2008.03.010
  • 10.1016/j.ydbio.2004.01.022
  • 10.1016/j.ydbio.2005.05.014
  • 10.1016/j.ydbio.2005.08.050
  • 10.1016/j.ydbio.2006.04.004
  • 10.1016/j.ydbio.2006.09.001
  • 10.1016/j.ydbio.2007.03.011
  • 10.1016/j.ydbio.2007.11.026
  • 10.1016/j.ydbio.2008.10.020
  • 10.1016/j.ydbio.2008.11.009
  • 10.1016/j.ydbio.2009.04.009
  • 10.1016/j.ydbio.2009.06.008
  • 10.1016/j.ydbio.2009.08.019
  • 10.1016/j.ydbio.2009.10.025
  • 10.1016/j.ydbio.2010.01.003
  • 10.1016/j.ydbio.2011.04.029
  • 10.1016/j.ydbio.2011.08.008
  • 10.1016/j.ydbio.2011.11.003
  • 10.1016/j.ydbio.2012.05.007
  • 10.1016/j.yexcr.2003.12.002
  • 10.1016/j.yexcr.2003.12.004
  • 10.1016/j.yexcr.2004.01.008
  • 10.1016/j.yexcr.2004.05.029
  • 10.1016/j.yexcr.2004.07.003
  • 10.1016/j.yexcr.2004.08.020
  • 10.1016/j.yexcr.2004.10.001
  • 10.1016/j.yexcr.2005.11.012
  • 10.1016/j.yexcr.2006.03.013
  • 10.1016/j.yexcr.2006.09.006
  • 10.1016/j.yexcr.2006.10.033
  • 10.1016/j.yexcr.2006.11.017
  • 10.1016/j.yexcr.2007.05.027
  • 10.1016/j.yexcr.2007.08.021
  • 10.1016/j.yexcr.2007.10.029
  • 10.1016/j.yexcr.2008.05.010
  • 10.1016/j.yexcr.2008.09.005
  • 10.1016/j.yexcr.2009.10.018
  • 10.1016/j.yexcr.2011.05.014
  • 10.1016/j.yexcr.2012.06.012
  • 10.1016/j.yexcr.2013.03.021
  • 10.1016/j.yexcr.2014.03.017
  • 10.1016/j.yexcr.2015.02.008
  • 10.1016/j.yexcr.2015.02.023
  • 10.1016/j.yexcr.2017.10.032
  • 10.1016/j.ygcen.2004.12.018
  • 10.1016/j.ygeno.2004.11.010
  • 10.1016/j.yjmcc.2010.11.014
  • 10.1016/j.ymeth.2012.06.014
  • 10.1016/j.ymgme.2006.04.005
  • 10.1016/s0002-8703(99)70484-9
  • 10.1016/s0002-9149(99)80413-5
  • 10.1016/s0002-9343(84)80033-9
  • 10.1016/s0002-9394(99)00076-8
  • 10.1016/s0002-9440(10)63970-3
  • 10.1016/s0002-9440(10)65325-4
  • 10.1016/s0006-291x(02)00239-5
  • 10.1016/s0006-291x(02)00652-6
  • 10.1016/s0006-291x(03)00259-6
  • 10.1016/s0006-291x(03)00635-1
  • 10.1016/s0006-291x(05)80288-8
  • 10.1016/s0006-291x(05)81261-6
  • 10.1016/s0006-291x(05)81332-4
  • 10.1016/s0006-291x(86)80418-1
  • 10.1016/s0006-291x(88)80308-5
  • 10.1016/s0006-2952(02)00924-3
  • 10.1016/s0006-2952(02)01515-0
  • 10.1016/s0006-2952(97)00070-1
  • 10.1016/s0006-2952(97)00631-x
  • 10.1016/s0009-9120(98)00045-9
  • 10.1016/s0009-9236(96)90127-7
  • 10.1016/s0014-2999(01)01486-8
  • 10.1016/s0014-2999(03)01855-7
  • 10.1016/s0014-2999(97)01556-2
  • 10.1016/s0014-2999(98)00483-x
  • 10.1016/s0014-2999(98)00667-0
  • 10.1016/s0014-2999(98)00678-5
  • 10.1016/s0014-2999(98)00744-4
  • 10.1016/s0014-2999(99)00026-6
  • 10.1016/s0014-2999(99)00196-x
  • 10.1016/s0014-2999(99)00803-1
  • 10.1016/s0014-4827(02)00040-x
  • 10.1016/s0014-4827(03)00206-4
  • 10.1016/s0014-5793(00)01510-6
  • 10.1016/s0014-5793(01)03227-6
  • 10.1016/s0014-5793(02)03274-x
  • 10.1016/s0014-5793(03)00213-8
  • 10.1016/s0014-5793(03)00454-x
  • 10.1016/s0014-5793(03)01033-0
  • 10.1016/s0014-5793(03)01089-5
  • 10.1016/s0014-5793(03)01212-2
  • 10.1016/s0014-5793(03)01351-6
  • 10.1016/s0014-5793(03)01490-x
  • 10.1016/s0014-5793(04)00287-x
  • 10.1016/s0014-5793(97)00167-1
  • 10.1016/s0014-5793(97)00557-7
  • 10.1016/s0014-5793(97)00964-2
  • 10.1016/s0014-5793(97)01499-3
  • 10.1016/s0014-5793(98)00533-x
  • 10.1016/s0014-5793(98)01541-5
  • 10.1016/s0014-5793(99)00009-5
  • 10.1016/s0014-5793(99)00358-0
  • 10.1016/s0014-5793(99)01161-8
  • 10.1016/s0014-5793(99)01270-3
  • 10.1016/s0014-5793(99)01530-6
  • 10.1016/s0021-9258(17)30526-4
  • 10.1016/s0021-9258(17)31518-1
  • 10.1016/s0021-9258(17)31521-1
  • 10.1016/s0021-9258(17)31534-x
  • 10.1016/s0021-9258(17)31844-6
  • 10.1016/s0021-9258(17)31874-4
  • 10.1016/s0021-9258(17)32112-9
  • 10.1016/s0021-9258(17)32489-4
  • 10.1016/s0021-9258(17)32654-6
  • 10.1016/s0021-9258(17)35278-x
  • 10.1016/s0021-9258(17)35956-2
  • 10.1016/s0021-9258(17)36705-4
  • 10.1016/s0021-9258(17)37120-x
  • 10.1016/s0021-9258(17)37451-3
  • 10.1016/s0021-9258(17)37564-6
  • 10.1016/s0021-9258(17)37574-9
  • 10.1016/s0021-9258(17)37708-6
  • 10.1016/s0021-9258(17)38013-4
  • 10.1016/s0021-9258(17)38404-1
  • 10.1016/s0021-9258(17)39206-2
  • 10.1016/s0021-9258(17)39236-0
  • 10.1016/s0021-9258(17)39694-1
  • 10.1016/s0021-9258(17)40144-x
  • 10.1016/s0021-9258(17)40767-8
  • 10.1016/s0021-9258(17)41863-1
  • 10.1016/s0021-9258(17)41991-0
  • 10.1016/s0021-9258(17)42297-6
  • 10.1016/s0021-9258(17)42313-1
  • 10.1016/s0021-9258(17)42425-2
  • 10.1016/s0021-9258(17)42625-1
  • 10.1016/s0021-9258(17)45856-x
  • 10.1016/s0021-9258(17)46844-x
  • 10.1016/s0021-9258(18)32330-5
  • 10.1016/s0021-9258(18)35208-6
  • 10.1016/s0021-9258(18)35665-5
  • 10.1016/s0021-9258(18)37395-2
  • 10.1016/s0021-9258(18)37707-x
  • 10.1016/s0021-9258(18)37810-4
  • 10.1016/s0021-9258(18)37979-1
  • 10.1016/s0021-9258(18)37983-3
  • 10.1016/s0021-9258(18)39930-7
  • 10.1016/s0021-9258(18)41509-8
  • 10.1016/s0021-9258(18)42643-9
  • 10.1016/s0021-9258(18)43823-9
  • 10.1016/s0021-9258(18)46863-9
  • 10.1016/s0021-9258(18)47129-3
  • 10.1016/s0021-9258(18)47237-7
  • 10.1016/s0021-9258(18)47305-x
  • 10.1016/s0021-9258(18)47424-8
  • 10.1016/s0021-9258(18)51471-x
  • 10.1016/s0021-9258(18)51628-8
  • 10.1016/s0021-9258(18)53088-x
  • 10.1016/s0021-9258(18)53415-3
  • 10.1016/s0021-9258(18)53554-7
  • 10.1016/s0021-9258(18)53623-1
  • 10.1016/s0021-9258(18)53721-2
  • 10.1016/s0021-9258(18)54743-8
  • 10.1016/s0021-9258(18)55031-6
  • 10.1016/s0021-9258(18)55129-2
  • 10.1016/s0021-9258(18)55368-0
  • 10.1016/s0021-9258(18)55395-3
  • 10.1016/s0021-9258(18)66599-8
  • 10.1016/s0021-9258(18)67379-x
  • 10.1016/s0021-9258(18)67389-2
  • 10.1016/s0021-9258(18)67649-5
  • 10.1016/s0021-9258(18)68692-2
  • 10.1016/s0021-9258(18)68804-0
  • 10.1016/s0021-9258(18)81674-x
  • 10.1016/s0021-9258(18)82142-1
  • 10.1016/s0021-9258(18)82304-3
  • 10.1016/s0021-9258(18)92984-4
  • 10.1016/s0021-9258(18)98418-8
  • 10.1016/s0021-9258(18)99089-7
  • 10.1016/s0021-9258(19)36703-1
  • 10.1016/s0021-9258(19)37065-6
  • 10.1016/s0021-9258(19)37125-x
  • 10.1016/s0021-9258(19)37146-7
  • 10.1016/s0021-9258(19)38697-1
  • 10.1016/s0021-9258(19)38849-0
  • 10.1016/s0021-9258(19)39685-1
  • 10.1016/s0021-9258(19)40080-x
  • 10.1016/s0021-9258(19)49854-2
  • 10.1016/s0021-9258(19)50098-9
  • 10.1016/s0021-9258(19)57454-3
  • 10.1016/s0021-9258(19)61431-6
  • 10.1016/s0021-9258(19)61461-4
  • 10.1016/s0021-9258(19)64861-1
  • 10.1016/s0021-9258(19)74379-8
  • 10.1016/s0021-9258(19)74439-1
  • 10.1016/s0021-9258(19)76412-6
  • 10.1016/s0021-9258(20)30059-4
  • 10.1016/s0021-9258(20)80562-6
  • 10.1016/s0022-2836(03)00144-x
  • 10.1016/s0022-2836(03)00514-x
  • 10.1016/s0022-3476(75)80706-2
  • 10.1016/s0022-3476(83)80526-5
  • 10.1016/s0022-3565(24)29226-0
  • 10.1016/s0022-3565(24)36532-2
  • 10.1016/s0022-3565(24)37012-0
  • 10.1016/s0022-3565(24)37340-9
  • 10.1016/s0022-3565(24)37731-6
  • 10.1016/s0022-3565(25)11335-9
  • 10.1016/s0022-3565(25)22357-6
  • 10.1016/s0022-3565(25)39380-8
  • 10.1016/s0022-5347(01)66361-4
  • 10.1016/s0024-3205(96)00701-1
  • 10.1016/s0024-3205(99)00074-0
  • 10.1016/s0025-7125(02)00031-7
  • 10.1016/s0026-895x(24)09236-8
  • 10.1016/s0026-895x(24)12288-2
  • 10.1016/s0026-895x(24)12763-0
  • 10.1016/s0026-895x(24)23093-5
  • 10.1016/s0026-895x(24)23263-6
  • 10.1016/s0026-895x(24)26476-2
  • 10.1016/s0026-895x(24)26486-5
  • 10.1016/s0026-895x(25)08566-9
  • 10.1016/s0026-895x(25)08607-9
  • 10.1016/s0026-895x(25)08894-7
  • 10.1016/s0026-895x(25)09674-9
  • 10.1016/s0026-895x(25)09676-2
  • 10.1016/s0026-895x(25)10517-8
  • 10.1016/s0026-895x(25)15388-1
  • 10.1016/s0028-3908(02)00041-2
  • 10.1016/s0028-3908(02)00335-0
  • 10.1016/s0028-3908(96)00172-4
  • 10.1016/s0028-3908(97)00138-x
  • 10.1016/s0031-6997(24)01328-0
  • 10.1016/s0031-6997(24)01362-0
  • 10.1016/s0041-1345(03)00211-2
  • 10.1016/s0076-6879(03)64012-7
  • 10.1016/s0076-6879(05)03022-3
  • 10.1016/s0083-6729(01)62006-5
  • 10.1016/s0090-4295(99)80264-7
  • 10.1016/s0090-4295(99)80409-9
  • 10.1016/s0092-8674(00)00043-x
  • 10.1016/s0092-8674(00)00056-8
  • 10.1016/s0092-8674(00)00085-4
  • 10.1016/s0092-8674(00)00086-6
  • 10.1016/s0092-8674(00)00188-4
  • 10.1016/s0092-8674(00)00192-6
  • 10.1016/s0092-8674(00)00196-3
  • 10.1016/s0092-8674(00)80112-9
  • 10.1016/s0092-8674(00)80252-4
  • 10.1016/s0092-8674(00)80303-7
  • 10.1016/s0092-8674(00)80324-4
  • 10.1016/s0092-8674(00)80336-0
  • 10.1016/s0092-8674(00)80438-9
  • 10.1016/s0092-8674(00)80545-0
  • 10.1016/s0092-8674(00)80595-4
  • 10.1016/s0092-8674(00)80705-9
  • 10.1016/s0092-8674(00)80706-0
  • 10.1016/s0092-8674(00)80712-6
  • 10.1016/s0092-8674(00)80732-1
  • 10.1016/s0092-8674(00)80784-9
  • 10.1016/s0092-8674(00)80838-7
  • 10.1016/s0092-8674(00)80949-6
  • 10.1016/s0092-8674(00)81189-7
  • 10.1016/s0092-8674(00)81193-9
  • 10.1016/s0092-8674(00)81208-8
  • 10.1016/s0092-8674(00)81226-x
  • 10.1016/s0092-8674(00)81250-7
  • 10.1016/s0092-8674(00)81265-9
  • 10.1016/s0092-8674(00)81374-4
  • 10.1016/s0092-8674(00)81432-4
  • 10.1016/s0092-8674(00)81583-4
  • 10.1016/s0092-8674(00)81677-3
  • 10.1016/s0092-8674(00)81701-8
  • 10.1016/s0092-8674(00)81817-6
  • 10.1016/s0092-8674(00)81925-x
  • 10.1016/s0092-8674(01)00520-7
  • 10.1016/s0092-8674(01)00530-x
  • 10.1016/s0092-8674(01)00614-6
  • 10.1016/s0092-8674(02)00679-7
  • 10.1016/s0092-8674(02)00685-2
  • 10.1016/s0092-8674(02)00715-8
  • 10.1016/s0092-8674(02)00754-7
  • 10.1016/s0092-8674(02)00800-0
  • 10.1016/s0092-8674(02)00801-2
  • 10.1016/s0092-8674(02)00833-4
  • 10.1016/s0092-8674(02)00977-7
  • 10.1016/s0092-8674(03)00278-2
  • 10.1016/s0092-8674(03)00314-3
  • 10.1016/s0092-8674(03)00521-x
  • 10.1016/s0092-8674(03)00559-2
  • 10.1016/s0092-8674(03)00688-3
  • 10.1016/s0092-8674(03)00810-9
  • 10.1016/s0092-8674(03)00929-2
  • 10.1016/s0092-8674(03)00934-6
  • 10.1016/s0092-8674(04)00133-3
  • 10.1016/s0092-8674(04)00210-7
  • 10.1016/s0092-8674(04)00215-6
  • 10.1016/s0092-8674(05)80095-9
  • 10.1016/s0140-6736(04)17666-6
  • 10.1016/s0140-6736(08)61764-x
  • 10.1016/s0140-6736(09)61913-9
  • 10.1016/s0140-6736(19)31606-x
  • 10.1016/s0140-6736(64)91275-9
  • 10.1016/s0140-6736(99)04440-2
  • 10.1016/s0149-2918(03)90091-9
  • 10.1016/s0149-2918(99)80052-6
  • 10.1016/s0165-0173(98)00018-6
  • 10.1016/s0165-6147(00)88988-9
  • 10.1016/s0166-2236(98)01343-5
  • 10.1016/s0167-0115(99)00028-2
  • 10.1016/s0167-4781(00)00066-x
  • 10.1016/s0167-4781(00)00094-4
  • 10.1016/s0167-4781(00)00207-4
  • 10.1016/s0167-4781(00)00215-3
  • 10.1016/s0167-4781(00)00260-8
  • 10.1016/s0167-4781(01)00283-4
  • 10.1016/s0167-4781(02)00529-8
  • 10.1016/s0167-4781(02)00546-8
  • 10.1016/s0167-4889(96)00159-0
  • 10.1016/s0167-4889(99)00164-0
  • 10.1016/s0168-9525(00)02028-x
  • 10.1016/s0169-328x(97)00277-5
  • 10.1016/s0169-328x(98)00116-8
  • 10.1016/s0169-409x(02)00154-0
  • 10.1016/s0300-9084(01)01263-9
  • 10.1016/s0300-9084(01)01301-3
  • 10.1016/s0301-0082(03)00019-4
  • 10.1016/s0301-472x(03)00002-x
  • 10.1016/s0303-7207(00)00379-8
  • 10.1016/s0303-7207(01)00720-1
  • 10.1016/s0303-7207(03)00255-7
  • 10.1016/s0304-3835(03)00009-0
  • 10.1016/s0304-3835(98)00146-3
  • 10.1016/s0304-3940(00)01692-x
  • 10.1016/s0304-419x(98)00015-8
  • 10.1016/s0378-1119(00)00161-x
  • 10.1016/s0378-1119(01)00518-2
  • 10.1016/s0378-1119(01)00651-5
  • 10.1016/s0378-1119(02)01106-x
  • 10.1016/s0378-1119(96)00456-8
  • 10.1016/s0378-1119(96)00633-6
  • 10.1016/s0893-133x(01)00285-8
  • 10.1016/s0896-6273(00)80395-5
  • 10.1016/s0896-6273(00)80543-7
  • 10.1016/s0896-6273(00)80591-7
  • 10.1016/s0896-6273(00)81176-9
  • 10.1016/s0896-6273(01)00275-6
  • 10.1016/s0896-6273(02)00750-x
  • 10.1016/s0896-6273(02)00942-x
  • 10.1016/s0896-6273(02)01168-6
  • 10.1016/s0898-6568(02)00076-1
  • 10.1016/s0898-6568(99)00076-5
  • 10.1016/s0925-4773(00)00459-7
  • 10.1016/s0925-4773(02)00120-x
  • 10.1016/s0960-0760(00)00037-6
  • 10.1016/s0960-0760(00)00104-7
  • 10.1016/s0960-9822(00)00359-6
  • 10.1016/s0960-9822(00)00535-2
  • 10.1016/s0960-9822(00)00868-x
  • 10.1016/s0960-9822(01)00225-1
  • 10.1016/s0960-9822(01)00290-1
  • 10.1016/s0960-9822(01)00506-1
  • 10.1016/s0960-9822(01)00603-0
  • 10.1016/s0960-9822(02)00423-2
  • 10.1016/s0960-9822(02)00658-9
  • 10.1016/s0960-9822(02)00895-3
  • 10.1016/s0960-9822(02)00933-8
  • 10.1016/s0960-9822(02)01387-8
  • 10.1016/s0960-9822(02)70786-0
  • 10.1016/s0960-9822(03)00053-8
  • 10.1016/s0960-9822(03)00086-1
  • 10.1016/s0960-9822(03)00418-4
  • 10.1016/s0960-9822(03)00506-2
  • 10.1016/s0960-9822(03)00535-9
  • 10.1016/s0960-9822(03)00568-2
  • 10.1016/s0960-9822(06)00052-2
  • 10.1016/s0960-9822(06)00122-9
  • 10.1016/s0960-9822(95)00080-7
  • 10.1016/s0960-9822(98)00017-7
  • 10.1016/s0960-9822(98)70082-x
  • 10.1016/s0960-9822(98)70227-1
  • 10.1016/s0960-9822(98)70274-x
  • 10.1016/s0960-9822(98)70300-8
  • 10.1016/s0960-9822(98)70302-1
  • 10.1016/s0960-9822(98)70468-3
  • 10.1016/s0960-9822(99)80018-9
  • 10.1016/s0960-9822(99)80041-4
  • 10.1016/s0960-9822(99)80164-x
  • 10.1016/s0960-9822(99)80310-8
  • 10.1016/s0960-9822(99)80332-7
  • 10.1016/s0960-9822(99)80447-3
  • 10.1016/s0968-0004(99)01442-5
  • 10.1016/s0968-0004(99)01539-x
  • 10.1016/s0969-2126(01)00679-7
  • 10.1016/s0969-2126(03)00096-0
  • 10.1016/s0969-2126(94)00125-1
  • 10.1016/s1043-2760(00)00362-3
  • 10.1016/s1043-2760(98)00136-2
  • 10.1016/s1050-1738(01)00072-x
  • 10.1016/s1074-7613(00)80019-9
  • 10.1016/s1074-7613(00)80273-3
  • 10.1016/s1074-7613(00)80501-4
  • 10.1016/s1074-7613(01)00230-8
  • 10.1016/s1074-7613(03)00270-x
  • 10.1016/s1096-4959(03)00046-0
  • 10.1016/s1097-2765(00)00053-8
  • 10.1016/s1097-2765(00)00087-3
  • 10.1016/s1097-2765(00)00134-9
  • 10.1016/s1097-2765(00)80019-2
  • 10.1016/s1097-2765(00)80120-3
  • 10.1016/s1097-2765(00)80200-2
  • 10.1016/s1097-2765(00)80201-4
  • 10.1016/s1097-2765(00)80375-5
  • 10.1016/s1097-2765(00)80389-5
  • 10.1016/s1097-2765(00)80399-8
  • 10.1016/s1097-2765(01)00224-6
  • 10.1016/s1097-2765(01)00323-9
  • 10.1016/s1097-2765(01)00369-0
  • 10.1016/s1097-2765(01)00378-1
  • 10.1016/s1097-2765(01)00383-5
  • 10.1016/s1097-2765(01)00393-8
  • 10.1016/s1097-2765(01)00417-8
  • 10.1016/s1097-2765(01)00421-x
  • 10.1016/s1097-2765(01)00428-2
  • 10.1016/s1097-2765(02)00428-8
  • 10.1016/s1097-2765(02)00434-3
  • 10.1016/s1097-2765(02)00468-9
  • 10.1016/s1097-2765(02)00631-7
  • 10.1016/s1097-2765(02)00637-8
  • 10.1016/s1097-2765(02)00689-5
  • 10.1016/s1097-2765(03)00220-x
  • 10.1016/s1097-2765(03)00234-x
  • 10.1016/s1097-2765(03)00406-4
  • 10.1016/s1097-2765(03)00426-x
  • 10.1016/s1097-2765(03)00427-1
  • 10.1016/s1097-2765(03)00484-2
  • 10.1016/s1097-2765(04)00050-4
  • 10.1016/s1357-2725(99)00078-3
  • 10.1016/s1388-1981(99)00164-x
  • 10.1016/s1474-4422(13)70225-4
  • 10.1016/s1474-4422(14)70209-1
  • 10.1016/s1474-4422(15)00249-5
  • 10.1016/s1534-5807(01)00035-1
  • 10.1016/s1534-5807(01)00092-2
  • 10.1016/s1534-5807(02)00140-5
  • 10.1016/s1534-5807(02)00180-6
  • 10.1016/s1534-5807(02)00364-7
  • 10.1016/s1534-5807(02)00409-4
  • 10.1016/s1534-5807(03)00394-0
  • 10.1016/s1535-6108(02)00045-4
  • 10.1016/s1535-6108(03)00085-0
  • 10.1016/s1535-6108(04)00083-2
  • 10.1017/s0022215100099151
  • 10.1017/s0033583506004306
  • 10.1021/acs.jmedchem.0c01093
  • 10.1021/acs.jmedchem.5b00067
  • 10.1021/acs.jmedchem.5b01372
  • 10.1021/acs.jmedchem.6b00389
  • 10.1021/acs.jmedchem.7b01306
  • 10.1021/acsmedchemlett.8b00220
  • 10.1021/bi00050a029
  • 10.1021/bi00121a035
  • 10.1021/bi00135a001
  • 10.1021/bi00176a021
  • 10.1021/bi00248a022
  • 10.1021/bi00356a023
  • 10.1021/bi00409a016
  • 10.1021/bi011953s
  • 10.1021/bi026020q
  • 10.1021/bi0363275
  • 10.1021/bi0472954
  • 10.1021/bi047443q
  • 10.1021/bi050560g
  • 10.1021/bi200039u
  • 10.1021/bi301688g
  • 10.1021/bi400987k
  • 10.1021/bi401216w
  • 10.1021/bi700833h
  • 10.1021/bi900667y
  • 10.1021/bi952182t
  • 10.1021/bi952950g
  • 10.1021/bi952961+
  • 10.1021/bi9602268
  • 10.1021/bi963100j
  • 10.1021/bi9718447
  • 10.1021/bi9803675
  • 10.1021/bi981254o
  • 10.1021/bi9818265
  • 10.1021/bi982054f
  • 10.1021/cr0002801
  • 10.1021/ja305518h
  • 10.1021/ja3096416
  • 10.1021/ja407147d
  • 10.1021/ja512204s
  • 10.1021/jm000170m
  • 10.1021/jm00140a001
  • 10.1021/jm031115r
  • 10.1021/jm040793q
  • 10.1021/jm049039v
  • 10.1021/jm049486a
  • 10.1021/jm101459g
  • 10.1021/jm200216q
  • 10.1021/jm200249a
  • 10.1021/jm3013147
  • 10.1021/jm400778d
  • 10.1021/jm500847m
  • 10.1021/jm8006454
  • 10.1021/jm9700068
  • 10.1021/jm980179c
  • 10.1021/jm980462b
  • 10.1021/jm9805945
  • 10.1021/jm990550b
  • 10.1021/ml300396r
  • 10.1021/pr0502065
  • 10.1021/pr060382t
  • 10.1021/pr200685r
  • 10.1023/a:1005417926585
  • 10.1023/a:1006806722619
  • 10.1023/a:1006808100755
  • 10.1023/a:1006883311233
  • 10.1023/a:1011907328682
  • 10.1023/a:1020557502795
  • 10.1024/0301-1526/a000845
  • 10.1034/j.1600-0463.2001.090503.x
  • 10.1034/j.1600-065x.2003.00008.x
  • 10.1034/j.1600-0854.2002.30504.x
  • 10.1038/11921
  • 10.1038/12867
  • 10.1038/12963
  • 10.1038/17611
  • 10.1038/17826
  • 10.1038/21658
  • 10.1038/21666
  • 10.1038/21674
  • 10.1038/22313
  • 10.1038/22321
  • 10.1038/236385a0
  • 10.1038/24184
  • 10.1038/25354
  • 10.1038/25533
  • 10.1038/27454
  • 10.1038/28548
  • 10.1038/295663a0
  • 10.1038/297431a0
  • 10.1038/301069a0
  • 10.1038/302832a0
  • 10.1038/30515
  • 10.1038/30666
  • 10.1038/308746a0
  • 10.1038/308850a0
  • 10.1038/310503a0
  • 10.1038/311666a0
  • 10.1038/31940
  • 10.1038/32660
  • 10.1038/334494a0
  • 10.1038/33451
  • 10.1038/34657
  • 10.1038/347072a0
  • 10.1038/349117a0
  • 10.1038/349614a0
  • 10.1038/35004513
  • 10.1038/35006129
  • 10.1038/35007072
  • 10.1038/35010008
  • 10.1038/35010517
  • 10.1038/35015579
  • 10.1038/35017011
  • 10.1038/35017038
  • 10.1038/35017080
  • 10.1038/35019000
  • 10.1038/35019075
  • 10.1038/35019553
  • 10.1038/35019649
  • 10.1038/35023008
  • 10.1038/35035117
  • 10.1038/35035131
  • 10.1038/35051599
  • 10.1038/35060032
  • 10.1038/35060104
  • 10.1038/350610a0
  • 10.1038/350614a0
  • 10.1038/35070009
  • 10.1038/35074516
  • 10.1038/35077108
  • 10.1038/35078562
  • 10.1038/35079135
  • 10.1038/35083081
  • 10.1038/35088082
  • 10.1038/356431a0
  • 10.1038/356526a0
  • 10.1038/356663a0
  • 10.1038/358681a0
  • 10.1038/363085a0
  • 10.1038/365061a0
  • 10.1038/367040a0
  • 10.1038/370341a0
  • 10.1038/370527a0
  • 10.1038/37138
  • 10.1038/371419a0
  • 10.1038/371423a0
  • 10.1038/373441a0
  • 10.1038/373699a0
  • 10.1038/373702a0
  • 10.1038/375338a0
  • 10.1038/376599a0
  • 10.1038/376768a0
  • 10.1038/376781a0
  • 10.1038/377355a0
  • 10.1038/38008
  • 10.1038/382638a0
  • 10.1038/383691a0
  • 10.1038/383707a0
  • 10.1038/383728a0
  • 10.1038/383832a0
  • 10.1038/384129a0
  • 10.1038/384173a0
  • 10.1038/384176a0
  • 10.1038/384427a0
  • 10.1038/385169a0
  • 10.1038/38520
  • 10.1038/385640a0
  • 10.1038/387512a0
  • 10.1038/39369
  • 10.1038/414799a
  • 10.1038/415339a
  • 10.1038/4156
  • 10.1038/416183a
  • 10.1038/416187a
  • 10.1038/416438a
  • 10.1038/416759a
  • 10.1038/417295a
  • 10.1038/42506
  • 10.1038/43466
  • 10.1038/43686
  • 10.1038/43705
  • 10.1038/43830
  • 10.1038/45230
  • 10.1038/45251
  • 10.1038/45809
  • 10.1038/70302
  • 10.1038/70496
  • 10.1038/82047
  • 10.1038/82644
  • 10.1038/83799
  • 10.1038/86011
  • 10.1038/9707
  • 10.1038/ajg.2013.304
  • 10.1038/aps.2010.185
  • 10.1038/aps.2014.123
  • 10.1038/bjc.2014.39
  • 10.1038/cdd.2009.81
  • 10.1038/cddis.2014.119
  • 10.1038/cddis.2015.210
  • 10.1038/cr.2008.325
  • 10.1038/cr.2009.41
  • 10.1038/cr.2009.95
  • 10.1038/cr.2010.105
  • 10.1038/cr.2013.27
  • 10.1038/cr.2014.99
  • 10.1038/cr.2015.90
  • 10.1038/ejhg.2008.206
  • 10.1038/emboj.2008.1
  • 10.1038/emboj.2008.211
  • 10.1038/emboj.2008.308
  • 10.1038/emboj.2008.9
  • 10.1038/emboj.2009.322
  • 10.1038/emboj.2010.100
  • 10.1038/emboj.2010.167
  • 10.1038/emboj.2010.300
  • 10.1038/emboj.2011.340
  • 10.1038/emboj.2011.393
  • 10.1038/emboj.2012.150
  • 10.1038/emboj.2012.21
  • 10.1038/emboj.2012.217
  • 10.1038/embor.2009.81
  • 10.1038/embor.2012.105
  • 10.1038/embor.2012.24
  • 10.1038/embor.2013.110
  • 10.1038/eye.1997.78
  • 10.1038/icb.1996.72
  • 10.1038/jid.2008.433
  • 10.1038/jid.2012.400
  • 10.1038/jid.2015.166
  • 10.1038/ki.2008.74
  • 10.1038/ki.2010.167
  • 10.1038/labinvest.3700348
  • 10.1038/mp.2014.115
  • 10.1038/msb.2011.59
  • 10.1038/nature00989
  • 10.1038/nature01147
  • 10.1038/nature01570
  • 10.1038/nature01611
  • 10.1038/nature01618
  • 10.1038/nature01905
  • 10.1038/nature02061
  • 10.1038/nature02237
  • 10.1038/nature02452
  • 10.1038/nature02488
  • 10.1038/nature02794
  • 10.1038/nature02835
  • 10.1038/nature03155
  • 10.1038/nature03345
  • 10.1038/nature03452
  • 10.1038/nature03604
  • 10.1038/nature04020
  • 10.1038/nature04117
  • 10.1038/nature04170
  • 10.1038/nature04185
  • 10.1038/nature04334
  • 10.1038/nature05246
  • 10.1038/nature05315
  • 10.1038/nature05674
  • 10.1038/nature05828
  • 10.1038/nature05939
  • 10.1038/nature06225
  • 10.1038/nature07261
  • 10.1038/nature07290
  • 10.1038/nature07358
  • 10.1038/nature07399
  • 10.1038/nature07829
  • 10.1038/nature07883
  • 10.1038/nature08137
  • 10.1038/nature08144
  • 10.1038/nature08314
  • 10.1038/nature08356
  • 10.1038/nature08684
  • 10.1038/nature08959
  • 10.1038/nature09144
  • 10.1038/nature09623
  • 10.1038/nature09814
  • 10.1038/nature09815
  • 10.1038/nature09816
  • 10.1038/nature09860
  • 10.1038/nature10280
  • 10.1038/nature11019
  • 10.1038/nature11071
  • 10.1038/nature12308
  • 10.1038/nature12441
  • 10.1038/nature12638
  • 10.1038/nature14107
  • 10.1038/nature14583
  • 10.1038/nature756
  • 10.1038/nbt1046
  • 10.1038/ncb0107-15
  • 10.1038/ncb0502-e131
  • 10.1038/ncb0806-783
  • 10.1038/ncb1001-861
  • 10.1038/ncb1001-927
  • 10.1038/ncb1056
  • 10.1038/ncb1082
  • 10.1038/ncb1101-973
  • 10.1038/ncb1134
  • 10.1038/ncb1141
  • 10.1038/ncb1152
  • 10.1038/ncb1183
  • 10.1038/ncb1201-1124
  • 10.1038/ncb1283
  • 10.1038/ncb1292
  • 10.1038/ncb1308
  • 10.1038/ncb1327
  • 10.1038/ncb1381
  • 10.1038/ncb1396
  • 10.1038/ncb1397
  • 10.1038/ncb1437
  • 10.1038/ncb1465
  • 10.1038/ncb1486
  • 10.1038/ncb1510
  • 10.1038/ncb1546
  • 10.1038/ncb1547
  • 10.1038/ncb1668
  • 10.1038/ncb1687
  • 10.1038/ncb1689
  • 10.1038/ncb1728
  • 10.1038/ncb1748
  • 10.1038/ncb1862
  • 10.1038/ncb1966
  • 10.1038/ncb2049
  • 10.1038/ncb2156
  • 10.1038/ncb2222
  • 10.1038/ncb2240
  • 10.1038/ncb2241
  • 10.1038/ncb2300
  • 10.1038/ncb2394
  • 10.1038/ncb2455
  • 10.1038/ncb2574
  • 10.1038/ncb2874
  • 10.1038/ncb2972
  • 10.1038/ncb2988
  • 10.1038/ncb3218
  • 10.1038/ncb3295
  • 10.1038/ncb3592
  • 10.1038/ncb435
  • 10.1038/ncb749
  • 10.1038/ncb750
  • 10.1038/ncb773
  • 10.1038/ncb786
  • 10.1038/ncb824
  • 10.1038/ncb834
  • 10.1038/ncb838
  • 10.1038/ncb935
  • 10.1038/nchembio.1629
  • 10.1038/nchembio.362
  • 10.1038/nchembio.686
  • 10.1038/nchembio.765
  • 10.1038/ncomms10664
  • 10.1038/ncomms10751
  • 10.1038/ncomms1861
  • 10.1038/ncomms2687
  • 10.1038/ncomms3910
  • 10.1038/ncomms6209
  • 10.1038/ncomms8088
  • 10.1038/ncomms8286
  • 10.1038/ncomms8769
  • 10.1038/ng.105
  • 10.1038/ng.268
  • 10.1038/ng.425
  • 10.1038/ng.730
  • 10.1038/ng.84
  • 10.1038/ng0296-144
  • 10.1038/ng0597-68
  • 10.1038/ng0792-251
  • 10.1038/ng0797-235
  • 10.1038/ng0797-243
  • 10.1038/ng0797-283
  • 10.1038/ng1003
  • 10.1038/ng1122
  • 10.1038/ng1617
  • 10.1038/ng1684
  • 10.1038/ng1753
  • 10.1038/ng1901
  • 10.1038/ng1987
  • 10.1038/ng916
  • 10.1038/ni.1649
  • 10.1038/ni.1891
  • 10.1038/ni.2210
  • 10.1038/ni.2457
  • 10.1038/ni.3103
  • 10.1038/ni0403-313
  • 10.1038/ni1396
  • 10.1038/ni1575
  • 10.1038/nm.2021
  • 10.1038/nm.2315
  • 10.1038/nm.2619
  • 10.1038/nm1168
  • 10.1038/nm1249
  • 10.1038/nm1528
  • 10.1038/nm1775
  • 10.1038/nm762
  • 10.1038/nm786
  • 10.1038/nn.3237
  • 10.1038/nn1052
  • 10.1038/nn1374
  • 10.1038/nn1462
  • 10.1038/nn1490
  • 10.1038/nn1492
  • 10.1038/nn1520
  • 10.1038/nn1547
  • 10.1038/nn1708
  • 10.1038/nn720
  • 10.1038/nrc.2017.79
  • 10.1038/nrc1673
  • 10.1038/nrc1880
  • 10.1038/nrc2290
  • 10.1038/nrc2291
  • 10.1038/nrc2695
  • 10.1038/nrc2735
  • 10.1038/nrc2960
  • 10.1038/nrc3106
  • 10.1038/nrc3580
  • 10.1038/nrc3743
  • 10.1038/nrc3818
  • 10.1038/nrc839
  • 10.1038/nrd4228
  • 10.1038/nrd4281
  • 10.1038/nrd747
  • 10.1038/nrendo.2011.122
  • 10.1038/nrg1879
  • 10.1038/nrg2340
  • 10.1038/nrg2774
  • 10.1038/nri3495
  • 10.1038/nrm1009
  • 10.1038/nrm1103
  • 10.1038/nrm1128
  • 10.1038/nrm1313
  • 10.1038/nrm1498
  • 10.1038/nrm1549
  • 10.1038/nrm1622
  • 10.1038/nrm1911
  • 10.1038/nrm2069
  • 10.1038/nrm2249
  • 10.1038/nrm2299
  • 10.1038/nrm2310
  • 10.1038/nrm2476
  • 10.1038/nrm2546
  • 10.1038/nrm2717
  • 10.1038/nrm2803
  • 10.1038/nrm3025
  • 10.1038/nrm3048
  • 10.1038/nrm3052
  • 10.1038/nrm3470
  • 10.1038/nrm3522
  • 10.1038/nrm3598
  • 10.1038/nrm3979
  • 10.1038/nrn3024
  • 10.1038/nsb0997-686
  • 10.1038/nsb720
  • 10.1038/nsb731
  • 10.1038/nsmb.1457
  • 10.1038/nsmb.1564
  • 10.1038/nsmb.1607
  • 10.1038/nsmb.1632
  • 10.1038/nsmb.1938
  • 10.1038/nsmb.2139
  • 10.1038/nsmb.2462
  • 10.1038/nsmb.2781
  • 10.1038/nsmb1129
  • 10.1038/nsmb1202
  • 10.1038/nsmb1247
  • 10.1038/nsmb859
  • 10.1038/nsmb885
  • 10.1038/nsmb912
  • 10.1038/onc.2008.109
  • 10.1038/onc.2008.29
  • 10.1038/onc.2008.394
  • 10.1038/onc.2008.435
  • 10.1038/onc.2009.261
  • 10.1038/onc.2009.310
  • 10.1038/onc.2009.363
  • 10.1038/onc.2009.515
  • 10.1038/onc.2010.247
  • 10.1038/onc.2010.298
  • 10.1038/onc.2010.394
  • 10.1038/onc.2010.398
  • 10.1038/onc.2010.505
  • 10.1038/onc.2011.642
  • 10.1038/onc.2012.12
  • 10.1038/onc.2012.195
  • 10.1038/onc.2012.551
  • 10.1038/onc.2013.293
  • 10.1038/onc.2014.312
  • 10.1038/oncsis.2014.40
  • 10.1038/oncsis.2016.67
  • 10.1038/s41374-018-0022-y
  • 10.1038/s41388-019-0913-4
  • 10.1038/s41418-020-00629-3
  • 10.1038/s41467-017-00498-4
  • 10.1038/s41467-017-01231-x
  • 10.1038/s41467-018-04705-8
  • 10.1038/s41467-018-06949-w
  • 10.1038/s41467-019-11839-w
  • 10.1038/s41467-019-12033-8
  • 10.1038/s41556-018-0146-8
  • 10.1038/s41556-019-0438-7
  • 10.1038/s41556-020-0488-x
  • 10.1038/s41568-018-0002-y
  • 10.1038/s41586-021-03959-5
  • 10.1038/s41586-021-04140-8
  • 10.1038/s41598-017-10392-0
  • 10.1038/s41598-017-13619-2
  • 10.1038/s41598-019-42181-2
  • 10.1038/s41598-020-72960-1
  • 10.1038/s42003-022-03668-3
  • 10.1038/sj.bjp.0701182
  • 10.1038/sj.bjp.0701636
  • 10.1038/sj.bjp.0702220
  • 10.1038/sj.bjp.0702609
  • 10.1038/sj.bjp.0703617
  • 10.1038/sj.bjp.0703788
  • 10.1038/sj.bjp.0704133
  • 10.1038/sj.bjp.0704430
  • 10.1038/sj.bjp.0704809
  • 10.1038/sj.bjp.0704973
  • 10.1038/sj.bjp.0705592
  • 10.1038/sj.bjp.0706048
  • 10.1038/sj.bjp.0706661
  • 10.1038/sj.bjp.0707140
  • 10.1038/sj.bjp.0707460
  • 10.1038/sj.bjp.0707644
  • 10.1038/sj.cdd.4401946
  • 10.1038/sj.cr.7290257
  • 10.1038/sj.emboj.7600031
  • 10.1038/sj.emboj.7600243
  • 10.1038/sj.emboj.7600334
  • 10.1038/sj.emboj.7600377
  • 10.1038/sj.emboj.7600467
  • 10.1038/sj.emboj.7600489
  • 10.1038/sj.emboj.7600587
  • 10.1038/sj.emboj.7600667
  • 10.1038/sj.emboj.7600709
  • 10.1038/sj.emboj.7600879
  • 10.1038/sj.emboj.7600980
  • 10.1038/sj.emboj.7601188
  • 10.1038/sj.emboj.7601286
  • 10.1038/sj.emboj.7601341
  • 10.1038/sj.emboj.7601360
  • 10.1038/sj.emboj.7601545
  • 10.1038/sj.emboj.7601607
  • 10.1038/sj.emboj.7601626
  • 10.1038/sj.emboj.7601781
  • 10.1038/sj.embor.7400013
  • 10.1038/sj.embor.7400300
  • 10.1038/sj.embor.7400349
  • 10.1038/sj.embor.7400453
  • 10.1038/sj.embor.7400822
  • 10.1038/sj.jhh.1000482
  • 10.1038/sj.jhh.1000991
  • 10.1038/sj.jhh.1001391
  • 10.1038/sj.ki.5000432
  • 10.1038/sj.leu.2401397
  • 10.1038/sj.leu.2401942
  • 10.1038/sj.leu.2404125
  • 10.1038/sj.leu.2404323
  • 10.1038/sj.npp.1300203
  • 10.1038/sj.onc.1200879
  • 10.1038/sj.onc.1201153
  • 10.1038/sj.onc.1201228
  • 10.1038/sj.onc.1201380
  • 10.1038/sj.onc.1201555
  • 10.1038/sj.onc.1201641
  • 10.1038/sj.onc.1201688
  • 10.1038/sj.onc.1202016
  • 10.1038/sj.onc.1202527
  • 10.1038/sj.onc.1202653
  • 10.1038/sj.onc.1202736
  • 10.1038/sj.onc.1202895
  • 10.1038/sj.onc.1202939
  • 10.1038/sj.onc.1202985
  • 10.1038/sj.onc.1203198
  • 10.1038/sj.onc.1203359
  • 10.1038/sj.onc.1203408
  • 10.1038/sj.onc.1203514
  • 10.1038/sj.onc.1203591
  • 10.1038/sj.onc.1203977
  • 10.1038/sj.onc.1204053
  • 10.1038/sj.onc.1204182
  • 10.1038/sj.onc.1204190
  • 10.1038/sj.onc.1204259
  • 10.1038/sj.onc.1204526
  • 10.1038/sj.onc.1204921
  • 10.1038/sj.onc.1205004
  • 10.1038/sj.onc.1205036
  • 10.1038/sj.onc.1205091
  • 10.1038/sj.onc.1205152
  • 10.1038/sj.onc.1205420
  • 10.1038/sj.onc.1205669
  • 10.1038/sj.onc.1205678
  • 10.1038/sj.onc.1205747
  • 10.1038/sj.onc.1205781
  • 10.1038/sj.onc.1205794
  • 10.1038/sj.onc.1206212
  • 10.1038/sj.onc.1206285
  • 10.1038/sj.onc.1206798
  • 10.1038/sj.onc.1206849
  • 10.1038/sj.onc.1207034
  • 10.1038/sj.onc.1207046
  • 10.1038/sj.onc.1207185
  • 10.1038/sj.onc.1207390
  • 10.1038/sj.onc.1208187
  • 10.1038/sj.onc.1208445
  • 10.1038/sj.onc.1208528
  • 10.1038/sj.onc.1208560
  • 10.1038/sj.onc.1208667
  • 10.1038/sj.onc.1208838
  • 10.1038/sj.onc.1208944
  • 10.1038/sj.onc.1209232
  • 10.1038/sj.onc.1209306
  • 10.1038/sj.onc.1209329
  • 10.1038/sj.onc.1209471
  • 10.1038/sj.onc.1209501
  • 10.1038/sj.onc.1209800
  • 10.1038/sj.onc.1209840
  • 10.1038/sj.onc.1209945
  • 10.1038/sj.onc.1210054
  • 10.1038/sj.onc.1210055
  • 10.1038/sj.onc.1210346
  • 10.1038/sj.onc.1210394
  • 10.1038/sj.onc.1210408
  • 10.1038/sj.onc.1210574
  • 10.1038/sj.onc.1210643
  • 10.1038/sj.onc.1210918
  • 10.1038/srep03450
  • 10.1038/srep04980
  • 10.1038/srep08782
  • 10.1038/srep19612
  • 10.1038/srep25520
  • 10.1038/srep27471
  • 10.1038/srep34877
  • 10.1038/srep37808
  • 10.1039/c5cs00911a
  • 10.1039/c9cp00101h
  • 10.1042/0264-6021:3470501
  • 10.1042/0264-6021:3570647
  • 10.1042/0264-6021:3600057
  • 10.1042/0264-6021:3600255
  • 10.1042/bc20050101
  • 10.1042/bcj20160832
  • 10.1042/bcj20170015
  • 10.1042/bcj20190203
  • 10.1042/bj20020654
  • 10.1042/bj20020716
  • 10.1042/bj20020809
  • 10.1042/bj20020829
  • 10.1042/bj20021429
  • 10.1042/bj20021941
  • 10.1042/bj20030727
  • 10.1042/bj20030786
  • 10.1042/bj20031041
  • 10.1042/bj20040025
  • 10.1042/bj20040176
  • 10.1042/bj20040738
  • 10.1042/bj20041078
  • 10.1042/bj20041284
  • 10.1042/bj20041638
  • 10.1042/bj20041835
  • 10.1042/bj20050067
  • 10.1042/bj20050525
  • 10.1042/bj20051493
  • 10.1042/bj20060890
  • 10.1042/bj20061476
  • 10.1042/bj20061696
  • 10.1042/bj20070511
  • 10.1042/bj20071369
  • 10.1042/bj20071594
  • 10.1042/bj20080887
  • 10.1042/bj20080948
  • 10.1042/bj20081668
  • 10.1042/bj20081834
  • 10.1042/bj20082182
  • 10.1042/bj20090387
  • 10.1042/bj20091604
  • 10.1042/bj20100609
  • 10.1042/bj20100870
  • 10.1042/bj20101320
  • 10.1042/bj20101700
  • 10.1042/bj20110521
  • 10.1042/bj20111111
  • 10.1042/bj20111286
  • 10.1042/bj20130709
  • 10.1042/bj20140006
  • 10.1042/bj20141446
  • 10.1042/bj2520607
  • 10.1042/bj2600427
  • 10.1042/bj2660235
  • 10.1042/bj2700027
  • 10.1042/bj2810413
  • 10.1042/bj2850933
  • 10.1042/bj3141009
  • 10.1042/bj3150709
  • 10.1042/bj3150775
  • 10.1042/bj3210561
  • 10.1042/bj3220193
  • 10.1042/bj3260709
  • 10.1042/bj3280871
  • 10.1042/bj3370575
  • 10.1042/bj3390319
  • 10.1042/bj3410211
  • 10.1042/bj3480481
  • 10.1042/bj3520319
  • 10.1042/bse0380079
  • 10.1042/bsr20100123
  • 10.1042/bst0300473
  • 10.1042/bst0320792
  • 10.1042/bst0370223
  • 10.1042/bst0370227
  • 10.1042/bst20130042
  • 10.1042/bst20160303
  • 10.1046/j.1365-2044.1999.00659.x
  • 10.1046/j.1365-2133.2002.04583.x
  • 10.1046/j.1365-2141.2003.04533.x
  • 10.1046/j.1365-2184.2003.00266.x
  • 10.1046/j.1365-2362.2001.00896.x
  • 10.1046/j.1365-2443.2003.00662.x
  • 10.1046/j.1365-2710.2003.00477.x
  • 10.1046/j.1432-1033.2002.03002.x
  • 10.1046/j.1432-1033.2002.03292.x
  • 10.1046/j.1432-1033.2002.03343.x
  • 10.1046/j.1432-1327.1999.00301.x
  • 10.1046/j.1432-1327.1999.00911.x
  • 10.1046/j.1462-5822.2000.00084.x
  • 10.1046/j.1463-1326.2002.0040s2s14.x
  • 10.1046/j.1471-4159.1995.65062682.x
  • 10.1046/j.1471-4159.1996.66010047.x
  • 10.1046/j.1471-4159.1996.67030952.x
  • 10.1046/j.1471-4159.1997.68041390.x
  • 10.1046/j.1471-4159.1997.69051810.x
  • 10.1046/j.1471-4159.1998.70062252.x
  • 10.1046/j.1471-4159.1998.71010106.x
  • 10.1046/j.1471-4159.1998.71062239.x
  • 10.1046/j.1471-4159.1999.0730913.x
  • 10.1046/j.1471-4159.2002.00876.x
  • 10.1046/j.1538-7836.2003.00263.x
  • 10.1049/sb:20045003
  • 10.1053/gast.2002.30329
  • 10.1053/hupa.2001.27102
  • 10.1053/j.gastro.2007.05.022
  • 10.1053/j.gastro.2009.02.003
  • 10.1053/j.gastro.2009.09.046
  • 10.1053/j.gastro.2010.08.040
  • 10.1053/joca.2001.0446
  • 10.1055/s-2001-18040
  • 10.1055/s-2003-40669
  • 10.1055/s-2007-996112
  • 10.1056/nejm198903163201101
  • 10.1056/nejmoa010307
  • 10.1056/nejmoa010713
  • 10.1056/nejmoa031884
  • 10.1056/nejmoa035322
  • 10.1056/nejmoa042760
  • 10.1056/nejmoa065181
  • 10.1056/nejmoa1205624
  • 10.1056/nejmoa1709038
  • 10.1056/nejmoa1813049
  • 10.1056/nejmoa2004325
  • 10.1056/nejmra022784
  • 10.1073/pnas.012074399
  • 10.1073/pnas.021541498
  • 10.1073/pnas.022644499
  • 10.1073/pnas.0234057100
  • 10.1073/pnas.0305894101
  • 10.1073/pnas.0307344101
  • 10.1073/pnas.0307812101
  • 10.1073/pnas.0308061100
  • 10.1073/pnas.0308250100
  • 10.1073/pnas.0308334100
  • 10.1073/pnas.032468199
  • 10.1073/pnas.0402795101
  • 10.1073/pnas.0402802101
  • 10.1073/pnas.0403506101
  • 10.1073/pnas.0404297101
  • 10.1073/pnas.0404631101
  • 10.1073/pnas.0404984102
  • 10.1073/pnas.040560897
  • 10.1073/pnas.0407492101
  • 10.1073/pnas.0409120102
  • 10.1073/pnas.0409817102
  • 10.1073/pnas.0504501102
  • 10.1073/pnas.0505328102
  • 10.1073/pnas.0505575102
  • 10.1073/pnas.050580497
  • 10.1073/pnas.0509040103
  • 10.1073/pnas.0510651103
  • 10.1073/pnas.052138899
  • 10.1073/pnas.0602558103
  • 10.1073/pnas.0602852103
  • 10.1073/pnas.0605779103
  • 10.1073/pnas.0606108103
  • 10.1073/pnas.0611092104
  • 10.1073/pnas.0611308104
  • 10.1073/pnas.061358098
  • 10.1073/pnas.0700104104
  • 10.1073/pnas.070042497
  • 10.1073/pnas.0701243104
  • 10.1073/pnas.0701298104
  • 10.1073/pnas.0702555104
  • 10.1073/pnas.0703589104
  • 10.1073/pnas.0704089104
  • 10.1073/pnas.0704315104
  • 10.1073/pnas.0704809104
  • 10.1073/pnas.0707277105
  • 10.1073/pnas.072090199
  • 10.1073/pnas.072345299
  • 10.1073/pnas.0801508105
  • 10.1073/pnas.0804709105
  • 10.1073/pnas.0805009105
  • 10.1073/pnas.0805371105
  • 10.1073/pnas.0806518106
  • 10.1073/pnas.0810571106
  • 10.1073/pnas.0810958105
  • 10.1073/pnas.0812110106
  • 10.1073/pnas.082096999
  • 10.1073/pnas.0830671100
  • 10.1073/pnas.0831079100
  • 10.1073/pnas.0837789100
  • 10.1073/pnas.0901590106
  • 10.1073/pnas.0906944106
  • 10.1073/pnas.0908279106
  • 10.1073/pnas.0908444106
  • 10.1073/pnas.0909896107
  • 10.1073/pnas.0912008106
  • 10.1073/pnas.0912180106
  • 10.1073/pnas.0913986107
  • 10.1073/pnas.0914514107
  • 10.1073/pnas.1000975107
  • 10.1073/pnas.1003023107
  • 10.1073/pnas.1004602107
  • 10.1073/pnas.1005191107
  • 10.1073/pnas.1006437108
  • 10.1073/pnas.1008499107
  • 10.1073/pnas.1011410108
  • 10.1073/pnas.1016071107
  • 10.1073/pnas.1016147107
  • 10.1073/pnas.1100319108
  • 10.1073/pnas.1102554108
  • 10.1073/pnas.111114298
  • 10.1073/pnas.1114802109
  • 10.1073/pnas.112495999
  • 10.1073/pnas.1130513100
  • 10.1073/pnas.1135239100
  • 10.1073/pnas.1213773111
  • 10.1073/pnas.1219004110
  • 10.1073/pnas.1220341110
  • 10.1073/pnas.1301328110
  • 10.1073/pnas.1302725110
  • 10.1073/pnas.1304340110
  • 10.1073/pnas.1307218110
  • 10.1073/pnas.1309078110
  • 10.1073/pnas.1312791110
  • 10.1073/pnas.1322362111
  • 10.1073/pnas.1412009111
  • 10.1073/pnas.1432869100
  • 10.1073/pnas.151105198
  • 10.1073/pnas.1520099112
  • 10.1073/pnas.1604720113
  • 10.1073/pnas.1608987113
  • 10.1073/pnas.161259898
  • 10.1073/pnas.1615316113
  • 10.1073/pnas.162241099
  • 10.1073/pnas.1807881115
  • 10.1073/pnas.181181198
  • 10.1073/pnas.192462299
  • 10.1073/pnas.200367697
  • 10.1073/pnas.202365899
  • 10.1073/pnas.202495599
  • 10.1073/pnas.211420498
  • 10.1073/pnas.220158597
  • 10.1073/pnas.220251997
  • 10.1073/pnas.2233056100
  • 10.1073/pnas.232580999
  • 10.1073/pnas.241358198
  • 10.1073/pnas.241398098
  • 10.1073/pnas.76.4.1653
  • 10.1073/pnas.78.12.7365
  • 10.1073/pnas.79.15.4575
  • 10.1073/pnas.80.14.4311
  • 10.1073/pnas.81.14.4577
  • 10.1073/pnas.81.15.4851
  • 10.1073/pnas.81.18.5704
  • 10.1073/pnas.82.7.1931
  • 10.1073/pnas.83.9.2797
  • 10.1073/pnas.84.1.46
  • 10.1073/pnas.84.22.7920
  • 10.1073/pnas.85.11.3753
  • 10.1073/pnas.85.7.2081
  • 10.1073/pnas.86.21.8323
  • 10.1073/pnas.86.24.9762
  • 10.1073/pnas.86.4.1218
  • 10.1073/pnas.86.8.2863
  • 10.1073/pnas.87.19.7732
  • 10.1073/pnas.88.13.5587
  • 10.1073/pnas.88.18.7908
  • 10.1073/pnas.88.24.11435
  • 10.1073/pnas.89.1.251
  • 10.1073/pnas.89.10.4285
  • 10.1073/pnas.89.23.11574
  • 10.1073/pnas.89.4.1281
  • 10.1073/pnas.89.5.1587
  • 10.1073/pnas.89.8.3630
  • 10.1073/pnas.89.9.3815
  • 10.1073/pnas.90.1.203
  • 10.1073/pnas.90.13.6120
  • 10.1073/pnas.90.15.7181
  • 10.1073/pnas.90.2.408
  • 10.1073/pnas.90.21.10365
  • 10.1073/pnas.90.22.10793
  • 10.1073/pnas.91.11.4731
  • 10.1073/pnas.91.21.10009
  • 10.1073/pnas.91.21.9780
  • 10.1073/pnas.91.21.9828
  • 10.1073/pnas.91.23.11089
  • 10.1073/pnas.91.26.12609
  • 10.1073/pnas.92.12.5734
  • 10.1073/pnas.92.15.6873
  • 10.1073/pnas.92.15.7006
  • 10.1073/pnas.92.17.7632
  • 10.1073/pnas.92.19.8601
  • 10.1073/pnas.92.19.8734
  • 10.1073/pnas.92.20.9284
  • 10.1073/pnas.92.22.10282
  • 10.1073/pnas.92.6.2179
  • 10.1073/pnas.92.7.2597
  • 10.1073/pnas.93.11.5466
  • 10.1073/pnas.93.16.8666
  • 10.1073/pnas.93.21.11540
  • 10.1073/pnas.93.21.11681
  • 10.1073/pnas.93.21.12002
  • 10.1073/pnas.93.5.1988
  • 10.1073/pnas.93.6.2576
  • 10.1073/pnas.93.9.4181
  • 10.1073/pnas.94.14.7192
  • 10.1073/pnas.94.17.9017
  • 10.1073/pnas.94.18.9562
  • 10.1073/pnas.94.18.9893
  • 10.1073/pnas.94.23.12419
  • 10.1073/pnas.94.25.13738
  • 10.1073/pnas.94.26.14671
  • 10.1073/pnas.94.9.4279
  • 10.1073/pnas.95.1.305
  • 10.1073/pnas.95.11.6061
  • 10.1073/pnas.95.11.6181
  • 10.1073/pnas.95.12.6941
  • 10.1073/pnas.95.14.8108
  • 10.1073/pnas.95.16.9214
  • 10.1073/pnas.95.19.11211
  • 10.1073/pnas.95.2.548
  • 10.1073/pnas.95.2.570
  • 10.1073/pnas.95.20.11590
  • 10.1073/pnas.95.21.12197
  • 10.1073/pnas.95.21.12202
  • 10.1073/pnas.95.25.14787
  • 10.1073/pnas.95.25.14991
  • 10.1073/pnas.95.3.1091
  • 10.1073/pnas.96.20.11217
  • 10.1073/pnas.96.22.12442
  • 10.1073/pnas.96.22.12548
  • 10.1073/pnas.96.25.14383
  • 10.1073/pnas.96.26.14911
  • 10.1073/pnas.96.4.1569
  • 10.1073/pnas.96.7.3546
  • 10.1073/pnas.97.1.185
  • 10.1073/pnas.97.13.7440
  • 10.1073/pnas.97.14.7732
  • 10.1073/pnas.97.2.817
  • 10.1073/pnas.97.26.14394
  • 10.1073/pnas.98.2.507
  • 10.1073/pnas.98.3.974
  • 10.1074/jbc.270.13.7587
  • 10.1074/jbc.270.14.7795
  • 10.1074/jbc.270.16.9031
  • 10.1074/jbc.270.16.9661
  • 10.1074/jbc.270.18.10618
  • 10.1074/jbc.270.19.11358
  • 10.1074/jbc.270.20.11723
  • 10.1074/jbc.270.21.12919
  • 10.1074/jbc.270.23.13973
  • 10.1074/jbc.270.23.14192
  • 10.1074/jbc.270.25.14863
  • 10.1074/jbc.270.25.15262
  • 10.1074/jbc.270.26.15455
  • 10.1074/jbc.270.27.15979
  • 10.1074/jbc.270.29.17437
  • 10.1074/jbc.270.32.18910
  • 10.1074/jbc.270.33.19495
  • 10.1074/jbc.270.34.20135
  • 10.1074/jbc.270.35.20242
  • 10.1074/jbc.270.35.20384
  • 10.1074/jbc.270.38.22473
  • 10.1074/jbc.270.39.23119
  • 10.1074/jbc.270.40.23337
  • 10.1074/jbc.270.40.23589
  • 10.1074/jbc.270.42.25070
  • 10.1074/jbc.270.45.26758
  • 10.1074/jbc.270.45.26762
  • 10.1074/jbc.270.45.26897
  • 10.1074/jbc.270.45.27266
  • 10.1074/jbc.270.48.28982
  • 10.1074/jbc.270.49.29176
  • 10.1074/jbc.270.50.29825
  • 10.1074/jbc.270.51.30717
  • 10.1074/jbc.270.52.30849
  • 10.1074/jbc.270.52.30919
  • 10.1074/jbc.270.9.4805
  • 10.1074/jbc.271.10.5603
  • 10.1074/jbc.271.12.6895
  • 10.1074/jbc.271.16.9403
  • 10.1074/jbc.271.19.11272
  • 10.1074/jbc.271.19.11325
  • 10.1074/jbc.271.20.11641
  • 10.1074/jbc.271.21.12481
  • 10.1074/jbc.271.21.12562
  • 10.1074/jbc.271.23.13556
  • 10.1074/jbc.271.28.16526
  • 10.1074/jbc.271.32.19443
  • 10.1074/jbc.271.33.20082
  • 10.1074/jbc.271.34.20231
  • 10.1074/jbc.271.34.20246
  • 10.1074/jbc.271.35.21049
  • 10.1074/jbc.271.35.21381
  • 10.1074/jbc.271.35.21542
  • 10.1074/jbc.271.36.22211
  • 10.1074/jbc.271.38.23363
  • 10.1074/jbc.271.41.25452
  • 10.1074/jbc.271.41.25533
  • 10.1074/jbc.271.43.26884
  • 10.1074/jbc.271.44.27707
  • 10.1074/jbc.271.47.29903
  • 10.1074/jbc.271.48.30366
  • 10.1074/jbc.271.48.30897
  • 10.1074/jbc.271.48.30942
  • 10.1074/jbc.271.5.2731
  • 10.1074/jbc.271.51.33026
  • 10.1074/jbc.271.6.3187
  • 10.1074/jbc.271.9.4813
  • 10.1074/jbc.272.1.448
  • 10.1074/jbc.272.10.6311
  • 10.1074/jbc.272.10.6370
  • 10.1074/jbc.272.10.6621
  • 10.1074/jbc.272.11.6823
  • 10.1074/jbc.272.16.10751
  • 10.1074/jbc.272.17.11408
  • 10.1074/jbc.272.21.13803
  • 10.1074/jbc.272.23.14893
  • 10.1074/jbc.272.24.15442
  • 10.1074/jbc.272.27.16999
  • 10.1074/jbc.272.28.17251
  • 10.1074/jbc.272.28.17756
  • 10.1074/jbc.272.29.18382
  • 10.1074/jbc.272.33.20384
  • 10.1074/jbc.272.35.21999
  • 10.1074/jbc.272.38.23843
  • 10.1074/jbc.272.39.24333
  • 10.1074/jbc.272.44.27558
  • 10.1074/jbc.272.44.27949
  • 10.1074/jbc.272.44.28107
  • 10.1074/jbc.272.47.29579
  • 10.1074/jbc.272.50.31730
  • 10.1074/jbc.272.51.31969
  • 10.1074/jbc.272.51.32686
  • 10.1074/jbc.272.52.32830
  • 10.1074/jbc.272.6.3860
  • 10.1074/jbc.272.7.4065
  • 10.1074/jbc.272.7.4378
  • 10.1074/jbc.272.9.5915
  • 10.1074/jbc.273.1.577
  • 10.1074/jbc.273.10.5908
  • 10.1074/jbc.273.11.6019
  • 10.1074/jbc.273.12.7118
  • 10.1074/jbc.273.13.7717
  • 10.1074/jbc.273.14.7906
  • 10.1074/jbc.273.15.8616
  • 10.1074/jbc.273.15.8776
  • 10.1074/jbc.273.18.11288
  • 10.1074/jbc.273.19.11962
  • 10.1074/jbc.273.2.829
  • 10.1074/jbc.273.22.13950
  • 10.1074/jbc.273.22.14037
  • 10.1074/jbc.273.28.17469
  • 10.1074/jbc.273.29.17987
  • 10.1074/jbc.273.31.19778
  • 10.1074/jbc.273.34.21512
  • 10.1074/jbc.273.36.23321
  • 10.1074/jbc.273.36.23410
  • 10.1074/jbc.273.45.29706
  • 10.1074/jbc.273.46.30097
  • 10.1074/jbc.273.48.31738
  • 10.1074/jbc.273.48.31880
  • 10.1074/jbc.273.49.32377
  • 10.1074/jbc.273.49.32408
  • 10.1074/jbc.273.51.34543
  • 10.1074/jbc.273.52.34671
  • 10.1074/jbc.273.52.34954
  • 10.1074/jbc.273.7.4065
  • 10.1074/jbc.273.8.4449
  • 10.1074/jbc.274.10.6035
  • 10.1074/jbc.274.10.6453
  • 10.1074/jbc.274.12.8012
  • 10.1074/jbc.274.12.8022
  • 10.1074/jbc.274.12.8143
  • 10.1074/jbc.274.12.8199
  • 10.1074/jbc.274.13.8379
  • 10.1074/jbc.274.13.8383
  • 10.1074/jbc.274.16.10681
  • 10.1074/jbc.274.16.11321
  • 10.1074/jbc.274.17.11693
  • 10.1074/jbc.274.18.12474
  • 10.1074/jbc.274.23.16180
  • 10.1074/jbc.274.24.16965
  • 10.1074/jbc.274.24.17179
  • 10.1074/jbc.274.25.17771
  • 10.1074/jbc.274.29.20704
  • 10.1074/jbc.274.31.21569
  • 10.1074/jbc.274.35.25051
  • 10.1074/jbc.274.36.25197
  • 10.1074/jbc.274.37.26044
  • 10.1074/jbc.274.37.26091
  • 10.1074/jbc.274.37.26584
  • 10.1074/jbc.274.39.27351
  • 10.1074/jbc.274.39.27776
  • 10.1074/jbc.274.42.30059
  • 10.1074/jbc.274.43.30487
  • 10.1074/jbc.274.46.32961
  • 10.1074/jbc.274.47.33194
  • 10.1074/jbc.274.47.33202
  • 10.1074/jbc.274.47.33587
  • 10.1074/jbc.274.48.34029
  • 10.1074/jbc.274.48.34483
  • 10.1074/jbc.274.6.3744
  • 10.1074/jbc.274.8.4551
  • 10.1074/jbc.275.1.288
  • 10.1074/jbc.275.12.8641
  • 10.1074/jbc.275.13.9749
  • 10.1074/jbc.275.14.10379
  • 10.1074/jbc.275.14.10661
  • 10.1074/jbc.275.15.10767
  • 10.1074/jbc.275.15.10772
  • 10.1074/jbc.275.15.11064
  • 10.1074/jbc.275.17.12701
  • 10.1074/jbc.275.19.14281
  • 10.1074/jbc.275.19.14700
  • 10.1074/jbc.275.5.3288
  • 10.1074/jbc.275.5.3577
  • 10.1074/jbc.275.9.6059
  • 10.1074/jbc.a808126200
  • 10.1074/jbc.c000509200
  • 10.1074/jbc.c000761200
  • 10.1074/jbc.c100008200
  • 10.1074/jbc.c100714200
  • 10.1074/jbc.c100762200
  • 10.1074/jbc.c109.009522
  • 10.1074/jbc.c110.205401
  • 10.1074/jbc.c110.212621
  • 10.1074/jbc.c200398200
  • 10.1074/jbc.c300186200
  • 10.1074/jbc.c300234200
  • 10.1074/jbc.c400046200
  • 10.1074/jbc.c400105200
  • 10.1074/jbc.c500125200
  • 10.1074/jbc.c500213200
  • 10.1074/jbc.c700030200
  • 10.1074/jbc.c800128200
  • 10.1074/jbc.m000465200
  • 10.1074/jbc.m000687200
  • 10.1074/jbc.m001144200
  • 10.1074/jbc.m001339200
  • 10.1074/jbc.m001461200
  • 10.1074/jbc.m002156200
  • 10.1074/jbc.m002704200
  • 10.1074/jbc.m003337200
  • 10.1074/jbc.m003339200
  • 10.1074/jbc.m003487200
  • 10.1074/jbc.m003490200
  • 10.1074/jbc.m003597200
  • 10.1074/jbc.m003839200
  • 10.1074/jbc.m004089200
  • 10.1074/jbc.m004385200
  • 10.1074/jbc.m004389200
  • 10.1074/jbc.m004613200
  • 10.1074/jbc.m005036200
  • 10.1074/jbc.m005109200
  • 10.1074/jbc.m005220200
  • 10.1074/jbc.m005459200
  • 10.1074/jbc.m005468200
  • 10.1074/jbc.m005492200
  • 10.1074/jbc.m005650200
  • 10.1074/jbc.m005984200
  • 10.1074/jbc.m006478200
  • 10.1074/jbc.m006864200
  • 10.1074/jbc.m006909200
  • 10.1074/jbc.m006945200
  • 10.1074/jbc.m007074200
  • 10.1074/jbc.m007210200
  • 10.1074/jbc.m007231200
  • 10.1074/jbc.m007333200
  • 10.1074/jbc.m008027200
  • 10.1074/jbc.m008773200
  • 10.1074/jbc.m008786200
  • 10.1074/jbc.m008866200
  • 10.1074/jbc.m008870200
  • 10.1074/jbc.m009128200
  • 10.1074/jbc.m009134200
  • 10.1074/jbc.m009316200
  • 10.1074/jbc.m010275200
  • 10.1074/jbc.m010660200
  • 10.1074/jbc.m100123200
  • 10.1074/jbc.m100188200
  • 10.1074/jbc.m100312200
  • 10.1074/jbc.m100943200
  • 10.1074/jbc.m101770200
  • 10.1074/jbc.m102750200
  • 10.1074/jbc.m103117200
  • 10.1074/jbc.m103339200
  • 10.1074/jbc.m103377200
  • 10.1074/jbc.m103540200
  • 10.1074/jbc.m103555200
  • 10.1074/jbc.m103565200
  • 10.1074/jbc.m103856200
  • 10.1074/jbc.m103992200
  • 10.1074/jbc.m104847200
  • 10.1074/jbc.m104933200
  • 10.1074/jbc.m105863200
  • 10.1074/jbc.m105912200
  • 10.1074/jbc.m106012200
  • 10.1074/jbc.m106155200
  • 10.1074/jbc.m106186200
  • 10.1074/jbc.m106375200
  • 10.1074/jbc.m106831200
  • 10.1074/jbc.m107234200
  • 10.1074/jbc.m108368200
  • 10.1074/jbc.m108504200
  • 10.1074/jbc.m108733200
  • 10.1074/jbc.m109.003194
  • 10.1074/jbc.m109.014399
  • 10.1074/jbc.m109.014845
  • 10.1074/jbc.m109.019455
  • 10.1074/jbc.m109.023283
  • 10.1074/jbc.m109.044131
  • 10.1074/jbc.m109.046599
  • 10.1074/jbc.m109.046862
  • 10.1074/jbc.m109.047282
  • 10.1074/jbc.m109.049155
  • 10.1074/jbc.m109.051151
  • 10.1074/jbc.m109.058248
  • 10.1074/jbc.m109.060699
  • 10.1074/jbc.m109.064972
  • 10.1074/jbc.m109.071639
  • 10.1074/jbc.m109.072660
  • 10.1074/jbc.m109.075036
  • 10.1074/jbc.m109.088971
  • 10.1074/jbc.m109.091041
  • 10.1074/jbc.m109.092130
  • 10.1074/jbc.m109462200
  • 10.1074/jbc.m109927200
  • 10.1074/jbc.m110.104356
  • 10.1074/jbc.m110.123729
  • 10.1074/jbc.m110.131680
  • 10.1074/jbc.m110.133991
  • 10.1074/jbc.m110.137471
  • 10.1074/jbc.m110.153429
  • 10.1074/jbc.m110.156505
  • 10.1074/jbc.m110.162388
  • 10.1074/jbc.m110.169870
  • 10.1074/jbc.m110.173468
  • 10.1074/jbc.m110.179499
  • 10.1074/jbc.m110.181529
  • 10.1074/jbc.m110.181743
  • 10.1074/jbc.m110.186072
  • 10.1074/jbc.m110.190397
  • 10.1074/jbc.m110.205146
  • 10.1074/jbc.m110.206672
  • 10.1074/jbc.m110.216564
  • 10.1074/jbc.m110390200
  • 10.1074/jbc.m111.226431
  • 10.1074/jbc.m111.235846
  • 10.1074/jbc.m111.236455
  • 10.1074/jbc.m111.258772
  • 10.1074/jbc.m111.274076
  • 10.1074/jbc.m111.274761
  • 10.1074/jbc.m111.293464
  • 10.1074/jbc.m111.298117
  • 10.1074/jbc.m111.307231
  • 10.1074/jbc.m111.308734
  • 10.1074/jbc.m111.312207
  • 10.1074/jbc.m111.315945
  • 10.1074/jbc.m111.317578
  • 10.1074/jbc.m111.321083
  • 10.1074/jbc.m111.333716
  • 10.1074/jbc.m111.334144
  • 10.1074/jbc.m111.335794
  • 10.1074/jbc.m111041200
  • 10.1074/jbc.m111131200
  • 10.1074/jbc.m111165200
  • 10.1074/jbc.m111421200
  • 10.1074/jbc.m111575200
  • 10.1074/jbc.m112.341958
  • 10.1074/jbc.m112.356667
  • 10.1074/jbc.m112.362681
  • 10.1074/jbc.m112.370718
  • 10.1074/jbc.m112.377499
  • 10.1074/jbc.m112.377960
  • 10.1074/jbc.m112.381970
  • 10.1074/jbc.m112.386938
  • 10.1074/jbc.m112.387878
  • 10.1074/jbc.m112.414441
  • 10.1074/jbc.m112.426833
  • 10.1074/jbc.m112.429746
  • 10.1074/jbc.m112.430371
  • 10.1074/jbc.m112.438937
  • 10.1074/jbc.m112.440677
  • 10.1074/jbc.m112.448480
  • 10.1074/jbc.m112065200
  • 10.1074/jbc.m112363200
  • 10.1074/jbc.m113.455212
  • 10.1074/jbc.m113.482737
  • 10.1074/jbc.m113.492066
  • 10.1074/jbc.m113.495846
  • 10.1074/jbc.m113.512962
  • 10.1074/jbc.m113.534636
  • 10.1074/jbc.m114.566893
  • 10.1074/jbc.m114.594341
  • 10.1074/jbc.m114.620724
  • 10.1074/jbc.m114.633024
  • 10.1074/jbc.m115.651703
  • 10.1074/jbc.m115.680009
  • 10.1074/jbc.m115.697334
  • 10.1074/jbc.m116.736967
  • 10.1074/jbc.m116.742536
  • 10.1074/jbc.m116.765875
  • 10.1074/jbc.m200061200
  • 10.1074/jbc.m200139200
  • 10.1074/jbc.m200730200
  • 10.1074/jbc.m201196200
  • 10.1074/jbc.m201409200
  • 10.1074/jbc.m201743200
  • 10.1074/jbc.m201901200
  • 10.1074/jbc.m202993200
  • 10.1074/jbc.m203004200
  • 10.1074/jbc.m203179200
  • 10.1074/jbc.m203194200
  • 10.1074/jbc.m203215200
  • 10.1074/jbc.m203229200
  • 10.1074/jbc.m203346200
  • 10.1074/jbc.m203569200
  • 10.1074/jbc.m203816200
  • 10.1074/jbc.m203877200
  • 10.1074/jbc.m203907200
  • 10.1074/jbc.m203953200
  • 10.1074/jbc.m203962200
  • 10.1074/jbc.m204597200
  • 10.1074/jbc.m204753200
  • 10.1074/jbc.m205111200
  • 10.1074/jbc.m205692200
  • 10.1074/jbc.m205749200
  • 10.1074/jbc.m206169200
  • 10.1074/jbc.m206399200
  • 10.1074/jbc.m206743200
  • 10.1074/jbc.m207187200
  • 10.1074/jbc.m207251200
  • 10.1074/jbc.m207401200
  • 10.1074/jbc.m207409200
  • 10.1074/jbc.m207850200
  • 10.1074/jbc.m208310200
  • 10.1074/jbc.m208518200
  • 10.1074/jbc.m208520200
  • 10.1074/jbc.m208896200
  • 10.1074/jbc.m209256200
  • 10.1074/jbc.m209492200
  • 10.1074/jbc.m209529200
  • 10.1074/jbc.m209706200
  • 10.1074/jbc.m209710200
  • 10.1074/jbc.m209755200
  • 10.1074/jbc.m209799200
  • 10.1074/jbc.m210318200
  • 10.1074/jbc.m210656200
  • 10.1074/jbc.m210695200
  • 10.1074/jbc.m210828200
  • 10.1074/jbc.m210837200
  • 10.1074/jbc.m210843200
  • 10.1074/jbc.m211230200
  • 10.1074/jbc.m211242200
  • 10.1074/jbc.m211329200
  • 10.1074/jbc.m211495200
  • 10.1074/jbc.m211609200
  • 10.1074/jbc.m212231200
  • 10.1074/jbc.m212457200
  • 10.1074/jbc.m212663200
  • 10.1074/jbc.m212856200
  • 10.1074/jbc.m213202200
  • 10.1074/jbc.m213265200
  • 10.1074/jbc.m301311200
  • 10.1074/jbc.m301317200
  • 10.1074/jbc.m301596200
  • 10.1074/jbc.m302002200
  • 10.1074/jbc.m302111200
  • 10.1074/jbc.m302339200
  • 10.1074/jbc.m302675200
  • 10.1074/jbc.m302724200
  • 10.1074/jbc.m302804200
  • 10.1074/jbc.m302830200
  • 10.1074/jbc.m302945200
  • 10.1074/jbc.m303399200
  • 10.1074/jbc.m303532200
  • 10.1074/jbc.m304313200
  • 10.1074/jbc.m304497200
  • 10.1074/jbc.m304499200
  • 10.1074/jbc.m304570200
  • 10.1074/jbc.m305332200
  • 10.1074/jbc.m305519200
  • 10.1074/jbc.m305597200
  • 10.1074/jbc.m306461200
  • 10.1074/jbc.m306499200
  • 10.1074/jbc.m306559200
  • 10.1074/jbc.m307388200
  • 10.1074/jbc.m308196200
  • 10.1074/jbc.m308405200
  • 10.1074/jbc.m308960200
  • 10.1074/jbc.m308995200
  • 10.1074/jbc.m308996200
  • 10.1074/jbc.m308999200
  • 10.1074/jbc.m309183200
  • 10.1074/jbc.m309252200
  • 10.1074/jbc.m309322200
  • 10.1074/jbc.m309527200
  • 10.1074/jbc.m310031200
  • 10.1074/jbc.m310223200
  • 10.1074/jbc.m310695200
  • 10.1074/jbc.m310739200
  • 10.1074/jbc.m311275200
  • 10.1074/jbc.m311602200
  • 10.1074/jbc.m312337200
  • 10.1074/jbc.m312389200
  • 10.1074/jbc.m312498200
  • 10.1074/jbc.m312575200
  • 10.1074/jbc.m312613200
  • 10.1074/jbc.m312729200
  • 10.1074/jbc.m312763200
  • 10.1074/jbc.m312786200
  • 10.1074/jbc.m313381200
  • 10.1074/jbc.m313504200
  • 10.1074/jbc.m400439200
  • 10.1074/jbc.m401312200
  • 10.1074/jbc.m402477200
  • 10.1074/jbc.m402782200
  • 10.1074/jbc.m403588200
  • 10.1074/jbc.m403954200
  • 10.1074/jbc.m404114200
  • 10.1074/jbc.m404675200
  • 10.1074/jbc.m404795200
  • 10.1074/jbc.m404936200
  • 10.1074/jbc.m405144200
  • 10.1074/jbc.m405493200
  • 10.1074/jbc.m405760200
  • 10.1074/jbc.m406534200
  • 10.1074/jbc.m406561200
  • 10.1074/jbc.m406703200
  • 10.1074/jbc.m406966200
  • 10.1074/jbc.m407676200
  • 10.1074/jbc.m408308200
  • 10.1074/jbc.m408495200
  • 10.1074/jbc.m408836200
  • 10.1074/jbc.m409579200
  • 10.1074/jbc.m409765200
  • 10.1074/jbc.m409916200
  • 10.1074/jbc.m410012200
  • 10.1074/jbc.m410026200
  • 10.1074/jbc.m410031200
  • 10.1074/jbc.m410508200
  • 10.1074/jbc.m411356200
  • 10.1074/jbc.m411765200
  • 10.1074/jbc.m411990200
  • 10.1074/jbc.m412038200
  • 10.1074/jbc.m412275200
  • 10.1074/jbc.m412495200
  • 10.1074/jbc.m413274200
  • 10.1074/jbc.m414548200
  • 10.1074/jbc.m500699200
  • 10.1074/jbc.m501185200
  • 10.1074/jbc.m501631200
  • 10.1074/jbc.m502546200
  • 10.1074/jbc.m504113200
  • 10.1074/jbc.m504163200
  • 10.1074/jbc.m504308200
  • 10.1074/jbc.m505368200
  • 10.1074/jbc.m505802200
  • 10.1074/jbc.m507807200
  • 10.1074/jbc.m508234200
  • 10.1074/jbc.m509075200
  • 10.1074/jbc.m509381200
  • 10.1074/jbc.m510215200
  • 10.1074/jbc.m510992200
  • 10.1074/jbc.m511079200
  • 10.1074/jbc.m511105200
  • 10.1074/jbc.m511205200
  • 10.1074/jbc.m511248200
  • 10.1074/jbc.m512330200
  • 10.1074/jbc.m512751200
  • 10.1074/jbc.m513605200
  • 10.1074/jbc.m513665200
  • 10.1074/jbc.m600274200
  • 10.1074/jbc.m600448200
  • 10.1074/jbc.m600620200
  • 10.1074/jbc.m600775200
  • 10.1074/jbc.m601019200
  • 10.1074/jbc.m601121200
  • 10.1074/jbc.m601252200
  • 10.1074/jbc.m602245200
  • 10.1074/jbc.m602469200
  • 10.1074/jbc.m603503200
  • 10.1074/jbc.m603603200
  • 10.1074/jbc.m603604200
  • 10.1074/jbc.m603670200
  • 10.1074/jbc.m603742200
  • 10.1074/jbc.m603928200
  • 10.1074/jbc.m604044200
  • 10.1074/jbc.m604342200
  • 10.1074/jbc.m606225200
  • 10.1074/jbc.m606248200
  • 10.1074/jbc.m606357200
  • 10.1074/jbc.m606601200
  • 10.1074/jbc.m606693200
  • 10.1074/jbc.m607563200
  • 10.1074/jbc.m608599200
  • 10.1074/jbc.m609048200
  • 10.1074/jbc.m609712200
  • 10.1074/jbc.m609734200
  • 10.1074/jbc.m610826200
  • 10.1074/jbc.m611063200
  • 10.1074/jbc.m611704200
  • 10.1074/jbc.m611741200
  • 10.1074/jbc.m611877200
  • 10.1074/jbc.m700075200
  • 10.1074/jbc.m700460200
  • 10.1074/jbc.m701294200
  • 10.1074/jbc.m701877200
  • 10.1074/jbc.m702636200
  • 10.1074/jbc.m702840200
  • 10.1074/jbc.m702895200
  • 10.1074/jbc.m703523200
  • 10.1074/jbc.m703800200
  • 10.1074/jbc.m704165200
  • 10.1074/jbc.m704188200
  • 10.1074/jbc.m704430200
  • 10.1074/jbc.m704505200
  • 10.1074/jbc.m704590200
  • 10.1074/jbc.m704873200
  • 10.1074/jbc.m705052200
  • 10.1074/jbc.m705170200
  • 10.1074/jbc.m706067200
  • 10.1074/jbc.m706238200
  • 10.1074/jbc.m706760200
  • 10.1074/jbc.m706974200
  • 10.1074/jbc.m707037200
  • 10.1074/jbc.m707839200
  • 10.1074/jbc.m708424200
  • 10.1074/jbc.m709037200
  • 10.1074/jbc.m709305200
  • 10.1074/jbc.m709336200
  • 10.1074/jbc.m709703200
  • 10.1074/jbc.m800327200
  • 10.1074/jbc.m800617200
  • 10.1074/jbc.m800723200
  • 10.1074/jbc.m801010200
  • 10.1074/jbc.m801266200
  • 10.1074/jbc.m801782200
  • 10.1074/jbc.m802059200
  • 10.1074/jbc.m802376200
  • 10.1074/jbc.m802917200
  • 10.1074/jbc.m803330200
  • 10.1074/jbc.m803901200
  • 10.1074/jbc.m803957200
  • 10.1074/jbc.m804599200
  • 10.1074/jbc.m804795200
  • 10.1074/jbc.m805611200
  • 10.1074/jbc.m805634200
  • 10.1074/jbc.m805749200
  • 10.1074/jbc.m805860200
  • 10.1074/jbc.m805916200
  • 10.1074/jbc.m806409200
  • 10.1074/jbc.m806838200
  • 10.1074/jbc.m806853200
  • 10.1074/jbc.m807216200
  • 10.1074/jbc.m807607200
  • 10.1074/jbc.m807845200
  • 10.1074/jbc.m807994200
  • 10.1074/jbc.m808048200
  • 10.1074/jbc.m808061200
  • 10.1074/jbc.m809348200
  • 10.1074/jbc.m809725200
  • 10.1074/jbc.m900365200
  • 10.1074/jbc.m905251199
  • 10.1074/jbc.m909259199
  • 10.1074/jbc.m910345199
  • 10.1074/jbc.r100029200
  • 10.1074/jbc.r400035200
  • 10.1074/jbc.r800082200
  • 10.1074/jbc.ra117.001596
  • 10.1074/mcp.m116.061531
  • 10.1074/mcp.m400118-mcp200
  • 10.1080/08037050152518302
  • 10.1080/08037050152669747
  • 10.1080/080370599438293
  • 10.1080/08038020410016548
  • 10.1080/08977194.2018.1473393
  • 10.1080/09546630410017275
  • 10.1080/10253890701248673
  • 10.1080/10408360490460933
  • 10.1080/10409238.2018.1431606
  • 10.1080/10799890600932220
  • 10.1080/14656566.2017.1293654
  • 10.1080/15216540050212132
  • 10.1080/15216540601019485
  • 10.1080/21541248.2017.1362495
  • 10.1080/21655979.2022.2081457
  • 10.1083/jcb.118.3.509
  • 10.1083/jcb.122.5.1079
  • 10.1083/jcb.124.4.557
  • 10.1083/jcb.137.7.1555
  • 10.1083/jcb.140.4.961
  • 10.1083/jcb.141.1.187
  • 10.1083/jcb.142.4.1075
  • 10.1083/jcb.143.4.901
  • 10.1083/jcb.145.6.1165
  • 10.1083/jcb.146.2.389
  • 10.1083/jcb.147.5.1023
  • 10.1083/jcb.147.5.921
  • 10.1083/jcb.148.4.691
  • 10.1083/jcb.148.6.1267
  • 10.1083/jcb.149.2.249
  • 10.1083/jcb.149.7.1419
  • 10.1083/jcb.150.4.905
  • 10.1083/jcb.150.6.1311
  • 10.1083/jcb.152.1.111
  • 10.1083/jcb.152.3.471
  • 10.1083/jcb.152.5.1087
  • 10.1083/jcb.153.3.569
  • 10.1083/jcb.200109100
  • 10.1083/jcb.200111026
  • 10.1083/jcb.200210115
  • 10.1083/jcb.200302047
  • 10.1083/jcb.200303082
  • 10.1083/jcb.200304105
  • 10.1083/jcb.200307151
  • 10.1083/jcb.200403127
  • 10.1083/jcb.200403155
  • 10.1083/jcb.200409157
  • 10.1083/jcb.200506033
  • 10.1083/jcb.200509067
  • 10.1083/jcb.200509096
  • 10.1083/jcb.200511061
  • 10.1083/jcb.200605006
  • 10.1083/jcb.200606017
  • 10.1083/jcb.200606020
  • 10.1083/jcb.200607025
  • 10.1083/jcb.200704152
  • 10.1083/jcb.200709033
  • 10.1083/jcb.200709091
  • 10.1083/jcb.200805107
  • 10.1083/jcb.200806076
  • 10.1083/jcb.200809144
  • 10.1083/jcb.200810133
  • 10.1083/jcb.200810179
  • 10.1083/jcb.200907126
  • 10.1083/jcb.200912082
  • 10.1083/jcb.201004108
  • 10.1083/jcb.201005141
  • 10.1083/jcb.201008087
  • 10.1083/jcb.201008090
  • 10.1083/jcb.201009069
  • 10.1083/jcb.201011038
  • 10.1083/jcb.201107021
  • 10.1083/jcb.201205041
  • 10.1083/jcb.201305158
  • 10.1083/jcb.201306041
  • 10.1083/jcb.201501072
  • 10.1084/jem.167.6.1883
  • 10.1084/jem.174.6.1355
  • 10.1084/jem.180.1.253
  • 10.1084/jem.182.2.593
  • 10.1084/jem.184.3.1185
  • 10.1084/jem.184.3.963
  • 10.1084/jem.185.11.2015
  • 10.1084/jem.186.1.165
  • 10.1084/jem.187.12.2009
  • 10.1084/jem.187.4.655
  • 10.1084/jem.188.3.561
  • 10.1084/jem.192.3.421
  • 10.1084/jem.20030382
  • 10.1084/jem.20031877
  • 10.1084/jem.20041277
  • 10.1084/jem.20042031
  • 10.1084/jem.20060807
  • 10.1084/jem.20080134
  • 10.1084/jem.20080829
  • 10.1084/jem.20091990
  • 10.1084/jem.20110198
  • 10.1084/jem.20111343
  • 10.1084/jem.20130498
  • 10.1086/505332
  • 10.1089/10807680260218489
  • 10.1089/aid.2011.0180
  • 10.1089/ars.2007.1556
  • 10.1089/ars.2012.4773
  • 10.1089/ars.2012.4970
  • 10.1089/dna.1985.4.293
  • 10.1089/dna.1992.11.21
  • 10.1089/dna.1993.12.465
  • 10.1089/jop.2017.0144
  • 10.1089/thy.2019.0807
  • 10.1091/mbc.01-10-0477
  • 10.1091/mbc.02-06-0092
  • 10.1091/mbc.10.4.1119
  • 10.1091/mbc.11.3.1023
  • 10.1091/mbc.11.8.2691
  • 10.1091/mbc.12.4.1079
  • 10.1091/mbc.12.4.931
  • 10.1091/mbc.4.1.49
  • 10.1091/mbc.4.12.1267
  • 10.1091/mbc.5.4.413
  • 10.1091/mbc.6.2.171
  • 10.1091/mbc.9.9.2627
  • 10.1091/mbc.e02-03-0153
  • 10.1091/mbc.e02-07-0427
  • 10.1091/mbc.e02-07-0441
  • 10.1091/mbc.e02-08-0497
  • 10.1091/mbc.e02-09-0578
  • 10.1091/mbc.e02-09-0621
  • 10.1091/mbc.e02-09-0623
  • 10.1091/mbc.e03-11-0847
  • 10.1091/mbc.e04-02-0141
  • 10.1091/mbc.e04-02-0146
  • 10.1091/mbc.e04-07-0547
  • 10.1091/mbc.e04-07-0614
  • 10.1091/mbc.e04-10-0904
  • 10.1091/mbc.e04-11-0960
  • 10.1091/mbc.e05-02-0090
  • 10.1091/mbc.e05-12-1158
  • 10.1091/mbc.e06-01-0002
  • 10.1091/mbc.e06-05-0466
  • 10.1091/mbc.e06-07-0590
  • 10.1091/mbc.e08-05-0448
  • 10.1091/mbc.e08-10-1029
  • 10.1091/mbc.e09-03-0230
  • 10.1091/mbc.e09-05-0437
  • 10.1091/mbc.e10-03-0256
  • 10.1091/mbc.e10-04-0324
  • 10.1091/mbc.e10-07-0605
  • 10.1091/mbc.e10-12-0969
  • 10.1091/mbc.e11-01-0020
  • 10.1091/mbc.e11-04-0300
  • 10.1091/mbc.e11-04-0364
  • 10.1091/mbc.e11-07-0638
  • 10.1091/mbc.e12-07-0555
  • 10.1091/mbc.e13-04-0212
  • 10.1091/mbc.e16-05-0326
  • 10.1091/mbc.e16-12-0885
  • 10.1093/abbs/gmr079
  • 10.1093/bja/aei021
  • 10.1093/brain/awh428
  • 10.1093/carcin/bgl254
  • 10.1093/carcin/bgn049
  • 10.1093/carcin/bgn119
  • 10.1093/carcin/bgq013
  • 10.1093/chemse/bjp092
  • 10.1093/clinchem/44.3.463
  • 10.1093/clinchem/48.1.176
  • 10.1093/cvr/18.5.302
  • 10.1093/cvr/20.5.358
  • 10.1093/cvr/cvs079
  • 10.1093/embo-reports/kvf008
  • 10.1093/embo-reports/kvf181
  • 10.1093/emboj/16.11.3089
  • 10.1093/emboj/16.13.3866
  • 10.1093/emboj/16.17.5353
  • 10.1093/emboj/16.3.441
  • 10.1093/emboj/16.6.1153
  • 10.1093/emboj/16.6.1268
  • 10.1093/emboj/17.12.3372
  • 10.1093/emboj/17.14.4056
  • 10.1093/emboj/17.14.4075
  • 10.1093/emboj/17.15.4426
  • 10.1093/emboj/17.16.4829
  • 10.1093/emboj/17.2.414
  • 10.1093/emboj/17.20.6010
  • 10.1093/emboj/17.21.6250
  • 10.1093/emboj/17.22.6527
  • 10.1093/emboj/17.22.6608
  • 10.1093/emboj/17.23.6932
  • 10.1093/emboj/17.5.1371
  • 10.1093/emboj/17.8.2224
  • 10.1093/emboj/18.15.4233
  • 10.1093/emboj/18.19.5347
  • 10.1093/emboj/18.3.664
  • 10.1093/emboj/18.4.904
  • 10.1093/emboj/18.8.2137
  • 10.1093/emboj/18.9.2500
  • 10.1093/emboj/19.19.5178
  • 10.1093/emboj/19.20.5429
  • 10.1093/emboj/19.22.6121
  • 10.1093/emboj/19.24.6778
  • 10.1093/emboj/19.5.1010
  • 10.1093/emboj/19.8.1839
  • 10.1093/emboj/20.11.2768
  • 10.1093/emboj/20.13.3414
  • 10.1093/emboj/20.14.3738
  • 10.1093/emboj/20.17.4762
  • 10.1093/emboj/20.21.6050
  • 10.1093/emboj/20.22.6203
  • 10.1093/emboj/20.23.6672
  • 10.1093/emboj/21.3.294
  • 10.1093/emboj/21.3.303
  • 10.1093/emboj/cdf343
  • 10.1093/emboj/cdf441
  • 10.1093/emboj/cdf493
  • 10.1093/emboj/cdg023
  • 10.1093/emboj/cdg068
  • 10.1093/emboj/cdg262
  • 10.1093/emboj/cdg287
  • 10.1093/emboj/cdg292
  • 10.1093/emboj/cdg490
  • 10.1093/emboj/cdg540
  • 10.1093/emboj/cdg632
  • 10.1093/eurheartj/10.suppl_c.25
  • 10.1093/eurheartj/ehs472
  • 10.1093/hmg/9.4.477
  • 10.1093/hmg/ddh020
  • 10.1093/hmg/ddp422
  • 10.1093/hmg/ddr457
  • 10.1093/hmg/dds409
  • 10.1093/jb/mvm034
  • 10.1093/jb/mvn136
  • 10.1093/jb/mvp148
  • 10.1093/jb/mvq015
  • 10.1093/jmcb/mjq038
  • 10.1093/nar/17.12.4887
  • 10.1093/nar/18.23.7142
  • 10.1093/nar/26.12.3044
  • 10.1093/nar/29.14.2905
  • 10.1093/nar/29.21.4274
  • 10.1093/nar/29.7.1410
  • 10.1093/nar/gkg346
  • 10.1093/nar/gkj407
  • 10.1093/nar/gkp398
  • 10.1093/nar/gks286
  • 10.1093/nar/gkt034
  • 10.1093/nar/gkt106
  • 10.1093/nar/gkt1341
  • 10.1093/nar/gkt469
  • 10.1093/ndt/gfq725
  • 10.1093/ndt/gft417
  • 10.1093/neuonc/not004
  • 10.1093/neuonc/now261
  • 10.1093/oxfordjournals.jbchem.a002955
  • 10.1093/oxfordjournals.jbchem.a002958
  • 10.1093/rheumatology/kei124
  • 10.1095/biolreprod.106.058982
  • 10.1096/fasebj.9.2.7781920
  • 10.1096/fj.04-2377fje
  • 10.1096/fj.06-7925com
  • 10.1096/fj.08-113910
  • 10.1096/fj.08-121392
  • 10.1096/fj.08-121947
  • 10.1096/fj.09-153452
  • 10.1096/fj.201601305r
  • 10.1096/fj.201700374r
  • 10.1097/00004714-200202000-00013
  • 10.1097/00005344-198205000-00023
  • 10.1097/00005344-199704000-00003
  • 10.1097/00006676-199801000-00004
  • 10.1097/01.iae.0000242842.14624.e7
  • 10.1097/01.pra.0000327312.04153.da
  • 10.1097/aln.0000000000000430
  • 10.1097/aog.0000000000002675
  • 10.1097/md.0000000000009864
  • 10.1097/mol.0b013e32813aeabf
  • 10.1097/mol.0b013e3283532947
  • 10.1097/wco.0000000000000163
  • 10.1097/wnf.0b013e3181cbf825
  • 10.1097/wno.0000000000000222
  • 10.1097/wnr.0000000000000316
  • 10.1097/wnr.0b013e3283186bf8
  • 10.1098/rstb.2006.1894
  • 10.1101/225722
  • 10.1101/cshperspect.a005017
  • 10.1101/cshperspect.a007864
  • 10.1101/cshperspect.a011148
  • 10.1101/cshperspect.a031476
  • 10.1101/cshperspect.a031484
  • 10.1101/gad.10.21.2684
  • 10.1101/gad.10.24.3116
  • 10.1101/gad.10.7.816
  • 10.1101/gad.1003302
  • 10.1101/gad.1017302
  • 10.1101/gad.1022203
  • 10.1101/gad.1026303
  • 10.1101/gad.1054703
  • 10.1101/gad.11.18.2295
  • 10.1101/gad.11.4.492
  • 10.1101/gad.11.8.984
  • 10.1101/gad.1102703
  • 10.1101/gad.1110003
  • 10.1101/gad.1116203
  • 10.1101/gad.1142603
  • 10.1101/gad.1171104
  • 10.1101/gad.1185804
  • 10.1101/gad.12.15.2269
  • 10.1101/gad.12.16.2610
  • 10.1101/gad.12.2.186
  • 10.1101/gad.1212704
  • 10.1101/gad.1239004
  • 10.1101/gad.13.14.1768
  • 10.1101/gad.13.17.2196
  • 10.1101/gad.13.17.2218
  • 10.1101/gad.13.3.270
  • 10.1101/gad.13.7.804
  • 10.1101/gad.1302105
  • 10.1101/gad.1380906
  • 10.1101/gad.1385806
  • 10.1101/gad.14.11.1313
  • 10.1101/gad.14.14.1741
  • 10.1101/gad.1413606
  • 10.1101/gad.1446006
  • 10.1101/gad.1461306
  • 10.1101/gad.1484707
  • 10.1101/gad.1543607
  • 10.1101/gad.1546307
  • 10.1101/gad.1592007
  • 10.1101/gad.1602907
  • 10.1101/gad.1653708
  • 10.1101/gad.1693008
  • 10.1101/gad.176826.111
  • 10.1101/gad.177642.111
  • 10.1101/gad.1777409
  • 10.1101/gad.1794109
  • 10.1101/gad.181289.111
  • 10.1101/gad.1902910
  • 10.1101/gad.190876.112
  • 10.1101/gad.191866.112
  • 10.1101/gad.1948710
  • 10.1101/gad.1951710
  • 10.1101/gad.1966210
  • 10.1101/gad.197434.112
  • 10.1101/gad.2000111
  • 10.1101/gad.251785.114
  • 10.1101/gad.291004
  • 10.1101/gad.296004
  • 10.1101/gad.310204
  • 10.1101/gad.326705
  • 10.1101/gad.5.3.358
  • 10.1101/gad.5.7.1224
  • 10.1101/gad.843800
  • 10.1101/gad.844900
  • 10.1101/gad.850400
  • 10.1101/gad.890501
  • 10.1101/gad.894301
  • 10.1101/gad.9.9.1087
  • 10.1101/gad.906301
  • 10.1101/gad.925702
  • 10.1101/gad.973602
  • 10.1101/gad.991602
  • 10.1101/gr.070961.107
  • 10.1101/gr.100479.109
  • 10.1101/gr.139469.112
  • 10.1101/lm.56003
  • 10.1107/s0907444998009032
  • 10.1110/ps.26702
  • 10.1110/ps.8.12.2589
  • 10.1111/1744-9987.13434
  • 10.1111/1753-0407.12081
  • 10.1111/boc.201300010
  • 10.1111/bph.12403
  • 10.1111/bph.12459
  • 10.1111/bph.13342
  • 10.1111/bph.13348
  • 10.1111/bph.13429
  • 10.1111/bph.13476
  • 10.1111/bph.13496
  • 10.1111/cge.12377
  • 10.1111/cxo.12853
  • 10.1111/dth.13961
  • 10.1111/eci.12951
  • 10.1111/exd.13381
  • 10.1111/febs.12116
  • 10.1111/febs.12419
  • 10.1111/febs.12453
  • 10.1111/head.13305
  • 10.1111/head.13929
  • 10.1111/ijcp.12194
  • 10.1111/iju.13596
  • 10.1111/imr.12447
  • 10.1111/j.0022-202x.2004.12645.x
  • 10.1111/j.1349-7006.2006.00242.x
  • 10.1111/j.1349-7006.2008.00840.x
  • 10.1111/j.1356-9597.2004.00733.x
  • 10.1111/j.1365-2125.1980.tb04899.x
  • 10.1111/j.1365-2125.1980.tb04904.x
  • 10.1111/j.1365-2125.1986.tb02856.x
  • 10.1111/j.1365-2125.1989.tb03570.x
  • 10.1111/j.1365-2141.2006.06259.x
  • 10.1111/j.1365-2443.2003.00692.x
  • 10.1111/j.1365-2443.2007.01068.x
  • 10.1111/j.1365-2443.2012.01616.x
  • 10.1111/j.1365-2567.2009.03209.x
  • 10.1111/j.1365-2826.2011.02206.x
  • 10.1111/j.1365-2958.2005.04877.x
  • 10.1111/j.1432-1033.1994.tb18983.x
  • 10.1111/j.1432-1033.1995.0023o.x
  • 10.1111/j.1432-1033.1995.0535d.x
  • 10.1111/j.1432-1033.1996.0842u.x
  • 10.1111/j.1460-9568.1995.tb00666.x
  • 10.1111/j.1469-7793.2000.t01-1-00221.x
  • 10.1111/j.1471-4159.1991.tb08248.x
  • 10.1111/j.1471-4159.2004.02183.x
  • 10.1111/j.1471-4159.2005.03056.x
  • 10.1111/j.1471-4159.2005.03284.x
  • 10.1111/j.1471-4159.2006.03789.x
  • 10.1111/j.1471-4159.2006.04176.x
  • 10.1111/j.1471-4159.2007.05186.x
  • 10.1111/j.1471-4159.2009.06261.x
  • 10.1111/j.1476-5381.1995.tb16381.x
  • 10.1111/j.1476-5381.2011.01508.x
  • 10.1111/j.1523-1747.2003.12617.x
  • 10.1111/j.1523-1755.2004.00843.x
  • 10.1111/j.1527-3458.2002.tb00219.x
  • 10.1111/j.1538-7836.2009.03527.x
  • 10.1111/j.1600-0749.2005.00240.x
  • 10.1111/j.1600-0749.2006.00292.x
  • 10.1111/j.1600-0773.1963.tb01730.x
  • 10.1111/j.1600-0854.2008.00858.x
  • 10.1111/j.1600-0854.2010.01075.x
  • 10.1111/j.1600-0854.2010.01076.x
  • 10.1111/j.1742-4658.2006.05427.x
  • 10.1111/j.1742-4658.2006.05462.x
  • 10.1111/j.1742-4658.2007.06184.x
  • 10.1111/j.1742-4658.2008.06760.x
  • 10.1111/j.1748-1716.2011.02308.x
  • 10.1111/j.1749-6632.1999.tb09405.x
  • 10.1111/j.1749-6632.2003.tb03219.x
  • 10.1111/j.1749-6632.2010.05191.x
  • 10.1111/j.1752-8062.2010.00217.x
  • 10.1111/j.1753-4887.2009.00261.x
  • 10.1111/j.1755-5949.2008.00067.x
  • 10.1111/jcmm.13960
  • 10.1111/jcmm.14211
  • 10.1111/jcmm.14360
  • 10.1111/jnc.12513
  • 10.1111/jnc.12635
  • 10.1111/joim.12019
  • 10.1111/jth.12360
  • 10.1111/tra.12115
  • 10.1111/tra.12121
  • 10.1124/dmd.113.053595
  • 10.1124/dmd.117.079574
  • 10.1124/dmd.30.11.1288
  • 10.1124/jpet.102.039867
  • 10.1124/jpet.105.097048
  • 10.1124/jpet.106.111039
  • 10.1124/jpet.106.115402
  • 10.1124/jpet.109.150730
  • 10.1124/jpet.110.165993
  • 10.1124/jpet.112.193284
  • 10.1124/jpet.113.204834
  • 10.1124/jpet.115.227793
  • 10.1124/jpet.116.237313
  • 10.1124/jpet.117.244129
  • 10.1124/mol.104.007559
  • 10.1124/mol.105.020172
  • 10.1124/mol.106.022376
  • 10.1124/mol.106.026344
  • 10.1124/mol.111.076976
  • 10.1124/mol.113.090068
  • 10.1124/mol.114.092817
  • 10.1124/mol.54.5.881
  • 10.1124/mol.60.6.1181
  • 10.1124/mol.63.3.471
  • 10.1124/mol.65.1.207
  • 10.1124/pr.114.010249
  • 10.1124/pr.115.011833
  • 10.1124/pr.118.016899
  • 10.1124/pr.54.2.161
  • 10.1126/science.1062030
  • 10.1126/science.1064437
  • 10.1126/science.1065412
  • 10.1126/science.1065654
  • 10.1126/science.1071552
  • 10.1126/science.1073776
  • 10.1126/science.1076469
  • 10.1126/science.1078197
  • 10.1126/science.1079817
  • 10.1126/science.1082808
  • 10.1126/science.1083195
  • 10.1126/science.1090772
  • 10.1126/science.1102160
  • 10.1126/science.1105166
  • 10.1126/science.1105718
  • 10.1126/science.1106148
  • 10.1126/science.1106943
  • 10.1126/science.1117255
  • 10.1126/science.1118890
  • 10.1126/science.1122511
  • 10.1126/science.1134389
  • 10.1126/science.1135344
  • 10.1126/science.1137065
  • 10.1126/science.1137509
  • 10.1126/science.1139740
  • 10.1126/science.1147674
  • 10.1126/science.1152066
  • 10.1126/science.1157535
  • 10.1126/science.1157983
  • 10.1126/science.1160741
  • 10.1126/science.1168974
  • 10.1126/science.1173569
  • 10.1126/science.1182364
  • 10.1126/science.1189123
  • 10.1126/science.1189862
  • 10.1126/science.1222879
  • 10.1126/science.1232389
  • 10.1126/science.1257132
  • 10.1126/science.1325670
  • 10.1126/science.1325671
  • 10.1126/science.1329206
  • 10.1126/science.1347957
  • 10.1126/science.1660188
  • 10.1126/science.1840698
  • 10.1126/science.1840701
  • 10.1126/science.1891716
  • 10.1126/science.2163110
  • 10.1126/science.2466336
  • 10.1126/science.2479986
  • 10.1126/science.2570461
  • 10.1126/science.271.5249.645
  • 10.1126/science.273.5272.245
  • 10.1126/science.276.5314.955
  • 10.1126/science.277.5324.333
  • 10.1126/science.277.5325.567
  • 10.1126/science.277.5331.1501
  • 10.1126/science.279.5350.558
  • 10.1126/science.279.5350.560
  • 10.1126/science.279.5351.710
  • 10.1126/science.280.5369.1614
  • 10.1126/science.281.5378.832
  • 10.1126/science.281.5382.1509
  • 10.1126/science.281.5383.1668
  • 10.1126/science.282.5392.1318
  • 10.1126/science.283.5401.543
  • 10.1126/science.283.5410.2083
  • 10.1126/science.283.5410.2089
  • 10.1126/science.284.5418.1362
  • 10.1126/science.284.5423.2184
  • 10.1126/science.2842868
  • 10.1126/science.286.5438.309
  • 10.1126/science.286.5440.771
  • 10.1126/science.288.5475.2351
  • 10.1126/science.289.5484.1524
  • 10.1126/science.290.5497.1771
  • 10.1126/science.2937147
  • 10.1126/science.3498214
  • 10.1126/science.3513311
  • 10.1126/science.3616618
  • 10.1126/science.3672127
  • 10.1126/science.7871433
  • 10.1126/science.7871435
  • 10.1126/science.8073283
  • 10.1126/science.8197458
  • 10.1126/science.8248782
  • 10.1126/science.8316835
  • 10.1126/science.8327893
  • 10.1126/science.8493579
  • 10.1126/science.aaa1975
  • 10.1126/science/1141515
  • 10.1126/scisignal.1162925
  • 10.1126/scisignal.125re5
  • 10.1126/scisignal.2000405
  • 10.1126/scisignal.2000594
  • 10.1126/scisignal.2001707
  • 10.1126/scisignal.2003669
  • 10.1126/scisignal.2005157
  • 10.1126/scisignal.2005722
  • 10.1126/scitranslmed.aao1690
  • 10.1126/stke.2882005pe28
  • 10.1128/jvi.67.4.2209-2220.1993
  • 10.1128/mcb.00009-06
  • 10.1128/mcb.00024-10
  • 10.1128/mcb.00077-06
  • 10.1128/mcb.00118-10
  • 10.1128/mcb.00125-15
  • 10.1128/mcb.00201-07
  • 10.1128/mcb.00206-14
  • 10.1128/mcb.00322-08
  • 10.1128/mcb.00324-10
  • 10.1128/mcb.00336-08
  • 10.1128/mcb.00365-16
  • 10.1128/mcb.00422-15
  • 10.1128/mcb.00546-06
  • 10.1128/mcb.00555-07
  • 10.1128/mcb.00569-09
  • 10.1128/mcb.00579-08
  • 10.1128/mcb.00595-08
  • 10.1128/mcb.00664-07
  • 10.1128/mcb.00739-08
  • 10.1128/mcb.00745-12
  • 10.1128/mcb.00757-06
  • 10.1128/mcb.00778-07
  • 10.1128/mcb.00899-06
  • 10.1128/mcb.00985-06
  • 10.1128/mcb.01089-09
  • 10.1128/mcb.01206-14
  • 10.1128/mcb.01230-07
  • 10.1128/mcb.01245-06
  • 10.1128/mcb.01354-09
  • 10.1128/mcb.01416-12
  • 10.1128/mcb.01469-10
  • 10.1128/mcb.01538-13
  • 10.1128/mcb.01608-06
  • 10.1128/mcb.01636-06
  • 10.1128/mcb.01646-09
  • 10.1128/mcb.01705-08
  • 10.1128/mcb.01716-12
  • 10.1128/mcb.01874-07
  • 10.1128/mcb.01894-06
  • 10.1128/mcb.01986-07
  • 10.1128/mcb.02030-07
  • 10.1128/mcb.02061-07
  • 10.1128/mcb.02179-06
  • 10.1128/mcb.02183-05
  • 10.1128/mcb.02186-05
  • 10.1128/mcb.02249-06
  • 10.1128/mcb.02354-05
  • 10.1128/mcb.06633-11
  • 10.1128/mcb.10.10.5596
  • 10.1128/mcb.10.2.435
  • 10.1128/mcb.10.2.634
  • 10.1128/mcb.10.5.1931
  • 10.1128/mcb.11.10.5068
  • 10.1128/mcb.11.4.2040
  • 10.1128/mcb.11.5.2335
  • 10.1128/mcb.11.8.3835
  • 10.1128/mcb.12.3.915
  • 10.1128/mcb.12.6.2534
  • 10.1128/mcb.13.11.6858
  • 10.1128/mcb.13.11.6889
  • 10.1128/mcb.13.6.3706
  • 10.1128/mcb.14.1.181
  • 10.1128/mcb.14.10.6715
  • 10.1128/mcb.14.10.6944
  • 10.1128/mcb.14.11.7483
  • 10.1128/mcb.14.12.8432
  • 10.1128/mcb.14.3.1680
  • 10.1128/mcb.14.6.3810
  • 10.1128/mcb.14.8.5192
  • 10.1128/mcb.15.1.505
  • 10.1128/mcb.15.10.5214
  • 10.1128/mcb.15.10.5770
  • 10.1128/mcb.15.11.6430
  • 10.1128/mcb.15.2.1086
  • 10.1128/mcb.15.2.954
  • 10.1128/mcb.15.5.2791
  • 10.1128/mcb.15.7.3479
  • 10.1128/mcb.15.8.4403
  • 10.1128/mcb.16.10.5313
  • 10.1128/mcb.16.10.5674
  • 10.1128/mcb.16.3.1066
  • 10.1128/mcb.16.3.977
  • 10.1128/mcb.16.4.1759
  • 10.1128/mcb.16.6.2670
  • 10.1128/mcb.16.6.2689
  • 10.1128/mcb.16.6.3169
  • 10.1128/mcb.16.7.3545
  • 10.1128/mcb.16.9.4621
  • 10.1128/mcb.16.9.4869
  • 10.1128/mcb.17.10.6057
  • 10.1128/mcb.17.11.6585
  • 10.1128/mcb.17.3.1244
  • 10.1128/mcb.17.3.1682
  • 10.1128/mcb.17.5.2497
  • 10.1128/mcb.17.7.3850
  • 10.1128/mcb.17.7.3977
  • 10.1128/mcb.17.8.4509
  • 10.1128/mcb.17.9.5106
  • 10.1128/mcb.18.1.130
  • 10.1128/mcb.18.1.512
  • 10.1128/mcb.18.12.6951
  • 10.1128/mcb.18.12.7259
  • 10.1128/mcb.18.12.7423
  • 10.1128/mcb.18.3.1248
  • 10.1128/mcb.18.3.1525
  • 10.1128/mcb.18.7.3966
  • 10.1128/mcb.18.7.4109
  • 10.1128/mcb.18.8.4499
  • 10.1128/mcb.19.1.229
  • 10.1128/mcb.19.1.251
  • 10.1128/mcb.19.1.431
  • 10.1128/mcb.19.10.6585
  • 10.1128/mcb.19.11.7759
  • 10.1128/mcb.19.11.7870
  • 10.1128/mcb.19.3.1821
  • 10.1128/mcb.19.5.3748
  • 10.1128/mcb.19.6.4465
  • 10.1128/mcb.19.8.5326
  • 10.1128/mcb.19.8.5523
  • 10.1128/mcb.19.9.6286
  • 10.1128/mcb.20.11.3906-3917.2000
  • 10.1128/mcb.20.15.5529-5539.2000
  • 10.1128/mcb.20.16.6114-6126.2000
  • 10.1128/mcb.20.17.6287-6299.2000
  • 10.1128/mcb.20.18.6872-6881.2000
  • 10.1128/mcb.20.18.6913-6922.2000
  • 10.1128/mcb.20.19.7388-7400.2000
  • 10.1128/mcb.20.2.429-440.2000
  • 10.1128/mcb.20.3.979-989.2000
  • 10.1128/mcb.20.4.1448-1459.2000
  • 10.1128/mcb.20.5.1825-1835.2000
  • 10.1128/mcb.20.7.2400-2410.2000
  • 10.1128/mcb.20.9.3079-3085.2000
  • 10.1128/mcb.21.21.7345-7354.2001
  • 10.1128/mcb.21.21.7403-7415.2001
  • 10.1128/mcb.21.22.7558-7568.2001
  • 10.1128/mcb.21.22.7641-7652.2001
  • 10.1128/mcb.21.23.8022-8034.2001
  • 10.1128/mcb.21.9.2991-3000.2001
  • 10.1128/mcb.22.1.171-181.2002
  • 10.1128/mcb.22.17.6100-6110.2002
  • 10.1128/mcb.22.17.6247-6260.2002
  • 10.1128/mcb.22.18.6363-6374.2002
  • 10.1128/mcb.22.19.6719-6725.2002
  • 10.1128/mcb.22.2.567-577.2002
  • 10.1128/mcb.22.22.7731-7743.2002
  • 10.1128/mcb.22.22.7758-7768.2002
  • 10.1128/mcb.22.22.7812-7819.2002
  • 10.1128/mcb.22.22.7953-7966.2002
  • 10.1128/mcb.22.4.1158-1171.2002
  • 10.1128/mcb.22.4.1172-1183.2002
  • 10.1128/mcb.22.4.1184-1193.2002
  • 10.1128/mcb.22.8.2536-2543.2002
  • 10.1128/mcb.22.8.2632-2641.2002
  • 10.1128/mcb.22.9.2952-2964.2002
  • 10.1128/mcb.23.1.131-139.2003
  • 10.1128/mcb.23.1.92-103.2003
  • 10.1128/mcb.23.11.4026-4033.2003
  • 10.1128/mcb.23.13.4542-4558.2003
  • 10.1128/mcb.23.14.4778-4787.2003
  • 10.1128/mcb.23.16.5780-5789.2003
  • 10.1128/mcb.23.16.5825-5835.2003
  • 10.1128/mcb.23.18.6609-6617.2003
  • 10.1128/mcb.23.21.7875-7886.2003
  • 10.1128/mcb.23.4.1379-1389.2003
  • 10.1128/mcb.23.5.1633-1646.2003
  • 10.1128/mcb.23.6.1994-2008.2003
  • 10.1128/mcb.23.6.2182-2191.2003
  • 10.1128/mcb.23.8.2883-2892.2003
  • 10.1128/mcb.24.1.58-70.2004
  • 10.1128/mcb.24.10.4341-4350.2004
  • 10.1128/mcb.24.11.4757-4768.2004
  • 10.1128/mcb.24.11.4955-4967.2004
  • 10.1128/mcb.24.14.6140-6150.2004
  • 10.1128/mcb.24.16.7260-7274.2004
  • 10.1128/mcb.24.17.7456-7468.2004
  • 10.1128/mcb.24.17.7643-7653.2004
  • 10.1128/mcb.24.2.823-836.2004
  • 10.1128/mcb.24.2.856-864.2004
  • 10.1128/mcb.24.23.10277-10288.2004
  • 10.1128/mcb.24.23.10340-10351.2004
  • 10.1128/mcb.24.24.10558-10572.2004
  • 10.1128/mcb.24.8.3404-3414.2004
  • 10.1128/mcb.25.1.250-263.2005
  • 10.1128/mcb.25.11.4466-4475.2005
  • 10.1128/mcb.25.18.7940-7952.2005
  • 10.1128/mcb.25.21.9632-9645.2005
  • 10.1128/mcb.25.22.9845-9858.2005
  • 10.1128/mcb.25.23.10286-10300.2005
  • 10.1128/mcb.25.7.2846-2852.2005
  • 10.1128/mcb.26.4.1209-1222.2006
  • 10.1128/mcb.26.5.1898-1907.2006
  • 10.1128/mcb.26.6.2160-2174.2006
  • 10.1128/mcb.26.6.2262-2272.2006
  • 10.1128/mcb.26.9.3365-3377.2006
  • 10.1128/mcb.26.9.3639-3648.2006
  • 10.1128/mcb.9.3.1165
  • 10.1128/mmbr.00031-10
  • 10.1128/mmbr.69.1.79-100.2005
  • 10.1134/s0006297912010038
  • 10.1136/bmj.3.5986.735
  • 10.1136/jclinpath-2017-204853
  • 10.1136/jcp.2003.009506
  • 10.1136/jmedgenet-2012-101442
  • 10.1136/thx.2009.128082
  • 10.1139/o10-138
  • 10.1139/o2012-009
  • 10.1139/o77-096
  • 10.1139/y02-025
  • 10.1146/annurev-cellbio-092910-154048
  • 10.1146/annurev-med-050913-021703
  • 10.1146/annurev.bi.56.070187.003151
  • 10.1146/annurev.biochem.67.1.753
  • 10.1146/annurev.biochem.70.1.535
  • 10.1146/annurev.biochem.72.121801.161629
  • 10.1146/annurev.biochem.75.103004.142422
  • 10.1146/annurev.biochem.75.103004.142647
  • 10.1146/annurev.biophys.35.040405.101936
  • 10.1146/annurev.cellbio.21.020604.150721
  • 10.1146/annurev.neuro.24.1.677
  • 10.1146/annurev.pa.29.040189.001011
  • 10.1146/annurev.ph.47.030185.002123
  • 10.1146/annurev.pharmtox.37.1.205
  • 10.1146/annurev.physiol.69.031905.160319
  • 10.1152/advan.00025.2003
  • 10.1152/ajpcell.00037.2009
  • 10.1152/ajpcell.00185.2009
  • 10.1152/ajpcell.00347.2009
  • 10.1152/ajpcell.2001.281.5.c1448
  • 10.1152/ajpendo.00022.2008
  • 10.1152/ajpendo.1996.270.2.e299
  • 10.1152/ajpendo.1996.271.1.e1
  • 10.1152/ajpendo.90897.2008
  • 10.1152/ajpgi.00557.2005
  • 10.1152/ajpgi.1998.274.3.g535
  • 10.1152/ajplegacy.1949.156.2.261
  • 10.1152/ajplung.00417.2012
  • 10.1152/ajplung.00423.2020
  • 10.1152/ajpregu.00374.2001
  • 10.1152/ajprenal.00594.2012
  • 10.1152/ajprenal.2001.280.2.f291
  • 10.1152/japplphysiol.00621.2004
  • 10.1152/jn.00737.2005
  • 10.1152/physrev.00003.2012
  • 10.1152/physrev.00021.2007
  • 10.1152/physrev.00023.2016
  • 10.1152/physrev.00024.2016
  • 10.1152/physrev.00044.2005
  • 10.1152/physrev.1999.79.4.1283
  • 10.1152/physrev.2000.80.4.1291
  • 10.1155/2013/527548
  • 10.1158/0008-5472.can-03-2868
  • 10.1158/0008-5472.can-03-3106
  • 10.1158/0008-5472.can-03-3681
  • 10.1158/0008-5472.can-04-1168
  • 10.1158/0008-5472.can-04-1949
  • 10.1158/0008-5472.can-04-3553
  • 10.1158/0008-5472.can-05-1150
  • 10.1158/0008-5472.can-05-2368
  • 10.1158/0008-5472.can-05-3610
  • 10.1158/0008-5472.can-05-4397
  • 10.1158/0008-5472.can-06-1650
  • 10.1158/0008-5472.can-06-2726
  • 10.1158/0008-5472.can-06-2909
  • 10.1158/0008-5472.can-06-3559
  • 10.1158/0008-5472.can-07-1585
  • 10.1158/0008-5472.can-07-1827
  • 10.1158/0008-5472.can-07-2488
  • 10.1158/0008-5472.can-07-5558
  • 10.1158/0008-5472.can-07-6307
  • 10.1158/0008-5472.can-07-6349
  • 10.1158/0008-5472.can-08-0517
  • 10.1158/0008-5472.can-08-0955
  • 10.1158/0008-5472.can-08-0997
  • 10.1158/0008-5472.can-08-1622
  • 10.1158/0008-5472.can-08-2791
  • 10.1158/0008-5472.can-08-3797
  • 10.1158/0008-5472.can-08-4447
  • 10.1158/0008-5472.can-09-0529
  • 10.1158/0008-5472.can-09-3068
  • 10.1158/0008-5472.can-09-3229
  • 10.1158/0008-5472.can-09-4063
  • 10.1158/0008-5472.can-10-0413
  • 10.1158/0008-5472.can-11-2181
  • 10.1158/0008-5472.can-11-2612
  • 10.1158/0008-5472.can-12-0775
  • 10.1158/0008-5472.can-12-3937
  • 10.1158/0008-5472.can-13-0297
  • 10.1158/0008-5472.can-13-0523
  • 10.1158/0008-5472.can-13-1825
  • 10.1158/0008-5472.can-13-3724
  • 10.1158/0008-5472.can-14-0268
  • 10.1158/0008-5472.can-15-0356
  • 10.1158/0008-5472.can-15-1722
  • 10.1158/0008-5472.can-15-2510
  • 10.1158/0008-5472.can-15-2923
  • 10.1158/0008-5472.can-18-0359
  • 10.1158/1078-0432.ccr-06-2237
  • 10.1158/1078-0432.ccr-06-2590
  • 10.1158/1078-0432.ccr-07-1181
  • 10.1158/1078-0432.ccr-09-2353
  • 10.1158/1078-0432.ccr-09-2660
  • 10.1158/1078-0432.ccr-10-1863
  • 10.1158/1078-0432.ccr-14-0543
  • 10.1158/1078-0432.ccr-17-1366
  • 10.1158/1078-0432.ccr-17-1588
  • 10.1158/1535-7163.mct-04-0114
  • 10.1158/1535-7163.mct-06-0720
  • 10.1158/1535-7163.mct-11-0682
  • 10.1158/1535-7163.mct-12-0431
  • 10.1158/1535-7163.mct-16-0703
  • 10.1158/1535-7163.mct-17-0456
  • 10.1158/1541-7786.mcr-07-2175
  • 10.1158/1541-7786.mcr-11-0382
  • 10.1158/1541-7786.mcr-13-0637
  • 10.1158/1541-7786.mcr-15-0165
  • 10.1158/2159-8290.cd-13-0070
  • 10.1158/2159-8290.cd-13-0146
  • 10.1158/2159-8290.cd-16-1431
  • 10.1159/000015658
  • 10.1159/000186690
  • 10.1159/000319859
  • 10.1159/000512234
  • 10.1160/th05-03-0208
  • 10.1161/01.atv.0000121202.72593.da
  • 10.1161/01.atv.0000200082.58536.e1
  • 10.1161/01.atv.19.1.178
  • 10.1161/01.cir.0000079163.97653.cd
  • 10.1161/01.hyp.0000251865.35728.2f
  • 10.1161/01.res.0000043282.39776.7c
  • 10.1161/01.res.0000059260.91342.6e
  • 10.1161/01.res.0000097607.14733.0c
  • 10.1161/01.res.0000126404.41421.be
  • 10.1161/01.res.0000156652.99586.9f
  • 10.1161/01.res.0000259593.07661.1e
  • 10.1161/01.res.84.8.891
  • 10.1161/01.res.87.8.677
  • 10.1161/atvbaha.109.194548
  • 10.1161/atvbaha.111.243519
  • 10.1161/atvbaha.112.250571
  • 10.1161/atvbaha.112.300234
  • 10.1161/atvbaha.116.308434
  • 10.1161/circheartfailure.108.846212
  • 10.1161/circresaha.107.165134
  • 10.1161/circresaha.108.184846
  • 10.1161/circresaha.109.208272
  • 10.1161/circresaha.112.300648
  • 10.1161/circresaha.113.301077
  • 10.1161/circresaha.115.307738
  • 10.1161/circulationaha.107.707257
  • 10.1161/hypertensionaha.123.21364
  • 10.1161/hypertensionaha.124.22693
  • 10.1164/rccm.2503006
  • 10.1165/rcmb.2002-0249oc
  • 10.1165/rcmb.2004-0405oc
  • 10.1167/iovs.14-16066
  • 10.1172/jci.insight.167092
  • 10.1172/jci.insight.91225
  • 10.1172/jci.insight.92352
  • 10.1172/jci0214340
  • 10.1172/jci0215593
  • 10.1172/jci0216000
  • 10.1172/jci116046
  • 10.1172/jci119006
  • 10.1172/jci119247
  • 10.1172/jci119365
  • 10.1172/jci119624
  • 10.1172/jci123462
  • 10.1172/jci18829
  • 10.1172/jci24311
  • 10.1172/jci27544
  • 10.1172/jci27987
  • 10.1172/jci32964
  • 10.1172/jci39374
  • 10.1172/jci41280
  • 10.1172/jci42542
  • 10.1172/jci45589
  • 10.1172/jci60376
  • 10.1172/jci6042
  • 10.1172/jci60498
  • 10.1172/jci60517
  • 10.1172/jci61492
  • 10.1172/jci69657
  • 10.1172/jci7447
  • 10.1172/jci81673
  • 10.1172/jci8573
  • 10.1172/jci88899
  • 10.1172/jci949
  • 10.1176/appi.ajp.157.4.514
  • 10.1177/000348949510400906
  • 10.1177/002215540305100402
  • 10.1177/002215540405200502
  • 10.1177/030006058201000102
  • 10.1177/070674370204700106
  • 10.1177/107424840300800204
  • 10.1177/1074248413511693
  • 10.1177/1087057109341407
  • 10.1177/1470320310391503
  • 10.1177/1636.17920
  • 10.1177/1756283x13502637
  • 10.1177/1759720x19828669
  • 10.1177/1947601911407323
  • 10.1177/1947601911408079
  • 10.1177/1947601911412376
  • 10.1177/2040622313518227
  • 10.1177/2042018810390259
  • 10.1177/44.8.8756760
  • 10.1182/blood-2002-05-1343
  • 10.1182/blood-2002-07-2250
  • 10.1182/blood-2002-11-3540
  • 10.1182/blood-2003-03-0820
  • 10.1182/blood-2003-04-1038
  • 10.1182/blood-2003-08-2857
  • 10.1182/blood-2004-03-1151
  • 10.1182/blood-2004-05-2005
  • 10.1182/blood-2004-06-2125
  • 10.1182/blood-2004-11-4377
  • 10.1182/blood-2006-04-017434
  • 10.1182/blood-2006-07-033662
  • 10.1182/blood-2006-07-034124
  • 10.1182/blood-2007-04-085514
  • 10.1182/blood-2007-05-092718
  • 10.1182/blood-2007-06-094060
  • 10.1182/blood-2007-11-126326
  • 10.1182/blood-2008-04-152587
  • 10.1182/blood-2009-12-261602
  • 10.1182/blood-2010-03-273094
  • 10.1182/blood-2010-03-275602
  • 10.1182/blood-2010-07-296616
  • 10.1182/blood-2010-12-324053
  • 10.1182/blood-2010-12-326629
  • 10.1182/blood-2011-06-358960
  • 10.1182/blood-2012-04-424275
  • 10.1182/blood-2012-05-432534
  • 10.1182/blood-2013-04-497933
  • 10.1182/blood-2016-03-707844
  • 10.1182/blood-2016-05-717793
  • 10.1182/blood-2017-04-780379
  • 10.1182/blood.v100.13.4462
  • 10.1182/blood.v69.1.219.219
  • 10.1182/blood.v83.2.476.476
  • 10.1182/blood.v87.9.3688.bloodjournal8793688
  • 10.1182/blood.v88.2.437.bloodjournal882437
  • 10.1182/blood.v90.10.3936
  • 10.1182/blood.v91.3.898
  • 10.1182/blood.v91.6.1873
  • 10.1182/blood.v94.2.539
  • 10.1182/blood.v94.4.1440
  • 10.1182/blood.v95.8.2624
  • 10.1182/blood.v96.13.4319
  • 10.1182/blood.v98.5.1365
  • 10.1182/blood.v99.10.3742
  • 10.1183/09031936.00060006
  • 10.1183/09031936.00145006
  • 10.1185/030079908x261113
  • 10.1185/03007995.2012.672405
  • 10.1185/03007995.2014.880050
  • 10.1186/1471-2121-10-56
  • 10.1186/1471-213x-8-11
  • 10.1186/1471-213x-8-69
  • 10.1186/1471-2199-9-11
  • 10.1186/1471-2407-4-43
  • 10.1186/1471-2407-9-159
  • 10.1186/1475-2859-13-29
  • 10.1186/1475-4924-2-28
  • 10.1186/1476-4598-12-132
  • 10.1186/1476-4598-3-10
  • 10.1186/1476-4598-6-69
  • 10.1186/1476-4598-7-49
  • 10.1186/1476-511x-12-32
  • 10.1186/1478-811x-7-13
  • 10.1186/1478-811x-7-23
  • 10.1186/1478-811x-7-24
  • 10.1186/1479-5876-12-112
  • 10.1186/1741-7007-10-23
  • 10.1186/1741-7007-5-15
  • 10.1186/1741-7007-8-65
  • 10.1186/1741-7007-9-14
  • 10.1186/1743-7075-9-75
  • 10.1186/1749-8104-4-36
  • 10.1186/1750-2187-7-2
  • 10.1186/1750-2187-7-9
  • 10.1186/1754-9493-2-13
  • 10.1186/2040-2392-4-43
  • 10.1186/bcr3644
  • 10.1186/bcr80
  • 10.1186/gb-2004-5-9-r66
  • 10.1186/jbiol46
  • 10.1186/s12885-018-4143-x
  • 10.1186/s12890-016-0266-5
  • 10.1186/s12915-018-0489-4
  • 10.1186/s12931-019-1142-7
  • 10.1186/s12943-016-0516-4
  • 10.1186/s12943-018-0776-2
  • 10.1186/s12944-016-0223-6
  • 10.1186/s12951-018-0364-z
  • 10.1186/s13064-016-0062-1
  • 10.1186/s13223-019-0375-9
  • 10.1186/s13613-018-0437-z
  • 10.1189/jlb.0113057
  • 10.1189/jlb.0208078
  • 10.1189/jlb.0504284
  • 10.1189/jlb.0704402
  • 10.1189/jlb.1008618
  • 10.1189/jlb.1a0716-305r
  • 10.1189/jlb.2a1214-623r
  • 10.1189/jlb.3a0114-025r
  • 10.1189/jlb.72.6.1092
  • 10.1194/jlr.c200014-jlr200
  • 10.1194/jlr.c400002-jlr200
  • 10.1194/jlr.m010686
  • 10.1194/jlr
Montezano AC, Kuriakose J, Hood KY, Sin YY, Camargo LL, Namkung Y, Castro CH, Santos RA, Alves-Lopes R, Tejeda G, Passaglia P, Basheer S, Gallen E, Findlay JE, Awan FR, Laporte SA, MacLean MR, Baillie GS, Touyz RM. Ang-(1-7) and ET-1 Interplay Through Mas and ETB Receptor Interaction Defines a Novel Vasoprotective Mechanism. Hypertension. 2025 Feb;82(2):267–81. doi: 10.1161/hypertensionaha.124.22693. PMID: 39633565.; Wang C, Liu Y, Lanier M, Yeager A, Singh I, Gumpper RH, Krumm BE, DeLeon C, Zhang S, Boehm M, Pittner R, Baron A, Dvorak L, Bacon C, Shoichet BK, Martinborough E, Fay JF, Cao C, Roth BL. High-affinity agonists reveal recognition motifs for the MRGPRD GPCR. Cell Reports. 2024 Dec;43(12):114942. doi: 10.1016/j.celrep.2024.114942.; Rukavina Mikusic NL, Silva MG, Erra Díaz FA, Pineda AM, Ferragut F, Gómez KA, Mazzitelli L, Gonzalez Maglio DH, Nuñez M, Santos RAS, Grecco HE, Gironacci MM. Alamandine, a protective component of the renin-angiotensin system, reduces cellular proliferation and interleukin-6 secretion in human macrophages through MasR-MrgDR heteromerization. Biochem Pharmacol. 2024 Nov;229():116480. doi: 10.1016/j.bcp.2024.116480. PMID: 39128587.; Bader M, Steckelings UM, Alenina N, Santos RAS, Ferrario CM. Alternative Renin-Angiotensin System. Hypertension. 2024 May;81(5):964–76. doi: 10.1161/hypertensionaha.123.21364.; Proença AB, Medeiros GR, Reis GDS, Losito LDF, Ferraz LM, Bargut TCL, Soares NP, Alexandre-Santos B, Campagnole-Santos MJ, Magliano DC, Nobrega ACLD, Santos RAS, Frantz EDC. Adipose tissue plasticity mediated by the counterregulatory axis of the renin-angiotensin system: Role of Mas and MrgD receptors. J Cell Physiol. 2024 Jun;239(6):e31265. doi: 10.1002/jcp.31265. PMID: 38577921.; Makkonen K, Jännäri M, Crisóstomo L, Kuusi M, Patyra K, Melnyk V, Linnossuo V, Ojala J, Ravi R, Löf C, Mäkelä JA, Miettinen P, Laakso S, Ojaniemi M, Jääskeläinen J, Laakso M, Bossowski F, Sawicka B, Stozek K, Bossowski A, Kleinau G, Scheerer P, FinnGen F, Reeve MP, Kero J. Mechanisms of thyrotropin receptor-mediated phenotype variability deciphered by gene mutations and M453T-knockin model. JCI Insight. 2024 Jan 09;9(4). PMID: 38194289; PMCID: PMC11143923.; Ramírez-Vidal L, Molina-Villa T, Mendoza V, Peralta-Álvarez CA, Poot-Hernández AC, Dotov D, López-Casillas F. Betaglycan promoter activity is differentially regulated during myogenesis in zebrafish embryo somites. Developmental Dynamics. 2023 May 24;252(9):1162–79. doi: 10.1002/dvdy.602.; Jing L, Zhang Q. Intrathyroidal feedforward and feedback network regulating thyroid hormone synthesis and secretion. Front Endocrinol (Lausanne). 2022;13():992883. PMID: 36187113; PMCID: PMC9519864.; Suzuki S, Iida M, Hiroaki Y, Tanaka K, Kawamoto A, Kato T, Oshima A. Structural insight into the activation mechanism of MrgD with heterotrimeric Gi-protein revealed by cryo-EM. Communications Biology. 2022 Jul 15;5(1):707. doi: 10.1038/s42003-022-03668-3.; Zhao H, Wang Y, Wu X, Zeng X, Lin B, Hu S, Zhang S, Li Y, Zhou Z, Zhou Y, Du C, Beer DG, Bai S, Chen G. FAM83A antisense RNA 1 (FAM83A-AS1) silencing impairs cell proliferation and induces autophagy via MET-AMPK? signaling in lung adenocarcinoma. Bioengineered. 2022 May 02;13(5):13312–27. doi: 10.1080/21655979.2022.2081457.; Chen X, Wang P, Ou T, Li J. KLF16 Downregulates the Expression of Tumor Suppressor Gene TGFBR3 to Promote Bladder Cancer Proliferation and Migration. Cancer Manag Res. 2022;14():465–77. PMID: 35173481; PMCID: PMC8841319.; Reshetnyak AV, Rossi P, Myasnikov AG, Sowaileh M, Mohanty J, Nourse A, Miller DJ, Lax I, Schlessinger J, Kalodimos CG. Mechanism for the activation of the anaplastic lymphoma kinase receptor. Nature. 2021 Nov 24;600(7887):153–7. doi: 10.1038/s41586-021-04140-8.; De Munck S, Provost M, Kurikawa M, Omori I, Mukohyama J, Felix J, Bloch Y, Abdel-Wahab O, Bazan JF, Yoshimi A, Savvides SN. Structural basis of cytokine-mediated activation of ALK family receptors. Nature. 2021 Oct 13;600(7887):143–7. doi: 10.1038/s41586-021-03959-5.; Ren Y, Wang A, Fang Y, Shu T, Wu D, Wang C, Huang M, Min J, Jin L, Zhou W, Qiu Y, Zhou X. SARS-CoV-2 Membrane Glycoprotein M Triggers Apoptosis With the Assistance of Nucleocapsid Protein N in Cells. Front. Cell. Infect. Microbiol. 2021 Aug 25;11(). doi: 10.3389/fcimb.2021.706252.; Cheuiche AV, da Silveira LG, de Paula LCP, Lucena IRS, Silveiro SP. Diagnosis and management of precocious sexual maturation: an updated review. European Journal of Pediatrics. 2021 Mar 21;180(10):3073–87. doi: 10.1007/s00431-021-04022-1.; O’Sullivan MJ, Mitchel JA, Mwase C, McGill M, Kanki P, Park J. In well-differentiated primary human bronchial epithelial cells, TGF-ß1 and TGF-ß2 induce expression of furin. American Journal of Physiology-Lung Cellular and Molecular Physiology. 2021 Feb 01;320(2):L246–53. doi: 10.1152/ajplung.00423.2020.; Zheng W, Wang Z, Jiang X, Zhao Q, Shen J. Targeted Drugs for Treatment of Pulmonary Arterial Hypertension: Past, Present, and Future Perspectives. J Med Chem. 2020 Dec 24;63(24):15153–86. doi: 10.1021/acs.jmedchem.0c01093. PMID: 33314936.; Shim YS, Lim KI, Lee HS, Hwang JS. Long-term outcomes after gonadotropin-releasing hormone agonist treatment in boys with central precocious puberty. PLoS ONE. 2020 Dec 10;15(12):e0243212. doi: 10.1371/journal.pone.0243212.; Hou X, Yang L, Wang K, Zhou Y, Li Q, Kong F, Liu X, He J. HELLS, a chromatin remodeler is highly expressed in pancreatic cancer and downregulation of it impairs tumor growth and sensitizes to cisplatin by reexpressing the tumor suppressor TGFBR3. Cancer Med. 2021 Jan;10(1):350–64. PMID: 33280236; PMCID: PMC7826454.; Tzoupis H, Nteli A, Androutsou ME, Tselios T. Gonadotropin-Releasing Hormone and GnRH Receptor: Structure, Function and Drug Development. Curr Med Chem. 2020;27(36):6136–58. doi: 10.2174/0929867326666190712165444. PMID: 31309882.; Maldonado V, Loza-Mejía MA, Chávez-Alderete J. Repositioning of pentoxifylline as an immunomodulator and regulator of the renin-angiotensin system in the treatment of COVID-19. Medical Hypotheses. 2020 Nov;144():109988. doi: 10.1016/j.mehy.2020.109988.; Ghasemnejad-Berenji M, Pashapour S, Sadeghpour S. Pentoxifylline: A Drug with Antiviral and Anti-Inflammatory Effects to Be Considered in the Treatment of Coronavirus Disease 2019. Med Princ Pract. 2021;30(1):98–100. PMID: 33049737; PMCID: PMC7923888.; Klann K, Bojkova D, Tascher G, Ciesek S, Münch C, Cinatl J. Growth Factor Receptor Signaling Inhibition Prevents SARS-CoV-2 Replication. Molecular Cell. 2020 Oct;80(1):164–174.e4. doi: 10.1016/j.molcel.2020.08.006.; Kist M, Komuves LG, Goncharov T, Dugger DL, Yu C, Roose-Girma M, Newton K, Webster JD, Vucic D. Impaired RIPK1 ubiquitination sensitizes mice to TNF toxicity and inflammatory cell death. Cell Death & Differentiation. 2020 Sep 30;28(3):985–1000. doi: 10.1038/s41418-020-00629-3.; Kappes L, Amer RL, Sommerlatte S, Bashir G, Plattfaut C, Gieseler F, Gemoll T, Busch H, Altahrawi A, Al-Sbiei A, Haneefa SM, Arafat K, Schimke LF, Khawanky NE, Schulze-Forster K, Heidecke H, Kerstein-Staehle A, Marschner G, Pitann S, Ochs HD, Mueller A, Attoub S, Fernandez-Cabezudo MJ, Riemekasten G, al-Ramadi BK, Cabral-Marques O. Ambrisentan, an endothelin receptor type A-selective antagonist, inhibits cancer cell migration, invasion, and metastasis. Scientific Reports. 2020 Sep 28;10(1):15931. doi: 10.1038/s41598-020-72960-1.; Donnez O, Donnez J. Gonadotropin-releasing hormone antagonist (linzagolix): a new therapy for uterine adenomyosis. Fertil Steril. 2020 Sep;114(3):640–5. doi: 10.1016/j.fertnstert.2020.04.017. PMID: 32507315.; Lane LC, Cheetham TD, Perros P, Pearce SHS. New Therapeutic Horizons for Graves' Hyperthyroidism. Endocr Rev. 2020 Dec 01;41(6). PMID: 32845332; PMCID: PMC7567404.; Broessner G, Reuter U, Bonner JH, Dodick DW, Hallström Y, Picard H, Zhang F, Lenz RA, Klatt J, Mikol DD. The Spectrum of Response to Erenumab in Patients With Episodic Migraine and Subgroup Analysis of Patients Achieving =50%, =75%, and 100% Response. Headache. 2020 Oct;60(9):2026–40. PMID: 32851644; PMCID: PMC7590156.; Gubar O, Croisé P, Kropyvko S, Gryaznova T, Tóth P, Blangy A, Vitale N, Rynditch A, Gasman S, Ory S. The atypical Rho GTPase RhoU interacts with intersectin-2 to regulate endosomal recycling pathways. J Cell Sci. 2020 Aug 27;133(16). doi: 10.1242/jcs.234104. PMID: 32737221.; Goadsby PJ, Reuter U, Hallström Y, Broessner G, Bonner JH, Zhang F, Wright IK, Chou DE, Klatt J, Picard H, Lenz RA, Mikol DD. One-year sustained efficacy of erenumab in episodic migraine: Results of the STRIVE study. Neurology. 2020 Aug 04;95(5):e469–79. PMID: 32636324; PMCID: PMC7455346.; Dalamaga M, Karampela I, Mantzoros CS. Commentary: Phosphodiesterase 4 inhibitors as potential adjunct treatment targeting the cytokine storm in COVID-19. Metabolism. 2020 Aug;109():154282. doi: 10.1016/j.metabol.2020.154282.; Giorgi M, Cardarelli S, Ragusa F, Saliola M, Biagioni S, Poiana G, Naro F, Massimi M. Phosphodiesterase Inhibitors: Could They Be Beneficial for the Treatment of COVID-19? Int J Mol Sci. 2020 Jul 27;21(15). PMID: 32727145; PMCID: PMC7432892.; Armesto S, González Vela C, Sánchez J, Illaro A, Mayorga J, López Sundh AE, Naharro Fernández C, Palmou N, Gómez-Fernández C, González López MA, González-Gay MA. Treating multidrug-resistant psoriasis with brodalumab, apremilast, methotrexate and prednisone combination therapy in the COVID-19 pandemic. Dermatol Ther. 2020 Nov;33(6):e14464. doi: 10.1111/dth.14464. PMID: 33112014.; Hendry BM, Stafford N, Arnold AD, Sangwaiya A, Manglam V, Rosen SD, Arnold J. Hypothesis: Pentoxifylline is a potential cytokine modulator therapeutic in COVID-19 patients. Pharmacol Res Perspect. 2020 Aug;8(4):e00631. PMID: 32715661; PMCID: PMC7383088.; Donnez J, Taylor HS, Taylor RN, Akin MD, Tatarchuk TF, Wilk K, Gotteland JP, Lecomte V, Bestel E. Treatment of endometriosis-associated pain with linzagolix, an oral gonadotropin-releasing hormone-antagonist: a randomized clinical trial. Fertil Steril. 2020 Jul;114(1):44–55. doi: 10.1016/j.fertnstert.2020.02.114. PMID: 32505383.; Sundararaman A, Fukushima Y, Norman JC, Uemura A, Mellor H. RhoJ Regulates a5ß1 Integrin Trafficking to Control Fibronectin Remodeling during Angiogenesis. Curr Biol. 2020 Jun 08;30(11):2146–2155.e5. doi: 10.1016/j.cub.2020.03.042. PMID: 32302585.; Shore ND, Saad F, Cookson MS, George DJ, Saltzstein DR, Tutrone R, Akaza H, Bossi A, van Veenhuyzen DF, Selby B, Fan X, Kang V, Walling J, Tombal B; HERO Study Investigators. Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer. N Engl J Med. 2020 Jun 04;382(23):2187–96. doi: 10.1056/nejmoa2004325. PMID: 32469183.; Stephenson A, Lau L, Eszlinger M, Paschke R. The Thyrotropin Receptor Mutation Database Update. Thyroid. 2020 Jun;30(6):931–5. doi: 10.1089/thy.2019.0807. PMID: 32111150.; Spindler BL, Ryan M. Medications Approved for Preventing Migraine Headaches. The American Journal of Medicine. 2020 Jun;133(6):664–7. doi: 10.1016/j.amjmed.2020.01.031.; Dhillon S. Eptinezumab: First Approval. Drugs. 2020 May;80(7):733–9. doi: 10.1007/s40265-020-01300-4. PMID: 32266704.; Farkas K, Kolossváry E, Járai Z. Simple assessment of quality of life and lower limb functional capacity during cilostazol treatment - results of the SHort-tERm cIlostazol eFFicacy and quality of life (SHERIFF) study. Vasa. 2020 Apr;49(3):235–42. doi: 10.1024/0301-1526/a000845. PMID: 31983287.; Franco I, Hoebeke P, Baka-Ostrowska M, Bolong D, Davies LN, Dahler E, Snijder R, Stroosma O, Verheggen F, Newgreen D, Bosman B, Vande Walle J. Long-term efficacy and safety of solifenacin in pediatric patients aged 6 months to 18 years with neurogenic detrusor overactivity: results from two phase 3 prospective open-label studies. J Pediatr Urol. 2020 Apr;16(2):180.e1–8. doi: 10.1016/j.jpurol.2019.12.012. PMID: 32007426.; Rosa SGV, Santos WC. Clinical trials on drug repositioning for COVID-19 treatment. Rev Panam Salud Publica. 2020;44():e40. PMID: 32256547; PMCID: PMC7105280.; Müller PM, Rademacher J, Bagshaw RD, Wortmann C, Barth C, van Unen J, Alp KM, Giudice G, Eccles RL, Heinrich LE, Pascual-Vargas P, Sanchez-Castro M, Brandenburg L, Mbamalu G, Tucholska M, Spatt L, Czajkowski MT, Welke RW, Zhang S, Nguyen V, Rrustemi T, Trnka P, Freitag K, Larsen B, Popp O, Mertins P, Gingras AC, Roth FP, Colwill K, Bakal C, Pertz O, Pawson T, Petsalaki E, Rocks O. Systems analysis of RhoGEF and RhoGAP regulatory proteins reveals spatially organized RAC1 signalling from integrin adhesions. Nat Cell Biol. 2020 Apr;22(4):498–511. doi: 10.1038/s41556-020-0488-x. PMID: 32203420.; Phillips JE. Inhaled Phosphodiesterase 4 (PDE4) Inhibitors for Inflammatory Respiratory Diseases. Front. Pharmacol. 2020 Mar 12;11(). doi: 10.3389/fphar.2020.00259.; Hashim PW, Chima M, Kim HJ, Bares J, Yao CJ, Singer G, Chen T, Genece J, Baum D, Kimmel GW, Nia JK, Gagliotti M, Lebwohl MG. Crisaborole 2% ointment for the treatment of intertriginous, anogenital, and facial psoriasis: A double-blind, randomized, vehicle-controlled trial. Journal of the American Academy of Dermatology. 2020 Feb;82(2):360–5. doi: 10.1016/j.jaad.2019.06.1288.; Yin J, Chang HM, Yi Y, Yao Y, Leung PCK. TGF-ß1 Increases GDNF Production by Upregulating the Expression of GDNF and Furin in Human Granulosa-Lutein Cells. Cells. 2020 Jan 10;9(1). PMID: 31936902; PMCID: PMC7016865.; Wendell SG, Fan H, Zhang C. G Protein–Coupled Receptors in Asthma Therapy: Pharmacology and Drug Action. Pharmacological Reviews. 2020 Jan;72(1):1–49. doi: 10.1124/pr.118.016899.; Bagci H, Sriskandarajah N, Robert A, Boulais J, Elkholi IE, Tran V, Lin ZY, Thibault MP, Dubé N, Faubert D, Hipfner DR, Gingras AC, Côté JF. Mapping the proximity interaction network of the Rho-family GTPases reveals signalling pathways and regulatory mechanisms. Nat Cell Biol. 2020 Jan;22(1):120–34. doi: 10.1038/s41556-019-0438-7. PMID: 31871319.; Aguilar-Cazares D, Chavez-Dominguez R, Carlos-Reyes A, Lopez-Camarillo C, Hernadez de la Cruz ON, Lopez-Gonzalez JS. Contribution of Angiogenesis to Inflammation and Cancer. Front Oncol. 2019;9():1399. PMID: 31921656; PMCID: PMC6920210.; Dodick DW, Lipton RB, Ailani J, Lu K, Finnegan M, Trugman JM, Szegedi A. Ubrogepant for the Treatment of Migraine. N Engl J Med. 2019 Dec 05;381(23):2230–41. doi: 10.1056/nejmoa1813049. PMID: 31800988.; Papachristos A, Kemos P, Katsila T, Panoilia E, Patrinos GP, Kalofonos H, Sivolapenko GB. VEGF-A and ICAM-1 Gene Polymorphisms as Predictors of Clinical Outcome to First-Line Bevacizumab-Based Treatment in Metastatic Colorectal Cancer. Int J Mol Sci. 2019 Nov 18;20(22). PMID: 31752122; PMCID: PMC6888109.; Fingeret M, Gaddie IB, Bloomenstein M. Latanoprostene bunod ophthalmic solution 0.024%: a new treatment option for open-angle glaucoma and ocular hypertension. Clinical and Experimental Optometry. 2019 Nov 01;102(6):541–50. doi: 10.1111/cxo.12853.; Akizawa T, Ikejiri K, Kondo Y, Endo Y, Fukagawa M. Evocalcet: A New Oral Calcimimetic for Dialysis Patients With Secondary Hyperparathyroidism. Ther Apher Dial. 2020 Jun;24(3):248–57. PMID: 31486206; PMCID: PMC7317959.; Fein MN, Fischer DA, O’Keefe AW, Sussman GL. CSACI position statement: Newer generation H1-antihistamines are safer than first-generation H1-antihistamines and should be the first-line antihistamines for the treatment of allergic rhinitis and urticaria. Allergy, Asthma & Clinical Immunology. 2019 Oct 01;15(1):61. doi: 10.1186/s13223-019-0375-9.; Chan C, Goadsby PJ. Recent Advances in Pharmacotherapy for Episodic Migraine. CNS Drugs. 2019 Nov;33(11):1053–71. doi: 10.1007/s40263-019-00665-9. PMID: 31556018.; Bocanegra JL, Fujita BM, Melton NR, Cowan JM, Schinski EL, Tamir TY, Major MB, Quintero OA. The MyMOMA domain of MYO19 encodes for distinct Miro-dependent and Miro-independent mechanisms of interaction with mitochondrial membranes. Cytoskeleton (Hoboken). 2020 Mar;77(3-4):149–66. PMID: 31479585; PMCID: PMC8556674.; Haga RB, Garg R, Collu F, Borda D'Agua B, Menéndez ST, Colomba A, Fraternali F, Ridley AJ. RhoBTB1 interacts with ROCKs and inhibits invasion. Biochem J. 2019 Sep 13;476(17):2499–514. PMID: 31431478; PMCID: PMC6744581.; Zhang X, Zhang H, Xu C, Li X, Li M, Wu X, Pu W, Zhou B, Wang H, Li D, Ding Q, Ying H, Wang H, Zhang H. Ubiquitination of RIPK1 suppresses programmed cell death by regulating RIPK1 kinase activation during embryogenesis. Nature Communications. 2019 Sep 13;10(1):4158. doi: 10.1038/s41467-019-11839-w.; Tang Y, Tu H, Zhang J, Zhao X, Wang Y, Qin J, Lin X. K63-linked ubiquitination regulates RIPK1 kinase activity to prevent cell death during embryogenesis and inflammation. Nature Communications. 2019 Sep 13;10(1):4157. doi: 10.1038/s41467-019-12033-8.; Yao S, Shi F, Wang Y, Sun X, Sun W, Zhang Y, Liu X, Liu X, Su L. Angio-associated migratory cell protein interacts with epidermal growth factor receptor and enhances proliferation and drug resistance in human non-small cell lung cancer cells. Cell Signal. 2019 Sep;61():10–9. doi: 10.1016/j.cellsig.2019.05.004. PMID: 31075398.; Croop R, Goadsby PJ, Stock DA, Conway CM, Forshaw M, Stock EG, Coric V, Lipton RB. Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial. Lancet. 2019 Aug 31;394(10200):737–45. doi: 10.1016/s0140-6736(19)31606-x. PMID: 31311674.; Taylor HS, Dun EC, Chwalisz K. Clinical evaluation of the oral gonadotropin-releasing hormone-antagonist elagolix for the management of endometriosis-associated pain. Pain Manag. 2019 Sep;9(5):497–515. doi: 10.2217/pmt-2019-0010. PMID: 31434540.; Cook LM, Frieling JS, Nerlakanti N, McGuire JJ, Stewart PA, Burger KL, Cleveland JL, Lynch CC. Betaglycan drives the mesenchymal stromal cell osteogenic program and prostate cancer-induced osteogenesis. Oncogene. 2019 Aug 13;38(44):6959–69. doi: 10.1038/s41388-019-0913-4.; Singh D, Beeh KM, Colgan B, Kornmann O, Leaker B, Watz H, Lucci G, Geraci S, Emirova A, Govoni M, Nandeuil MA. Effect of the inhaled PDE4 inhibitor CHF6001 on biomarkers of inflammation in COPD. Respiratory Research. 2019 Aug 09;20(1):180. doi: 10.1186/s12931-019-1142-7.; Zhang X, Fang J, Chen S, Wang W, Meng S, Liu B. Nonconserved miR-608 suppresses prostate cancer progression through RAC2/PAK4/LIMK1 and BCL2L1/caspase-3 pathways by targeting the 3'-UTRs of RAC2/BCL2L1 and the coding region of PAK4. Cancer Med. 2019 Sep;8(12):5716–34. PMID: 31389670; PMCID: PMC6746107.; Chen CY, Choong OK, Liu LW, Cheng YC, Li SC, Yen CYT, Wu MR, Chiang MH, Tsang TJ, Wu YW, Lin LC, Chen YL, Lin WC, Hacker TA, Kamp TJ, Hsieh PCH. MicroRNA let-7-TGFBR3 signalling regulates cardiomyocyte apoptosis after infarction. EBioMedicine. 2019 Aug;46():236–47. PMID: 31401194; PMCID: PMC6712055.; Barra F, Seca M, Della Corte L, Giampaolino P, Ferrero S. Relugolix for the treatment of uterine fibroids. Drugs Today (Barc). 2019 Aug;55(8):503–12. doi: 10.1358/dot.2019.55.8.3020179. PMID: 31461087.; Kim EJ, Lin WV, Rodriguez SM, Chen A, Loya A, Weng CY. Treatment of Diabetic Macular Edema. Curr Diab Rep. 2019 Jul 29;19(9):68. doi: 10.1007/s11892-019-1188-4. PMID: 31359157.; Yannuzzi NA, Freund KB. Brolucizumab: evidence to date in the treatment of neovascular age-related macular degeneration. Clin Ophthalmol. 2019;13():1323–9. PMID: 31413539; PMCID: PMC6661993.; Moehle MS, Conn PJ. Roles of the M4 acetylcholine receptor in the basal ganglia and the treatment of movement disorders. Movement Disorders. 2019 Jun 18;34(8):1089–99. doi: 10.1002/mds.27740.; Budnar S, Husain KB, Gomez GA, Naghibosadat M, Varma A, Verma S, Hamilton NA, Morris RG, Yap AS. Anillin Promotes Cell Contractility by Cyclic Resetting of RhoA Residence Kinetics. Dev Cell. 2019 Jun 17;49(6):894–906.e12. doi: 10.1016/j.devcel.2019.04.031. PMID: 31105010.; Gambi G, Di Simone E, Basso V, Ricci L, Wang R, Verma A, Elemento O, Ponzoni M, Inghirami G, Icardi L, Mondino A. The Transcriptional Regulator Sin3A Contributes to the Oncogenic Potential of STAT3. Cancer Res. 2019 Jun 15;79(12):3076–87. doi: 10.1158/0008-5472.can-18-0359. PMID: 30692217.; Zhang M, Jang H, Nussinov R. The structural basis for Ras activation of PI3Ka lipid kinase. Phys Chem Chem Phys. 2019 Jun 05;21(22):12021–8. PMID: 31135801; PMCID: PMC6556208.; Ztaou S, Amalric M. Contribution of cholinergic interneurons to striatal pathophysiology in Parkinson's disease. Neurochem Int. 2019 Jun;126():1–10. doi: 10.1016/j.neuint.2019.02.019. PMID: 30825602.; Amato D, Kruyer A, Samaha AN, Heinz A. Hypofunctional Dopamine Uptake and Antipsychotic Treatment-Resistant Schizophrenia. Front Psychiatry. 2019;10():314. PMID: 31214054; PMCID: PMC6557273.; Smith BD, Kaufman MD, Lu WP, Gupta A, Leary CB, Wise SC, Rutkoski TJ, Ahn YM, Al-Ani G, Bulfer SL, Caldwell TM, Chun L, Ensinger CL, Hood MM, McKinley A, Patt WC, Ruiz-Soto R, Su Y, Telikepalli H, Town A, Turner BA, Vogeti L, Vogeti S, Yates K, Janku F, Abdul Razak AR, Rosen O, Heinrich MC, Flynn DL. Ripretinib (DCC-2618) Is a Switch Control Kinase Inhibitor of a Broad Spectrum of Oncogenic and Drug-Resistant KIT and PDGFRA Variants. Cancer Cell. 2019 May 13;35(5):738–751.e9. doi: 10.1016/j.ccell.2019.04.006. PMID: 31085175.; Fiddes IT, Pollen AA, Davis JM, Sikela JM. Paired involvement of human-specific Olduvai domains and NOTCH2NL genes in human brain evolution. Human Genetics. 2019 May 13;138(7):715–21. doi: 10.1007/s00439-019-02018-4.; Kukimoto-Niino M, Tsuda K, Ihara K, Mishima-Tsumagari C, Honda K, Ohsawa N, Shirouzu M. Structural Basis for the Dual Substrate Specificity of DOCK7 Guanine Nucleotide Exchange Factor. Structure. 2019 May 07;27(5):741–748.e3. doi: 10.1016/j.str.2019.02.001. PMID: 30853411.; Mukohda M, Fang S, Wu J, Agbor LN, Nair AR, Ibeawuchi SC, Hu C, Liu X, Lu KT, Guo DF, Davis DR, Keen HL, Quelle FW, Sigmund CD. RhoBTB1 protects against hypertension and arterial stiffness by restraining phosphodiesterase 5 activity. J Clin Invest. 2019 Mar 21;129(6):2318–32. PMID: 30896450; PMCID: PMC6546477.; Zhang Q, Yu S, Lok SIS, Wong AST, Jiao Y, Lee LTO. FAM83D promotes ovarian cancer progression and its potential application in diagnosis of invasive ovarian cancer. J Cellular Molecular Medi. 2019 Apr 30;23(7):4569–81. doi: 10.1111/jcmm.14360.; Kim SH, Riaposova L, Ahmed H, Pohl O, Chollet A, Gotteland J, Hanyaloglu A, Bennett PR, Terzidou V. Oxytocin Receptor Antagonists, Atosiban and Nolasiban, Inhibit Prostaglandin F2a-induced Contractions and Inflammatory Responses in Human Myometrium. Scientific Reports. 2019 Apr 08;9(1):5792. doi: 10.1038/s41598-019-42181-2.; Roskoski R. Targeting ERK1/2 protein-serine/threonine kinases in human cancers. Pharmacol Res. 2019 Apr;142():151–68. doi: 10.1016/j.phrs.2019.01.039. PMID: 30794926.; Burghi V, Echeverría EB, Sosa MH, Quiroga DT, Muñoz MC, Davio C, Monczor F, Fernández NC, Dominici FP. Participation of Gai-Adenylate Cyclase and ERK1/2 in Mas Receptor Signaling Pathways. Front. Pharmacol. 2019 Feb 22;10(). doi: 10.3389/fphar.2019.00146.; Yang Z, Xiao Z, Guo H, Fang X, Liang J, Zhu J, Yang J, Li H, Pan R, Yuan S, Dong W, Zheng X, Wu S, Shan Z. Novel role of the clustered miR-23b-3p and miR-27b-3p in enhanced expression of fibrosis-associated genes by targeting TGFBR3 in atrial fibroblasts. J Cellular Molecular Medi. 2019 Feb 07;23(5):3246–56. doi: 10.1111/jcmm.14211.; Pascua-Maestro R, González E, Lillo C, Ganfornina MD, Falcón-Pérez JM, Sanchez D. Extracellular Vesicles Secreted by Astroglial Cells Transport Apolipoprotein D to Neurons and Mediate Neuronal Survival Upon Oxidative Stress. Front. Cell. Neurosci. 2019 Jan 10;12(). doi: 10.3389/fncel.2018.00526.; Kragstrup TW, Adams M, Lomholt S, Nielsen MA, Heftdal LD, Schafer P, Deleuran B. IL-12/IL-23p40 identified as a downstream target of apremilast in ex vivo models of arthritis. Therapeutic Advances in Musculoskeletal. 2019 Jan;11(). doi: 10.1177/1759720x19828669.; An R, Liu J, He J, Wang F, Zhang Q, Yu Q. PDE3A inhibitor anagrelide activates death signaling pathway genes and synergizes with cell death-inducing cytokines to selectively inhibit cancer cell growth. Am J Cancer Res. 2019;9(9):1905–21. PMID: 31598394; PMCID: PMC6780660.; Peters DT, Kay L, Eswaran J, Lakey JH, Soundararajan M. Human Miro Proteins Act as NTP Hydrolases through a Novel, Non-Canonical Catalytic Mechanism. Int J Mol Sci. 2018 Dec 02;19(12). PMID: 30513825; PMCID: PMC6321465.; Wang S, Zhou H, Wu D, Ni H, Chen Z, Chen C, Xiang Y, Dai K, Chen X, Li X. MicroRNA let-7a regulates angiogenesis by targeting TGFBR3 mRNA. J Cellular Molecular Medi. 2018 Nov 22;23(1):556–67. doi: 10.1111/jcmm.13960.; Ip CKM, Ng PKS, Jeong KJ, Shao SH, Ju Z, Leonard PG, Hua X, Vellano CP, Woessner R, Sahni N, Scott KL, Mills GB. Neomorphic PDGFRA extracellular domain driver mutations are resistant to PDGFRA targeted therapies. Nature Communications. 2018 Nov 02;9(1):4583. doi: 10.1038/s41467-018-06949-w.; Tanna AP, Johnson M. Rho Kinase Inhibitors as a Novel Treatment for Glaucoma and Ocular Hypertension. Ophthalmology. 2018 Nov;125(11):1741–56. doi: 10.1016/j.ophtha.2018.04.040.; Wu M, Liang Y, Dai Z, Wang S. Perioperative dexmedetomidine reduces delirium after cardiac surgery: A meta-analysis of randomized controlled trials. Journal of Clinical Anesthesia. 2018 Nov;50():33–42. doi: 10.1016/j.jclinane.2018.06.045.; Klug LR, Kent JD, Heinrich MC. Structural and clinical consequences of activation loop mutations in class III receptor tyrosine kinases. Pharmacol Ther. 2018 Nov;191():123–34. doi: 10.1016/j.pharmthera.2018.06.016. PMID: 29964125.; Flükiger J, Hollinger A, Speich B, Meier V, Tontsch J, Zehnder T, Siegemund M. Dexmedetomidine in prevention and treatment of postoperative and intensive care unit delirium: a systematic review and meta-analysis. Annals of Intensive Care. 2018 Sep 20;8(1):92. doi: 10.1186/s13613-018-0437-z.; Lamb YN. Elagolix: First Global Approval. Drugs. 2018 Sep 08;78(14):1501–8. doi: 10.1007/s40265-018-0977-4.; Oeding SJ, Majstrowicz K, Hu XP, Schwarz V, Freitag A, Honnert U, Nikolaus P, Bähler M. Identification of Miro1 and Miro2 as mitochondrial receptors for myosin XIX. J Cell Sci. 2018 Sep 10;131(17). doi: 10.1242/jcs.219469. PMID: 30111583.; Poch E, Rodas L, Blasco M, Molina A, Quintana L. An update on tolvaptan for autosomal dominant polycystic kidney disease. Drugs Today (Barc). 2018 Sep;54(9):519–33. doi: 10.1358/dot.2018.54.9.2776624. PMID: 30303493.; Aygun N. Biological and Genetic Features of Neuroblastoma and Their Clinical Importance. Curr Pediatr Rev. 2018;14(2):73–90. doi: 10.2174/1573396314666180129101627. PMID: 29380702.; Papadopoulos N, Lennartsson J. The PDGF/PDGFR pathway as a drug target. Mol Aspects Med. 2018 Aug;62():75–88. doi: 10.1016/j.mam.2017.11.007. PMID: 29137923.; Blom M, Reis K, Aspenström P. RhoD localization and function is dependent on its GTP/GDP-bound state and unique N-terminal motif. European Journal of Cell Biology. 2018 Aug;97(6):393–401. doi: 10.1016/j.ejcb.2018.05.003.; Reshetnyak AV, Mohanty J, Tomé F, Puleo DE, Plotnikov AN, Ahmed M, Kaur N, Poliakov A, Cinnaiyan AM, Lax I, Schlessinger J. Identification of a biologically active fragment of ALK and LTK-Ligand 2 (augmentor-a). Proc Natl Acad Sci U S A. 2018 Aug 14;115(33):8340–5. PMID: 30061385; PMCID: PMC6099872.; Chan Wah Hak L, Khan S, Di Meglio I, Law A, Lucken-Ardjomande Häsler S, Quintaneiro LM, Ferreira APA, Krause M, McMahon HT, Boucrot E. FBP17 and CIP4 recruit SHIP2 and lamellipodin to prime the plasma membrane for fast endophilin-mediated endocytosis. Nature Cell Biology. 2018 Jul 30;20(9):1023–31. doi: 10.1038/s41556-018-0146-8.; Talati N, Kamato D, Piva TJ, Little PJ, Osman N. Thrombin promotes PAI-1 expression and migration in keratinocytes via ERK dependent Smad linker region phosphorylation. Cell Signal. 2018 Jul;47():37–43. doi: 10.1016/j.cellsig.2018.03.009. PMID: 29577978.; Glaenzel U, Jin Y, Nufer R, Li W, Schroer K, Adam-Stitah S, Peter van Marle S, Legangneux E, Borell H, James AD, Meissner A, Camenisch G, Gardin A: Metabolism and Disposition of Siponimod, a Novel Selective S1P1/S1P5 Agonist, in Healthy Volunteers and In Vitro Identification of Human Cytochrome P450 Enzymes Involved in Its Oxidative Metabolism. Drug Metab Dispos. 2018 Jul;46(7):1001-1013. doi: 10.1124/dmd.117.079574. Epub 2018 May 7.; Roskoski R. The role of small molecule Kit protein-tyrosine kinase inhibitors in the treatment of neoplastic disorders. Pharmacol Res. 2018 Jul;133():35–52. doi: 10.1016/j.phrs.2018.04.020. PMID: 29704617.; Surrey E, Taylor HS, Giudice L, Lessey BA, Abrao MS, Archer DF, Diamond MP, Johnson NP, Watts NB, Gallagher JC, Simon JA, Carr BR, Dmowski WP, Leyland N, Singh SS, Rechberger T, Agarwal SK, Duan WR, Schwefel B, Thomas JW, Peloso PM, Ng J, Soliman AM, Chwalisz K. Long-Term Outcomes of Elagolix in Women With Endometriosis: Results From Two Extension Studies. Obstet Gynecol. 2018 Jul;132(1):147–60. doi: 10.1097/aog.0000000000002675. PMID: 29889764.; Tian J, Wu J, Chen X, Guo T, Chen ZJ, Goldstein JL, Brown MS. Author response: BHLHE40, a third transcription factor required for insulin induction of SREBP-1c mRNA in rodent liver. 2018 Jun 15;(). doi: 10.7554/elife.36826.016.; Osland ST, Steeves TD, Pringsheim T. Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders. Cochrane Database Syst Rev. 2018 Jun 26;6():CD007990. PMID: 29944175; PMCID: PMC6513283.; Cohen SM, Suutari B, He X, Wang Y, Sanchez S, Tirko NN, Mandelberg NJ, Mullins C, Zhou G, Wang S, Kats I, Salah A, Tsien RW, Ma H. Calmodulin shuttling mediates cytonuclear signaling to trigger experience-dependent transcription and memory. Nature Communications. 2018 Jun 22;9(1):2451. doi: 10.1038/s41467-018-04705-8.; Boga SB, Deng Y, Zhu L, Nan Y, Cooper AB, Shipps GW, Doll R, Shih N, Zhu H, Sun R, Wang T, Paliwal S, Tsui H, Gao X, Yao X, Desai J, Wang J, Alhassan AB, Kelly J, Patel M, Muppalla K, Gudipati S, Zhang L, Buevich A, Hesk D, Carr D, Dayananth P, Black S, Mei H, Cox K, Sherborne B, Hruza AW, Xiao L, Jin W, Long B, Liu G, Taylor SA, Kirschmeier P, Windsor WT, Bishop R, Samatar AA. MK-8353: Discovery of an Orally Bioavailable Dual Mechanism ERK Inhibitor for Oncology. ACS Med. Chem. Lett. 2018 Jun 14;9(7):761–7. doi: 10.1021/acsmedchemlett.8b00220.; Ferrero S, Barra F, Leone Roberti Maggiore U. Current and Emerging Therapeutics for the Management of Endometriosis. Drugs. 2018 Jul;78(10):995–1012. doi: 10.1007/s40265-018-0928-0. PMID: 29946962.; Belambri SA, Rolas L, Raad H, Hurtado-Nedelec M, Dang PM, El-Benna J. NADPH oxidase activation in neutrophils: Role of the phosphorylation of its subunits. Eur J Clin Invest. 2018 Nov;48 Suppl 2():e12951. doi: 10.1111/eci.12951. PMID: 29757466.; Zaiou M, Rihn BH, Bakillah A. Epigenetic regulation of genes involved in the reverse cholesterol transport through interaction with miRNAs. Front Biosci (Landmark Ed). 2018 Jun 01;23(11):2090–105. doi: 10.2741/4692. PMID: 29772548.; Tran HDM, Tran YH, Tran TD, Jong M, Coroneo M, Sankaridurg P. A Review of Myopia Control with Atropine. Journal of Ocular Pharmacology and Therapeutics. 2018 Jun;34(5):374–9. doi: 10.1089/jop.2017.0144.; Suzuki IK, Gacquer D, Van Heurck R, Kumar D, Wojno M, Bilheu A, Herpoel A, Lambert N, Cheron J, Polleux F, Detours V, Vanderhaeghen P. Human-Specific NOTCH2NL Genes Expand Cortical Neurogenesis through Delta/Notch Regulation. Cell. 2018 May 31;173(6):1370–1384.e16. PMID: 29856955; PMCID: PMC6092419.; Fiddes IT, Lodewijk GA, Mooring M, Bosworth CM, Ewing AD, Mantalas GL, Novak AM, van den Bout A, Bishara A, Rosenkrantz JL, Lorig-Roach R, Field AR, Haeussler M, Russo L, Bhaduri A, Nowakowski TJ, Pollen AA, Dougherty ML, Nuttle X, Addor MC, Zwolinski S, Katzman S, Kriegstein A, Eichler EE, Salama SR, Jacobs FMJ, Haussler D. Human-Specific NOTCH2NL Genes Affect Notch Signaling and Cortical Neurogenesis. Cell. 2018 May 31;173(6):1356–1369.e22. PMID: 29856954; PMCID: PMC5986104.; Yoshida M, Kakizaki H, Takahashi S, Nagai S, Kurose T. Long-term safety and efficacy of the novel ß 3 -adrenoreceptor agonist vibegron in Japanese patients with overactive bladder: A phase III prospective study. Int J of Urology. 2018 May 11;25(7):668–75. doi: 10.1111/iju.13596.; Zhu X, Bao Y, Guo Y, Yang W. Proline-Rich Protein Tyrosine Kinase 2 in Inflammation and Cancer. Cancers (Basel). 2018 May 08;10(5). PMID: 29738483; PMCID: PMC5977112.; Yoshida M, Takeda M, Gotoh M, Nagai S, Kurose T. Vibegron, a Novel Potent and Selective ß3-Adrenoreceptor Agonist, for the Treatment of Patients with Overactive Bladder: A Randomized, Double-blind, Placebo-controlled Phase 3 Study. Eur Urol. 2018 May;73(5):783–90. doi: 10.1016/j.eururo.2017.12.022. PMID: 29366513.; Phillips MC. Is ABCA1 a lipid transfer protein? Journal of Lipid Research. 2018;59(5):749–63. doi: 10.1194/jlr.r082313.; Epstein I, Finkbeiner S. The Arc of cognition: Signaling cascades regulating Arc and implications for cognitive function and disease. Seminars in Cell & Developmental Biology. 2018 May;77():63–72. doi: 10.1016/j.semcdb.2017.09.023.; Jiang X. Phospholipid transfer protein: its impact on lipoprotein homeostasis and atherosclerosis. Journal of Lipid Research. 2018;59(5):764–71. doi: 10.1194/jlr.r082503.; Edvinsson L. The CGRP Pathway in Migraine as a Viable Target for Therapies. Headache. 2018 May;58 Suppl 1():33–47. doi: 10.1111/head.13305. PMID: 29697153.; Nemani N, Carvalho E, Tomar D, Dong Z, Ketschek A, Breves SL, Jaña F, Worth AM, Heffler J, Palaniappan P, Tripathi A, Subbiah R, Riitano MF, Seelam A, Manfred T, Itoh K, Meng S, Sesaki H, Craigen WJ, Rajan S, Shanmughapriya S, Caplan J, Prosser BL, Gill DL, Stathopulos PB, Gallo G, Chan DC, Mishra P, Madesh M. MIRO-1 Determines Mitochondrial Shape Transition upon GPCR Activation and Ca2+ Stress. Cell Reports. 2018 Apr;23(4):1005–19. doi: 10.1016/j.celrep.2018.03.098.; Gómez-Aguayo F, Paczka JA, Leñero-Córdova R, Jiménez-Román J, Davila-Villarreal J, Hartleben C, Baiza-Durán L, Olvera-Montaño O, García-Velez F, Muñoz-Villegas P. A Phase III Randomized Clinical Trial of a 0.5% Timolol + 0.2% Brimonidine + 2.0% Dorzolamide Fixed Combination, Preservative-Free Ophthalmic Solution vs. 0.5% Timolol + 0.2% Brimonidine + 2.0% Dorzolamide Fixed Combination in Patients with Controlled Primary Open-Angle Glaucoma. Ophthalmology and Therapy. 2018 Apr 21;7(1):145–56. doi: 10.1007/s40123-018-0128-8.; Comoglio PM, Trusolino L, Boccaccio C. Known and novel roles of the MET oncogene in cancer: a coherent approach to targeted therapy. Nat Rev Cancer. 2018 Jun;18(6):341–58. doi: 10.1038/s41568-018-0002-y. PMID: 29674709.; Kawata T, Tokunaga S, Murai M, Masuda N, Haruyama W, Shoukei Y, Hisada Y, Yanagida T, Miyazaki H, Wada M, Akizawa T, Fukagawa M. A novel calcimimetic agent, evocalcet (MT-4580/KHK7580), suppresses the parathyroid cell function with little effect on the gastrointestinal tract or CYP isozymes in vivo and in vitro. PLoS ONE. 2018 Apr 03;13(4):e0195316. doi: 10.1371/journal.pone.0195316.; Hidalgo M, Martinez-Garcia M, Le Tourneau C, Massard C, Garralda E, Boni V, Taus A, Albanell J, Sablin MP, Alt M, Bahleda R, Varga A, Boetsch C, Franjkovic I, Heil F, Lahr A, Lechner K, Morel A, Nayak T, Rossomanno S, Smart K, Stubenrauch K, Krieter O. First-in-Human Phase I Study of Single-agent Vanucizumab, A First-in-Class Bispecific Anti-Angiopoietin-2/Anti-VEGF-A Antibody, in Adult Patients with Advanced Solid Tumors. Clin Cancer Res. 2018 Apr 01;24(7):1536–45. doi: 10.1158/1078-0432.ccr-17-1588. PMID: 29217526.; Liu F, Yu H, Lin C, Elzoghby AO, Hwang T, Fang J. Use of cilomilast-loaded phosphatiosomes to suppress neutrophilic inflammation for attenuating acute lung injury: the effect of nanovesicular surface charge. Journal of Nanobiotechnology. 2018 Mar 30;16(1):35. doi: 10.1186/s12951-018-0364-z.; Audo R, Deckert V, Daien CI, Che H, Elhmioui J, Lemaire S, Pais de Barros J, Desrumaux C, Combe B, Hahne M, Lagrost L, Morel J. PhosphoLipid transfer protein (PLTP) exerts a direct pro-inflammatory effect on rheumatoid arthritis (RA) fibroblasts-like-synoviocytes (FLS) independently of its lipid transfer activity. PLoS ONE. 2018 Mar 22;13(3):e0193815. doi: 10.1371/journal.pone.0193815.; Ozdemir ES, Jang H, Gursoy A, Keskin O, Li Z, Sacks DB, Nussinov R. Unraveling the molecular mechanism of interactions of the Rho GTPases Cdc42 and Rac1 with the scaffolding protein IQGAP2. Journal of Biological Chemistry. 2018 Mar;293(10):3685–99. doi: 10.1074/jbc.ra117.001596.; Tajadura-Ortega V, Garg R, Allen R, Owczarek C, Bright MD, Kean S, Mohd-Noor A, Grigoriadis A, Elston TC, Hahn KM, Ridley AJ. An RNAi screen of Rho signalling networks identifies RhoH as a regulator of Rac1 in prostate cancer cell migration. BMC Biology. 2018 Mar 06;16(1):29. doi: 10.1186/s12915-018-0489-4.; Florio M, Heide M, Pinson A, Brandl H, Albert M, Winkler S, Wimberger P, Huttner WB, Hiller M. Author response: Evolution and cell-type specificity of human-specific genes preferentially expressed in progenitors of fetal neocortex. 2018 Mar 05;(). doi: 10.7554/elife.32332.045.; Guanizo AC, Fernando CD, Garama DJ, Gough DJ. STAT3: a multifaceted oncoprotein. Growth Factors. 2018 Apr;36(1-2):1–14. doi: 10.1080/08977194.2018.1473393. PMID: 29873274.; Maadi H, Nami B, Tong J, Li G, Wang Z. The effects of trastuzumab on HER2-mediated cell signaling in CHO cells expressing human HER2. BMC Cancer. 2018 Mar 01;18(1):238. PMID: 29490608; PMCID: PMC5831215.; Roskoski R. The role of small molecule platelet-derived growth factor receptor (PDGFR) inhibitors in the treatment of neoplastic disorders. Pharmacol Res. 2018 Mar;129():65–83. doi: 10.1016/j.phrs.2018.01.021. PMID: 29408302.; Hilberg F, Tontsch-Grunt U, Baum A, Le AT, Doebele RC, Lieb S, Gianni D, Voss T, Garin-Chesa P, Haslinger C, Kraut N. Triple Angiokinase Inhibitor Nintedanib Directly Inhibits Tumor Cell Growth and Induces Tumor Shrinkage via Blocking Oncogenic Receptor Tyrosine Kinases. The Journal of Pharmacology and Experimental Therapeutics. 2018 Mar;364(3):494–503. doi: 10.1124/jpet.117.244129.; Moschos SJ, Sullivan RJ, Hwu WJ, Ramanathan RK, Adjei AA, Fong PC, Shapira-Frommer R, Tawbi HA, Rubino J, Rush TS, Zhang D, Miselis NR, Samatar AA, Chun P, Rubin EH, Schiller J, Long BJ, Dayananth P, Carr D, Kirschmeier P, Bishop WR, Deng Y, Cooper A, Shipps GW, Moreno BH, Robert L, Ribas A, Flaherty KT. Development of MK-8353, an orally administered ERK1/2 inhibitor, in patients with advanced solid tumors. JCI Insight. 2018 Feb 22;3(4). PMID: 29467321; PMCID: PMC5916243.; Agianian B, Gavathiotis E: Current Insights of BRAF Inhibitors in Cancer. J Med Chem. 2018 Jul 26;61(14):5775-5793. doi: 10.1021/acs.jmedchem.7b01306. Epub 2018 Mar 6.; Della Corte CM, Viscardi G, Di Liello R, Fasano M, Martinelli E, Troiani T, Ciardiello F, Morgillo F. Role and targeting of anaplastic lymphoma kinase in cancer. Molecular Cancer. 2018 Feb 19;17(1):30. doi: 10.1186/s12943-018-0776-2.; Hampton SE, Dore TM, Schmidt WK. Rce1: mechanism and inhibition. Critical Reviews in Biochemistry and Molecular Biology. 2018 Feb 09;53(2):157–74. doi: 10.1080/10409238.2018.1431606.; Skljarevski V, Oakes TM, Zhang Q, Ferguson MB, Martinez J, Camporeale A, Johnson KW, Shan Q, Carter J, Schacht A, Goadsby PJ, Dodick DW. Effect of Different Doses of Galcanezumab vs Placebo for Episodic Migraine Prevention: A Randomized Clinical Trial. JAMA Neurol. 2018 Feb 01;75(2):187–93. PMID: 29255900; PMCID: PMC5838630.; Liu DY, Wang ZG, Gao Y, Zhang HM, Zhang YX, Wang XJ, Peng D. Effect and safety of roflumilast for chronic obstructive pulmonary disease in Chinese patients. Medicine (Baltimore). 2018 Feb;97(7):e9864. PMID: 29443750; PMCID: PMC5839818.; Filardo EJ. A role for G-protein coupled estrogen receptor (GPER) in estrogen-induced carcinogenesis: Dysregulated glandular homeostasis, survival and metastasis. The Journal of Steroid Biochemistry and Molecular Biology. 2018 Feb;176():38–48. doi: 10.1016/j.jsbmb.2017.05.005.; Fukusumi T, Guo TW, Sakai A, Ando M, Ren S, Haft S, Liu C, Amornphimoltham P, Gutkind JS, Califano JA. The NOTCH4HEY1 Pathway Induces Epithelial–Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma. 2018 Jan 31;24(3):619–33. doi: 10.1158/1078-0432.ccr-17-1366.; Zhou H, Cai L, Zhang X, Li A, Miao Y, Li Q, Qiu X, Wang E. ARHGEF39 promotes tumor progression via activation of Rac1/P38 MAPK/ATF2 signaling and predicts poor prognosis in non-small cell lung cancer patients. Laboratory Investigation. 2018 Jan 30;98(5):670–81. doi: 10.1038/s41374-018-0022-y.; Li Y, Jin C, Bai H, Gao Y, Sun S, Chen L, Qin L, Liu PP, Cheng L, Wang QF. Human NOTCH4 is a key target of RUNX1 in megakaryocytic differentiation. Blood. 2018 Jan 11;131(2):191–201. PMID: 29101237; PMCID: PMC5757696.; Ahearn I, Zhou M, Philips MR. Posttranslational Modifications of RAS Proteins. Cold Spring Harb Perspect Med. 2018 Jan 08;8(11):a031484. doi: 10.1101/cshperspect.a031484.; Santos RAS, Sampaio WO, Alzamora AC, Motta-Santos D, Alenina N, Bader M, Campagnole-Santos MJ. The ACE2/Angiotensin-(1–7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1–7). Physiological Reviews. 2018 Jan 01;98(1):505–53. doi: 10.1152/physrev.00023.2016.; Melincovici CS, Bosca AB, Susman S, Marginean M, Mihu C, Istrate M, Moldovan IM, Roman AL, Mihu CM. Vascular endothelial growth factor (VEGF) - key factor in normal and pathological angiogenesis. Rom J Morphol Embryol. 2018;59(2):455–67. PMID: 30173249.; Chen L, Sun Q, Zhou D, Song W, Yang Q, Ju B, Zhang L, Xie H, Zhou L, Hu Z, Yao H, Zheng S, Wang W. HINT2 triggers mitochondrial Ca2+ influx by regulating the mitochondrial Ca2+ uniporter (MCU) complex and enhances gemcitabine apoptotic effect in pancreatic cancer. Cancer Lett. 2017 Dec 28;411():106–16. doi: 10.1016/j.canlet.2017.09.020. PMID: 28947137.; Nazir M, Senkowski W, Nyberg F, Blom K, Edqvist PH, Jarvius M, Andersson C, Gustafsson MG, Nygren P, Larsson R, Fryknäs M. Targeting tumor cells based on Phosphodiesterase 3A expression. Exp Cell Res. 2017 Dec 15;361(2):308–15. doi: 10.1016/j.yexcr.2017.10.032. PMID: 29107068.; Wolska A, Dunbar RL, Freeman LA, Ueda M, Amar MJ, Sviridov DO, Remaley AT. Apolipoprotein C-II: New findings related to genetics, biochemistry, and role in triglyceride metabolism. Atherosclerosis. 2017 Dec;267():49–60. doi: 10.1016/j.atherosclerosis.2017.10.025.; Silberstein SD, Dodick DW, Bigal ME, Yeung PP, Goadsby PJ, Blankenbiller T, Grozinski-Wolff M, Yang R, Ma Y, Aycardi E. Fremanezumab for the Preventive Treatment of Chronic Migraine. N Engl J Med. 2017 Nov 30;377(22):2113–22. doi: 10.1056/nejmoa1709038. PMID: 29171818.; Hodge RG, Ridley AJ. Regulation and functions of RhoU and RhoV. Small GTPases. 2017 Nov 30;11(1):8–15. doi: 10.1080/21541248.2017.1362495.; Chen A, Arora PD, McCulloch CA, Wilde A. Cytokinesis requires localized ß-actin filament production by an actin isoform specific nucleator. Nature Communications. 2017 Nov 16;8(1):1530. doi: 10.1038/s41467-017-01231-x.; Kythreotou A, Siddique A, Mauri FA, Bower M, Pinato DJ. PD-L1. J Clin Pathol. 2018 Mar;71(3):189–94. doi: 10.1136/jclinpath-2017-204853. PMID: 29097600.; Evans EK, Gardino AK, Kim JL, Hodous BL, Shutes A, Davis A, Zhu XJ, Schmidt-Kittler O, Wilson D, Wilson K, DiPietro L, Zhang Y, Brooijmans N, LaBranche TP, Wozniak A, Gebreyohannes YK, Schöffski P, Heinrich MC, DeAngelo DJ, Miller S, Wolf B, Kohl N, Guzi T, Lydon N, Boral A, Lengauer C. A precision therapy against cancers driven by KIT/PDGFRA mutations. Sci Transl Med. 2017 Nov 01;9(414). doi: 10.1126/scitranslmed.aao1690. PMID: 29093181.; Germann UA, Furey BF, Markland W, Hoover RR, Aronov AM, Roix JJ, Hale M, Boucher DM, Sorrell DA, Martinez-Botella G, Fitzgibbon M, Shapiro P, Wick MJ, Samadani R, Meshaw K, Groover A, DeCrescenzo G, Namchuk M, Emery CM, Saha S, Welsch DJ: Targeting the MAPK Signaling Pathway in Cancer: Promising Preclinical Activity with the Novel Selective ERK1/2 Inhibitor BVD-523 (Ulixertinib). Mol Cancer Ther. 2017 Nov;16(11):2351-2363. doi: 10.1158/1535-7163.MCT-17-0456. Epub 2017 Sep 22.; Ferrandez Y, Zhang W, Peurois F, Akendengué L, Blangy A, Zeghouf M, Cherfils J. Allosteric inhibition of the guanine nucleotide exchange factor DOCK5 by a small molecule. Scientific Reports. 2017 Oct 31;7(1):14409. doi: 10.1038/s41598-017-13619-2.; Rodrigues BA, Kuga GK, Muñoz VR, Gaspar RC, Tavares MR, Botezelli JD, da Silva ASR, Cintra DE, de Moura LP, Simabuco FM, Ropelle ER, Pauli JR. Overexpression of Mitogen-activated protein kinase phosphatase-3 (MKP-3) reduces FoxO1 phosphorylation in mice hypothalamus. Neurosci Lett. 2017 Oct 17;659():14–7. doi: 10.1016/j.neulet.2017.08.067. PMID: 28866049.; Karoulia Z, Gavathiotis E, Poulikakos PI. New perspectives for targeting RAF kinase in human cancer. Nature Reviews Cancer. 2017 Oct 06;17(11):676–91. doi: 10.1038/nrc.2017.79.; Dubin A, Lattanzio B, Gatti L. The spectrum of cardiovascular effects of dobutamine - from healthy subjects to septic shock patients. Rev Bras Ter Intensiva. 2017 Oct;29(4):490–8. PMID: 29340539; PMCID: PMC5764562.; Beier J, Fuhr R, Seoane B, Massana E, de Miquel G, Pujol H, Ruiz S. Efficacy, safety, and tolerability of once-daily abediterol in patients with stable, persistent asthma: a Phase II, randomized, 7-day, crossover study. Pharmacology Res & Perspec. 2017 Sep 27;5(5). doi: 10.1002/prp2.356.; Liu M, Liang K, Zhen J, Zhou M, Wang X, Wang Z, Wei X, Zhang Y, Sun Y, Zhou Z, Su H, Zhang C, Li N, Gao C, Peng J, Yi F. Sirt6 deficiency exacerbates podocyte injury and proteinuria through targeting Notch signaling. Nature Communications. 2017 Sep 04;8(1):413. doi: 10.1038/s41467-017-00498-4.; Hardy LM, Frisdal E, Le Goff W. Critical Role of the Human ATP-Binding Cassette G1 Transporter in Cardiometabolic Diseases. Int J Mol Sci. 2017 Sep 02;18(9). PMID: 28869506; PMCID: PMC5618541.; Gold LS, Papp K, Lynde C, Lain E, Gooderham M, Johnson S, Kerrouche N. Treatment of Rosacea With Concomitant Use of Topical Ivermectin 1% Cream and Brimonidine 0.33% Gel: A Randomized, Vehicle-controlled Study. J Drugs Dermatol. 2017 Sep 01;16(9):909–16. PMID: 28915286.; Amado-Azevedo J, Reinhard NR, van Bezu J, de Menezes RX, van Beusechem VW, van Nieuw Amerongen GP, van Hinsbergh VWM, Hordijk PL. A CDC42-centered signaling unit is a dominant positive regulator of endothelial integrity. Scientific Reports. 2017 Aug 31;7(1):10132. doi: 10.1038/s41598-017-10392-0.; Zihni C, Vlassaks E, Terry S, Carlton J, Leung TKC, Olson M, Pichaud F, Balda MS, Matter K. An apical MRCK-driven morphogenetic pathway controls epithelial polarity. Nat Cell Biol. 2017 Sep;19(9):1049–60. PMID: 28825699; PMCID: PMC5617103.; Lai CJ, Cheng HC, Lin CY, Huang SH, Chen TH, Chung CJ, Chang CH, Wang HD, Chuu CP. Activation of liver X receptor suppresses angiogenesis via induction of ApoD. FASEB J. 2017 Dec;31(12):5568–76. doi: 10.1096/fj.201700374r. PMID: 28842423.; Kim M, Kim J, Jeong S, Jo H, Woo YR, Park HJ. Inhibition of mast cell infiltration in an LL-37-induced rosacea mouse model using topical brimonidine tartrate 0.33% gel. Experimental Dermatology. 2017 Aug 15;26(11):1143–5. doi: 10.1111/exd.13381.; Pei D, Chen K, Liao H. Targeting Ras with Macromolecules. Cold Spring Harb Perspect Med. 2017 Aug 04;8(3):a031476. doi: 10.1101/cshperspect.a031476.; Keeshin BR, Ding Q, Presson AP, Berkowitz SJ, Strawn JR. Use of Prazosin for Pediatric PTSD-Associated Nightmares and Sleep Disturbances: A Retrospective Chart Review. Neurology and Therapy. 2017 Jul 28;6(2):247–57. doi: 10.1007/s40120-017-0078-4.; Luo W, Janoštiak R, Tolde O, Ryzhova LM, Koudelková L, Dibus M, Brábek J, Hanks SK, Rosel D. ARHGAP42 is activated by Src-mediated tyrosine phosphorylation to promote cell motility. J Cell Sci. 2017 Jul 15;130(14):2382–93. PMID: 28584191; PMCID: PMC5536916.; Arnal JF, Lenfant F, Metivier R, Flouriot G, Henrion D, Adlanmerini M, Fontaine C, Gourdy P, Chambon P, Katzenellenbogen B, Katzenellenbogen J. Membrane and Nuclear Estrogen Receptor Alpha Actions: From Tissue Specificity to Medical Implications. Physiol Rev. 2017 Jul 01;97(3):1045–87. doi: 10.1152/physrev.00024.2016. PMID: 28539435.; Goto K, Doi M, Wang T, Kunisue S, Murai I, Okamura H. G-protein-coupled receptor signaling through Gpr176, Gz, and RGS16 tunes time in the center of the circadian clock [Review]. Endocr J. 2017 Jun 29;64(6):571–9. doi: 10.1507/endocrj.ej17-0130. PMID: 28502923.; Simanshu DK, Nissley DV, McCormick F. RAS Proteins and Their Regulators in Human Disease. Cell. 2017 Jun 29;170(1):17–33. PMID: 28666118; PMCID: PMC5555610.; Lin DTS, Davis NG, Conibear E. Targeting the Ras palmitoylation/depalmitoylation cycle in cancer. Biochem Soc Trans. 2017 Aug 15;45(4):913–21. doi: 10.1042/bst20160303. PMID: 28630138.; Gonzalez de Valdivia E, Broselid S, Kahn R, Olde B, Leeb-Lundberg LMF. G protein-coupled estrogen receptor 1 (GPER1)/GPR30 increases ERK1/2 activity through PDZ motif-dependent and -independent mechanisms. Journal of Biological Chemistry. 2017 Jun;292(24):9932–43. doi: 10.1074/jbc.m116.765875.; Zhang R, Engler A, Taylor V. Notch: an interactive player in neurogenesis and disease. Cell Tissue Res. 2018 Jan;371(1):73–89. doi: 10.1007/s00441-017-2641-9. PMID: 28620760.; Hanker AB, Brewer MR, Sheehan JH, Koch JP, Sliwoski GR, Nagy R, Lanman R, Berger MF, Hyman DM, Solit DB, He J, Miller V, Cutler RE, Lalani AS, Cross D, Lovly CM, Meiler J, Arteaga CL. An Acquired HER2T798I Gatekeeper Mutation Induces Resistance to Neratinib in a Patient with HER2 Mutant-Driven Breast Cancer. Cancer Discov. 2017 Jun;7(6):575–85. PMID: 28274957; PMCID: PMC5457707.; Nguyen V, Tiemann D, Park E, Salehi A. Alpha-2 Agonists. Anesthesiol Clin. 2017 Jun;35(2):233–45. doi: 10.1016/j.anclin.2017.01.009. PMID: 28526145.; Wijemanne S, Vijayakumar D, Jankovic J. Apraclonidine in the treatment of ptosis. Journal of the Neurological Sciences. 2017 May;376():129–32. doi: 10.1016/j.jns.2017.03.025.; Rosenberg BJ, Gil-Henn H, Mader CC, Halo T, Yin T, Condeelis J, Machida K, Wu YI, Koleske AJ. Phosphorylated cortactin recruits Vav2 guanine nucleotide exchange factor to activate Rac3 and promote invadopodial function in invasive breast cancer cells. Mol Biol Cell. 2017 May 15;28(10):1347–60. PMID: 28356423; PMCID: PMC5426849.; Li S, Cai J, Feng ZB, Jin ZR, Liu BH, Zhao HY, Jing HB, Wei TJ, Yang GN, Liu LY, Cui YJ, Xing GG. BDNF Contributes to Spinal Long-Term Potentiation and Mechanical Hypersensitivity Via Fyn-Mediated Phosphorylation of NMDA Receptor GluN2B Subunit at Tyrosine 1472 in Rats Following Spinal Nerve Ligation. Neurochem Res. 2017 Oct;42(10):2712–29. doi: 10.1007/s11064-017-2274-0. PMID: 28497343.; Durkin CH, Leite F, Cordeiro JV, Handa Y, Arakawa Y, Valderrama F, Way M. RhoD Inhibits RhoC-ROCK-Dependent Cell Contraction via PAK6. Developmental Cell. 2017 May;41(3):315–329.e7. doi: 10.1016/j.devcel.2017.04.010.; Manu KA, Chai TF, Teh JT, Zhu WL, Casey PJ, Wang M. Inhibition of Isoprenylcysteine Carboxylmethyltransferase Induces Cell-Cycle Arrest and Apoptosis through p21 and p21-Regulated BNIP3 Induction in Pancreatic Cancer. Mol Cancer Ther. 2017 May;16(5):914–23. doi: 10.1158/1535-7163.mct-16-0703. PMID: 28167504.; Hooker E, Baldwin C, Roodman V, Batra A, Isa NN, Takano T, Lemay S. Binding and inhibition of the ternary complex factor Elk-4/Sap1 by the adapter protein Dok-4. Biochem J. 2017 Apr 19;474(9):1509–28. doi: 10.1042/bcj20160832. PMID: 28275114.; Baker JG, Gardiner SM, Woolard J, Fromont C, Jadhav GP, Mistry SN, Thompson KSJ, Kellam B, Hill SJ, Fischer PM. Novel selective ß 1 -adrenoceptor antagonists for concomitant cardiovascular and respiratory disease. The FASEB Journal. 2017 Apr 11;31(7):3150–66. doi: 10.1096/fj.201601305r.; Peurois F, Veyron S, Ferrandez Y, Ladid I, Benabdi S, Zeghouf M, Peyroche G, Cherfils J. Characterization of the activation of small GTPases by their GEFs on membranes using artificial membrane tethering. Biochem J. 2017 Mar 23;474(7):1259–72. doi: 10.1042/bcj20170015. PMID: 28196833.; Endres K, Deller T. Regulation of Alpha-Secretase ADAM10 In vitro and In vivo: Genetic, Epigenetic, and Protein-Based Mechanisms. Front. Mol. Neurosci. 2017 Mar 17;10(). doi: 10.3389/fnmol.2017.00056.; Esnault C, Gualdrini F, Horswell S, Kelly G, Stewart A, East P, Matthews N, Treisman R. ERK-Induced Activation of TCF Family of SRF Cofactors Initiates a Chromatin Modification Cascade Associated with Transcription. Molecular Cell. 2017 Mar;65(6):1081–1095.e5. doi: 10.1016/j.molcel.2017.02.005.; Higgins EM, Bos JM, Mason-Suares H, Tester DJ, Ackerman JP, MacRae CA, Sol-Church K, Gripp KW, Urrutia R, Ackerman MJ. Elucidation of MRAS-mediated Noonan syndrome with cardiac hypertrophy. JCI Insight. 2017 Mar 09;2(5):e91225. PMID: 28289718; PMCID: PMC5333962.; Nelson JK, Koenis DS, Scheij S, Cook EC, Moeton M, Santos A, Lobaccaro JA, Baron S, Zelcer N. EEPD1 Is a Novel LXR Target Gene in Macrophages Which Regulates ABCA1 Abundance and Cholesterol Efflux. Arterioscler Thromb Vasc Biol. 2017 Mar;37(3):423–32. PMID: 28082258; PMCID: PMC5321112.; Westman PC, Lipinski MJ, Torguson R, Waksman R. A comparison of cangrelor, prasugrel, ticagrelor, and clopidogrel in patients undergoing percutaneous coronary intervention: A network meta-analysis. Cardiovascular Revascularization Medicine. 2017 Mar;18(2):79–85. doi: 10.1016/j.carrev.2016.10.005.; Thiel G, Rössler OG. Resveratrol regulates gene transcription via activation of stimulus-responsive transcription factors. Pharmacol Res. 2017 Mar;117():166–76. doi: 10.1016/j.phrs.2016.12.029. PMID: 28012964.; Barford K, Deppmann C, Winckler B. The neurotrophin receptor signaling endosome: Where trafficking meets signaling. Developmental Neurobiology. 2017 Feb 24;77(4):405–18. doi: 10.1002/dneu.22427.; Kaufman PL: Latanoprostene bunod ophthalmic solution 0.024% for IOP lowering in glaucoma and ocular hypertension. Expert Opin Pharmacother. 2017 Mar;18(4):433-444. doi: 10.1080/14656566.2017.1293654. Epub 2017 Feb 20.; Werner MT, Zhao C, Zhang Q, Wasik MA. Nucleophosmin-anaplastic lymphoma kinase: the ultimate oncogene and therapeutic target. Blood. 2017 Feb 16;129(7):823–31. doi: 10.1182/blood-2016-05-717793. PMID: 27879258.; Mockett BG, Richter M, Abraham WC, Müller UC. Therapeutic Potential of Secreted Amyloid Precursor Protein APPsa. Front. Mol. Neurosci. 2017 Feb 07;10(). doi: 10.3389/fnmol.2017.00030.; Melaiu O, Catalano C, De Santi C, Cipollini M, Figlioli G, Pellè L, Barone E, Evangelista M, Guazzelli A, Boldrini L, Sensi E, Bonotti A, Foddis R, Cristaudo A, Mutti L, Fontanini G, Gemignani F, Landi S. Inhibition of the platelet-derived growth factor receptor beta (PDGFRB) using gene silencing, crenolanib besylate, or imatinib mesylate hampers the malignant phenotype of mesothelioma cell lines. Genes Cancer. 2017 Feb 01;8(1-2):438–52. doi: 10.18632/genesandcancer.129.; Di Salvo J, Nagabukuro H, Wickham LA, Abbadie C, DeMartino JA, Fitzmaurice A, Gichuru L, Kulick A, Donnelly MJ, Jochnowitz N, Hurley AL, Pereira A, Sanfiz A, Veronin G, Villa K, Woods J, Zamlynny B, Zycband E, Salituro GM, Frenkl T, Weber AE, Edmondson SD, Struthers M. Pharmacological Characterization of a Novel Beta 3 Adrenergic Agonist, Vibegron: Evaluation of Antimuscarinic Receptor Selectivity for Combination Therapy for Overactive Bladder. The Journal of Pharmacology and Experimental Therapeutics. 2017 Feb;360(2):346–55. doi: 10.1124/jpet.116.237313.; Alexander A, Irving AJ, Harvey J. Emerging roles for the novel estrogen-sensing receptor GPER1 in the CNS. Neuropharmacology. 2017 Feb;113(Pt B):652–60. doi: 10.1016/j.neuropharm.2016.07.003. PMID: 27392633.; Noronha Neto C C, Maia SSB, Katz L, Coutinho IC, Souza AR, Amorim MM. Clonidine versus Captopril for Severe Postpartum Hypertension: A Randomized Controlled Trial. PLoS ONE. 2017 Jan 26;12(1):e0168124. doi: 10.1371/journal.pone.0168124.; Bai X, Mangum KD, Dee RA, Stouffer GA, Lee CR, Oni-Orisan A, Patterson C, Schisler JC, Viera AJ, Taylor JM, Mack CP. Blood pressure-associated polymorphism controls ARHGAP42 expression via serum response factor DNA binding. J Clin Invest. 2017 Feb 01;127(2):670–80. PMID: 28112683; PMCID: PMC5272192.; Martin-Vilchez S, Whitmore L, Asmussen H, Zareno J, Horwitz R, Newell-Litwa K. RhoGTPase Regulators Orchestrate Distinct Stages of Synaptic Development. PLoS ONE. 2017 Jan 23;12(1):e0170464. doi: 10.1371/journal.pone.0170464.; Song ZM, Bouchab L, Hudik E, Le Bars R, Nüsse O, Dupré-Crochet S. Phosphoinositol 3-phosphate acts as a timer for reactive oxygen species production in the phagosome. J Leukoc Biol. 2017 May;101(5):1155–68. doi: 10.1189/jlb.1a0716-305r. PMID: 28096301.; Vijayakumar D, Wijemanne S, Jankovic J. Treatment of blepharospasm with apraclonidine. Journal of the Neurological Sciences. 2017 Jan;372():57–9. doi: 10.1016/j.jns.2016.11.029.; Toffali L, Montresor A, Mirenda M, Scita G, Laudanna C. SOS1, ARHGEF1, and DOCK2 rho-GEFs Mediate JAK-Dependent LFA-1 Activation by Chemokines. J Immunol. 2017 Jan 15;198(2):708–17. doi: 10.4049/jimmunol.1600933. PMID: 27986909.; Freire MO, Dalli J, Serhan CN, Van Dyke TE. Neutrophil Resolvin E1 Receptor Expression and Function in Type 2 Diabetes. J Immunol. 2017 Jan 15;198(2):718–28. PMID: 27994073; PMCID: PMC5224973.; Sun Y, Alberta JA, Pilarz C, Calligaris D, Chadwick EJ, Ramkissoon SH, Ramkissoon LA, Garcia VM, Mazzola E, Goumnerova L, Kane M, Yao Z, Kieran MW, Ligon KL, Hahn WC, Garraway LA, Rosen N, Gray NS, Agar NY, Buhrlage SJ, Segal RA, Stiles CD. A brain-penetrant RAF dimer antagonist for the noncanonical BRAF oncoprotein of pediatric low-grade astrocytomas. Neuro Oncol. 2017 Jun 01;19(6):774–85. PMID: 28082416; PMCID: PMC5464455.; Adams KW, Kletsov S, Lamm RJ, Elman JS, Mullenbrock S, Cooper GM. Role for Egr1 in the Transcriptional Program Associated with Neuronal Differentiation of PC12 Cells. PLoS ONE. 2017 Jan 11;12(1):e0170076. doi: 10.1371/journal.pone.0170076.; Paul F, Zauber H, von Berg L, Rocks O, Daumke O, Selbach M. Quantitative GTPase Affinity Purification Identifies Rho Family Protein Interaction Partners. Molecular & Cellular Proteomics. 2017 Jan;16(1):73–85. doi: 10.1074/mcp.m116.061531.; Vakana E, Pratt S, Blosser W, Dowless M, Simpson N, Yuan XJ, Jaken S, Manro J, Stephens J, Zhang Y, Huber L, Peng SB, Stancato LF. LY3009120, a panRAF inhibitor, has significant anti-tumor activity in BRAF and KRAS mutant preclinical models of colorectal cancer. Oncotarget. 2017 Feb 07;8(6):9251–66. PMID: 27999210; PMCID: PMC5354729.; Aungraheeta R, Conibear A, Butler M, Kelly E, Nylander S, Mumford A, Mundell SJ. Inverse agonism at the P2Y12 receptor and ENT1 transporter blockade contribute to platelet inhibition by ticagrelor. Blood. 2016 Dec 08;128(23):2717–28. PMID: 27694321; PMCID: PMC5161012.; Cho K, Casteel DE, Prakash P, Tan L, van der Hoeven D, Salim AA, Kim C, Capon RJ, Lacey E, Cunha SR, Gorfe AA, Hancock JF. AMPK and Endothelial Nitric Oxide Synthase Signaling Regulates K-Ras Plasma Membrane Interactions via Cyclic GMP-Dependent Protein Kinase 2. Molecular and Cellular Biology. 2016 Dec 01;36(24):3086–99. doi: 10.1128/mcb.00365-16.; Yasar P, Ayaz G, Muyan M. Estradiol-Estrogen Receptor a Mediates the Expression of the CXXC5 Gene through the Estrogen Response Element-Dependent Signaling Pathway. Scientific Reports. 2016 Nov 25;6(1):37808. doi: 10.1038/srep37808.; Zhang X, Liu X, Luo J, Xiao W, Ye X, Chen M, Li Y, Zhang GJ. Notch3 inhibits epithelial-mesenchymal transition by activating Kibra-mediated Hippo/YAP signaling in breast cancer epithelial cells. Oncogenesis. 2016 Nov 14;5(11):e269. PMID: 27841855; PMCID: PMC5141289.; Baranov MV, Revelo NH, Dingjan I, Maraspini R, ter Beest M, Honigmann A, van den Bogaart G. SWAP70 Organizes the Actin Cytoskeleton and Is Essential for Phagocytosis. Cell Reports. 2016 Nov;17(6):1518–31. doi: 10.1016/j.celrep.2016.10.021.; Xu C, Fu X, Zhu S, Liu JJ. Retrolinkin recruits the WAVE1 protein complex to facilitate BDNF-induced TrkB endocytosis and dendrite outgrowth. Mol Biol Cell. 2016 Nov 01;27(21):3342–56. PMID: 27605705; PMCID: PMC5170866.; Dharmaiah S, Bindu L, Tran TH, Gillette WK, Frank PH, Ghirlando R, Nissley DV, Esposito D, McCormick F, Stephen AG, Simanshu DK. Structural basis of recognition of farnesylated and methylated KRAS4b by PDEd. Proc Natl Acad Sci U S A. 2016 Nov 01;113(44):E6766–75. PMID: 27791178; PMCID: PMC5098621.; Rehman M, Gurrapu S, Cagnoni G, Capparuccia L, Tamagnone L. PlexinD1 Is a Novel Transcriptional Target and Effector of Notch Signaling in Cancer Cells. PLoS ONE. 2016 Oct 17;11(10):e0164660. doi: 10.1371/journal.pone.0164660.; Zamboni V, Armentano M, Sarò G, Ciraolo E, Ghigo A, Germena G, Umbach A, Valnegri P, Passafaro M, Carabelli V, Gavello D, Bianchi V, D’Adamo P, de Curtis I, El-Assawi N, Mauro A, Priano L, Ferri N, Hirsch E, Merlo GR. Disruption of ArhGAP15 results in hyperactive Rac1, affects the architecture and function of hippocampal inhibitory neurons and causes cognitive deficits. Scientific Reports. 2016 Oct 07;6(1):34877. doi: 10.1038/srep34877.; Ding L, Lei Y, Han Y, Li Y, Ji X, Liu L. Vimar Is a Novel Regulator of Mitochondrial Fission through Miro. PLoS Genet. 2016 Oct 07;12(10):e1006359. doi: 10.1371/journal.pgen.1006359.; Csépányi-Kömi R, Wisniewski É, Bartos B, Lévai P, Németh T, Balázs B, Kurz AR, Bierschenk S, Sperandio M, Ligeti E. Rac GTPase Activating Protein ARHGAP25 Regulates Leukocyte Transendothelial Migration in Mice. J Immunol. 2016 Oct 01;197(7):2807–15. doi: 10.4049/jimmunol.1502342. PMID: 27566826.; Teo CR, Casey PJ, Rasheed SA. The GNA13-RhoA signaling axis suppresses expression of tumor protective Kallikreins. Cell Signal. 2016 Oct;28(10):1479–88. doi: 10.1016/j.cellsig.2016.07.001. PMID: 27424208.; Amin E, Jaiswal M, Derewenda U, Reis K, Nouri K, Koessmeier KT, Aspenström P, Somlyo AV, Dvorsky R, Ahmadian MR. Deciphering the Molecular and Functional Basis of RHOGAP Family Proteins: A SYSTEMATIC APPROACH TOWARD SELECTIVE INACTIVATION OF RHO FAMILY PROTEINS. J Biol Chem. 2016 Sep 23;291(39):20353–71. PMID: 27481945; PMCID: PMC5034035.; Lu S, Jang H, Gu S, Zhang J, Nussinov R. Drugging Ras GTPase: a comprehensive mechanistic and signaling structural view. Chem Soc Rev. 2016 Sep 21;45(18):4929–52. PMID: 27396271; PMCID: PMC5021603.; Wangler NJ, Jayaraman S, Zhu R, Mechref Y, Abbruscato TJ, Bickel U, Karamyan VT. Preparation and preliminary characterization of recombinant neurolysin for in vivo studies. J Biotechnol. 2016 Sep 20;234():105–15. doi: 10.1016/j.jbiotec.2016.07.007. PMID: 27496565.; Bajracharya SR, Prasad PN, Ghimire R. Management of Organophosphorus Poisoning. J Nepal Health Res Counc. 2016 Sep;14(34):131–8. PMID: 28327676.; Schwartz N, Verma A, Bivens CB, Schwartz Z, Boyan BD. Rapid steroid hormone actions via membrane receptors. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 2016 Sep;1863(9):2289–98. doi: 10.1016/j.bbamcr.2016.06.004.; Bahrami S, Drabløs F. Gene regulation in the immediate-early response process. Advances in Biological Regulation. 2016 Sep;62():37–49. doi: 10.1016/j.jbior.2016.05.001.; Kuboyama K, Fujikawa A, Suzuki R, Tanga N, Noda M. Role of Chondroitin Sulfate (CS) Modification in the Regulation of Protein-tyrosine Phosphatase Receptor Type Z (PTPRZ) Activity: PLEIOTROPHIN-PTPRZ-A SIGNALING IS INVOLVED IN OLIGODENDROCYTE DIFFERENTIATION. J Biol Chem. 2016 Aug 26;291(35):18117–28. PMID: 27445335; PMCID: PMC5000061.; El-Benna J, Hurtado-Nedelec M, Marzaioli V, Marie JC, Gougerot-Pocidalo MA, Dang PM. Priming of the neutrophil respiratory burst: role in host defense and inflammation. Immunol Rev. 2016 Sep;273(1):180–93. doi: 10.1111/imr.12447. PMID: 27558335.; Nguyen TT, Park WS, Park BO, Kim CY, Oh Y, Kim JM, Choi H, Kyung T, Kim CH, Lee G, Hahn KM, Meyer T, Heo WD. PLEKHG3 enhances polarized cell migration by activating actin filaments at the cell front. Proc Natl Acad Sci U S A. 2016 Sep 06;113(36):10091–6. PMID: 27555588; PMCID: PMC5018766.; Alabi RO, Glomski K, Haxaire C, Weskamp G, Monette S, Blobel CP. ADAM10-Dependent Signaling Through Notch1 and Notch4 Controls Development of Organ-Specific Vascular Beds. Circulation Research. 2016 Aug 05;119(4):519–31. doi: 10.1161/circresaha.115.307738.; Abbaspour Babaei M, Kamalidehghan B, Saleem M, Huri HZ, Ahmadipour F. Receptor tyrosine kinase (c-Kit) inhibitors: a potential therapeutic target in cancer cells. Drug Des Devel Ther. 2016;10():2443–59. PMID: 27536065; PMCID: PMC4975146.; Niermann C, Gorressen S, Klier M, Gowert NS, Billuart P, Kelm M, Merx MW, Elvers M. Oligophrenin1 protects mice against myocardial ischemia and reperfusion injury by modulating inflammation and myocardial apoptosis. Cell Signal. 2016 Aug;28(8):967–78. doi: 10.1016/j.cellsig.2016.04.008. PMID: 27117132.; Rostam MA, Kamato D, Piva TJ, Zheng W, Little PJ, Osman N. The role of specific Smad linker region phosphorylation in TGF-ß mediated expression of glycosaminoglycan synthesizing enzymes in vascular smooth muscle. Cell Signal. 2016 Aug;28(8):956–66. doi: 10.1016/j.cellsig.2016.05.002. PMID: 27153775.; Beier J, Pujol H, Seoane B, Jimenez E, Astbury C, Massana E, Ruiz S, de Miquel G. Abediterol, a novel long-acting ß2-agonist: bronchodilation, safety, tolerability and pharmacokinetic results from a single-dose, dose-ranging, active-comparator study in patients with COPD. BMC Pulmonary Medicine. 2016 Jul 20;16(1):102. doi: 10.1186/s12890-016-0266-5.; Sudhaharan T, Sem KP, Liew HF, Yu YH, Goh WI, Chou AM, Ahmed S. The Rho GTPase Rif signals through IRTKS, Eps8 and WAVE2 to generate dorsal membrane ruffles and filopodia. J Cell Sci. 2016 Jul 15;129(14):2829–40. doi: 10.1242/jcs.179655. PMID: 27278019.; Sperlich B, Kapoor S, Waldmann H, Winter R, Weise K. Regulation of K-Ras4B Membrane Binding by Calmodulin. Biophysical Journal. 2016 Jul;111(1):113–22. doi: 10.1016/j.bpj.2016.05.042.; Tian J, Goldstein JL, Brown MS. Insulin induction of SREBP-1c in rodent liver requires LXRa-C/EBPß complex. Proc Natl Acad Sci U S A. 2016 Jul 19;113(29):8182–7. PMID: 27382175; PMCID: PMC4961151.; Lawson CD, Fan C, Mitin N, Baker NM, George SD, Graham DM, Perou CM, Burridge K, Der CJ, Rossman KL. Rho GTPase Transcriptome Analysis Reveals Oncogenic Roles for Rho GTPase-Activating Proteins in Basal-like Breast Cancers. Cancer Res. 2016 Jul 01;76(13):3826–37. PMID: 27216196; PMCID: PMC4930678.; Ji W, Rivero F. Atypical Rho GTPases of the RhoBTB Subfamily: Roles in Vesicle Trafficking and Tumorigenesis. Cells. 2016 Jun 14;5(2). PMID: 27314390; PMCID: PMC4931677.; Blake JF, Burkard M, Chan J, Chen H, Chou K, Diaz D, Dudley DA, Gaudino JJ, Gould SE, Grina J, Hunsaker T, Liu L, Martinson M, Moreno D, Mueller L, Orr C, Pacheco P, Qin A, Rasor K, Ren L, Robarge K, Shahidi-Latham S, Stults J, Sullivan F, Wang W, Yin J, Zhou A, Belvin M, Merchant M, Moffat J, Schwarz JB. Discovery of (S)-1-(1-(4-Chloro-3-fluorophenyl)-2-hydroxyethyl)-4-(2-((1-methyl-1H-pyrazol-5-yl)amino)pyrimidin-4-yl)pyridin-2(1H)-one (GDC-0994), an Extracellular Signal-Regulated Kinase 1/2 (ERK1/2) Inhibitor in Early Clinical Development. J. Med. Chem. 2016 Jun 07;59(12):5650–60. doi: 10.1021/acs.jmedchem.6b00389.; Huang WL, Li Z, Lin TY, Wang SW, Wu FJ, Luo CW. Thyrostimulin-TSHR signaling promotes the proliferation of NIH:OVCAR-3 ovarian cancer cells via trans-regulation of the EGFR pathway. Sci Rep. 2016 Jun 07;6():27471. PMID: 27273257; PMCID: PMC4895341.; Gripp KW, Aldinger KA, Bennett JT, Baker L, Tusi J, Powell-Hamilton N, Stabley D, Sol-Church K, Timms AE, Dobyns WB. A novel rasopathy caused by recurrent de novo missense mutations in PPP1CB closely resembles Noonan syndrome with loose anagen hair. American J of Med Genetics Pt A. 2016 Jun 05;170(9):2237–47. doi: 10.1002/ajmg.a.37781.; Bower RL, Hay DL. Amylin structure–function relationships and receptor pharmacology: implications for amylin mimetic drug development. British J Pharmacology. 2016 May 18;173(12):1883–98. doi: 10.1111/bph.13496.; Sturdivant JM, Royalty SM, Lin C, Moore LA, Yingling JD, Laethem CL, Sherman B, Heintzelman GR, Kopczynski CC, deLong MA. Discovery of the ROCK inhibitor netarsudil for the treatment of open-angle glaucoma. Bioorganic & Medicinal Chemistry Letters. 2016 May;26(10):2475–80. doi: 10.1016/j.bmcl.2016.03.104.; Nederpelt I, Vergroesen RD, IJzerman AP, Heitman LH. Persistent GnRH receptor activation in pituitary aT3-1 cells analyzed with a label-free technology. Biosens Bioelectron. 2016 May 15;79():721–7. doi: 10.1016/j.bios.2015.12.066. PMID: 26774084.; Tran Q, Firkins R, Giles J, Francis S, Matnishian V, Tran P, VerMeer M, Jasurda J, Burgard MA, Gebert-Oberle B. Estrogen Enhances Linkage in the Vascular Endothelial Calmodulin Network via a Feedforward Mechanism at the G Protein-coupled Estrogen Receptor 1. Journal of Biological Chemistry. 2016 May;291(20):10805–23. doi: 10.1074/jbc.m115.697334.; Rutkowska A, O’Sullivan SA, Christen I, Zhang J, Sailer AW, Dev KK. The EBI2 signalling pathway plays a role in cellular crosstalk between astrocytes and macrophages. Scientific Reports. 2016 May 11;6(1):25520. doi: 10.1038/srep25520.; Fukushima H, Yasumoto M, Ogasawara S, Akiba J, Kitasato Y, Nakayama M, Naito Y, Ishida Y, Okabe Y, Yasunaga M, Horiuchi H, Sakamoto E, Itadani H, Mizuarai S, Oie S, Yano H. ARHGEF15 overexpression worsens the prognosis in patients with pancreatic ductal adenocarcinoma through enhancing the motility and proliferative activity of the cancer cells. Molecular Cancer. 2016 May 04;15(1):32. doi: 10.1186/s12943-016-0516-4.; Uljon S, Xu X, Durzynska I, Stein S, Adelmant G, Marto JA, Pear WS, Blacklow SC. Structural Basis for Substrate Selectivity of the E3 Ligase COP1. Structure. 2016 May 03;24(5):687–96. PMID: 27041596; PMCID: PMC4856590.; Alamo C, López-Muñoz F, Sánchez-García J. Mechanism of action of guanfacine: a postsynaptic differential approach to the treatment of attention deficit hyperactivity disorder (adhd). Actas Esp Psiquiatr. 2016 May;44(3):107–12. PMID: 27254403.; Al-Inany HG, Youssef MA, Ayeleke RO, Brown J, Lam WS, Broekmans FJ: Gonadotrophin-releasing hormone antagonists for assisted reproductive technology. Cochrane Database Syst Rev. 2016 Apr 29;4:CD001750. doi: 10.1002/14651858.CD001750.pub4.; Zhao Q, Chang C, Gonzalez JP, Alzahrani K, Button JL, Fraidenraich D. Combined Id1 and Id3 Deletion Leads to Severe Erythropoietic Disturbances. PLoS ONE. 2016 Apr 29;11(4):e0154480. doi: 10.1371/journal.pone.0154480.; Scott FL, Clemons B, Brooks J, Brahmachary E, Powell R, Dedman H, Desale HG, Timony GA, Martinborough E, Rosen H, Roberts E, Boehm MF, Peach RJ. Ozanimod (RPC1063) is a potent sphingosine-1-phosphate receptor-1 (S1P 1 ) and receptor-5 (S1P 5 ) agonist with autoimmune disease-modifying activity. British J Pharmacology. 2016 Apr 28;173(11):1778–92. doi: 10.1111/bph.13476.; Swinstead EE, Miranda TB, Paakinaho V, Baek S, Goldstein I, Hawkins M, Karpova TS, Ball D, Mazza D, Lavis LD, Grimm JB, Morisaki T, Grøntved L, Presman DM, Hager GL. Steroid Receptors Reprogram FoxA1 Occupancy through Dynamic Chromatin Transitions. Cell. 2016 Apr 21;165(3):593–605. PMID: 27062924; PMCID: PMC4842147.; Akizawa T, Kurita N, Mizobuchi M, Fukagawa M, Onishi Y, Yamaguchi T, Ellis AR, Fukuma S, Alan Brookhart M, Hasegawa T, Kurokawa K, Fukuhara S. PTH-dependence of the effectiveness of cinacalcet in hemodialysis patients with secondary hyperparathyroidism. Scientific Reports. 2016 Apr 13;6(1):19612. doi: 10.1038/srep19612.; Rapoport B, McLachlan SM. TSH Receptor Cleavage Into Subunits and Shedding of the A-Subunit; A Molecular and Clinical Perspective. Endocr Rev. 2016 Apr;37(2):114–34. PMID: 26799472; PMCID: PMC4823380.; Davenport AP, Hyndman KA, Dhaun N, Southan C, Kohan DE, Pollock JS, Pollock DM, Webb DJ, Maguire JJ. Endothelin. Pharmacological Reviews. 2016 Apr;68(2):357–418. doi: 10.1124/pr.115.011833.; Bonyadi Rad E, Hammerlindl H, Wels C, Popper U, Ravindran Menon D, Breiteneder H, Kitzwoegerer M, Hafner C, Herlyn M, Bergler H, Schaider H. Notch4 Signaling Induces a Mesenchymal-Epithelial-like Transition in Melanoma Cells to Suppress Malignant Behaviors. Cancer Res. 2016 Apr 01;76(7):1690–7. PMID: 26801977; PMCID: PMC5167360.; Li Y, Tsang CK, Wang S, Li XX, Yang Y, Fu L, Huang W, Li M, Wang HY, Zheng XF. MAF1 suppresses AKT-mTOR signaling and liver cancer through activation of PTEN transcription. Hepatology. 2016 Jun;63(6):1928–42. PMID: 26910647; PMCID: PMC5021206.; Tuand K, Stijnen P, Volders K, Declercq J, Nuytens K, Meulemans S, Creemers J. Nuclear Localization of the Autism Candidate Gene Neurobeachin and Functional Interaction with the NOTCH1 Intracellular Domain Indicate a Role in Regulating Transcription. PLoS ONE. 2016 Mar 21;11(3):e0151954. doi: 10.1371/journal.pone.0151954.; Shimada A, Kimura H, Oida K, Kanehara H, Bando Y, Sakamoto S, Wakasugi T, Saga T, Ito Y, Kamiyama K, Mikami D, Iwano M, Hirano T, Yoshida H. Serum CETP status is independently associated with reduction rates in LDL-C in pitavastatin-treated diabetic patients and possible involvement of LXR in its association. Lipids in Health and Disease. 2016 Mar 17;15(1):57. doi: 10.1186/s12944-016-0223-6.; Regan Anderson TM, Ma SH, Raj GV, Cidlowski JA, Helle TM, Knutson TP, Krutilina RI, Seagroves TN, Lange CA. Breast Tumor Kinase (Brk/PTK6) Is Induced by HIF, Glucocorticoid Receptor, and PELP1-Mediated Stress Signaling in Triple-Negative Breast Cancer. Cancer Res. 2016 Mar 15;76(6):1653–63. PMID: 26825173; PMCID: PMC4794366.; Ali SA, Justilien V, Jamieson L, Murray NR, Fields AP. Protein Kinase C? Drives a NOTCH3-dependent Stem-like Phenotype in Mutant KRAS Lung Adenocarcinoma. Cancer Cell. 2016 Mar 14;29(3):367–78. PMID: 26977885; PMCID: PMC4795153.; Gladwyn-Ng I, Huang L, Ngo L, Li SS, Qu Z, Vanyai HK, Cullen HD, Davis JM, Heng JI. Bacurd1/Kctd13 and Bacurd2/Tnfaip1 are interacting partners to Rnd proteins which influence the long-term positioning and dendritic maturation of cerebral cortical neurons. Neural Development. 2016 Mar 11;11(1):7. doi: 10.1186/s13064-016-0062-1.; Sun WT, Xiang W, Ng BL, Asari K, Bunte RM, Casey PJ, Wang M, Chuah C. Inhibition of isoprenylcysteine carboxylmethyltransferase augments BCR-ABL1 tyrosine kinase inhibition-induced apoptosis in chronic myeloid leukemia. Exp Hematol. 2016 Mar;44(3):189–93.e2. doi: 10.1016/j.exphem.2015.12.002. PMID: 26706195.; Chimge N, Little GH, Baniwal SK, Adisetiyo H, Xie Y, Zhang T, O’Laughlin A, Liu ZY, Ulrich P, Martin A, Mhawech-Fauceglia P, Ellis MJ, Tripathy D, Groshen S, Liang C, Li Z, Schones DE, Frenkel B. RUNX1 prevents oestrogen-mediated AXIN1 suppression and ß-catenin activation in ER-positive breast cancer. Nature Communications. 2016 Feb 26;7(1):10751. doi: 10.1038/ncomms10751.; Nylander S, Schulz R. Effects of P2Y12 receptor antagonists beyond platelet inhibition – comparison of ticagrelor with thienopyridines. British J Pharmacology. 2016 Feb 24;173(7):1163–78. doi: 10.1111/bph.13429.; Marei H, Carpy A, Woroniuk A, Vennin C, White G, Timpson P, Macek B, Malliri A. Differential Rac1 signalling by guanine nucleotide exchange factors implicates FLII in regulating Rac1-driven cell migration. Nature Communications. 2016 Feb 18;7(1):10664. doi: 10.1038/ncomms10664.; Kienast Y, Jucknischke U, Scheiblich S, Thier M, de Wouters M, Haas A, Lehmann C, Brand V, Bernicke D, Honold K, Lorenz S. Rapid Activation of Bone Morphogenic Protein 9 by Receptor-mediated Displacement of Pro-domains. Journal of Biological Chemistry. 2016 Feb;291(7):3395–410. doi: 10.1074/jbc.m115.680009.; Vujic I, Sanlorenzo M, Esteve-Puig R, Vujic M, Kwong A, Tsumura A, Murphy R, Moy A, Posch C, Monshi B, Rappersberger K, Ortiz-Urda S. Acyl protein thioesterase 1 and 2 (APT-1, APT-2) inhibitors palmostatin B, ML348 and ML349 have different effects on NRAS mutant melanoma cells. Oncotarget. 2016 Feb 09;7(6):7297–306. PMID: 26771141; PMCID: PMC4872786.; Lin A, Li C, Xing Z, Hu Q, Liang K, Han L, Wang C, Hawke DH, Wang S, Zhang Y, Wei Y, Ma G, Park PK, Zhou J, Zhou Y, Hu Z, Zhou Y, Marks JR, Liang H, Hung MC, Lin C, Yang L. The LINK-A lncRNA activates normoxic HIF1a signalling in triple-negative breast cancer. Nat Cell Biol. 2016 Feb;18(2):213–24. PMID: 26751287; PMCID: PMC4791069.; Edmondson SD, Zhu C, Kar NF, Di Salvo J, Nagabukuro H, Sacre-Salem B, Dingley K, Berger R, Goble SD, Morriello G, Harper B, Moyes CR, Shen DM, Wang L, Ball R, Fitzmaurice A, Frenkl T, Gichuru LN, Ha S, Hurley AL, Jochnowitz N, Levorse D, Mistry S, Miller RR, Ormes J, Salituro GM, Sanfiz A, Stevenson AS, Villa K, Zamlynny B, Green S, Struthers M, Weber AE. Discovery of Vibegron: A Potent and Selective ß3 Adrenergic Receptor Agonist for the Treatment of Overactive Bladder. J Med Chem. 2016 Jan 28;59(2):609–23. doi: 10.1021/acs.jmedchem.5b01372. PMID: 26709102.; Shi L, Lehto SG, Zhu DXD, Sun H, Zhang J, Smith BP, Immke DC, Wild KD, Xu C. Pharmacologic Characterization of AMG 334, a Potent and Selective Human Monoclonal Antibody against the Calcitonin Gene-Related Peptide Receptor. The Journal of Pharmacology and Experimental Therapeutics. 2016 Jan;356(1):223–31. doi: 10.1124/jpet.115.227793.; Lin DT, Conibear E. ABHD17 proteins are novel protein depalmitoylases that regulate N-Ras palmitate turnover and subcellular localization. Elife. 2015 Dec 23;4():e11306. PMID: 26701913; PMCID: PMC4755737.; Gaudet HM, Cheng SB, Christensen EM, Filardo EJ. The G-protein coupled estrogen receptor, GPER: The inside and inside-out story. Mol Cell Endocrinol. 2015 Dec 15;418 Pt 3():207–19. doi: 10.1016/j.mce.2015.07.016. PMID: 26190834.; Anbalagan M, Rowan BG. Estrogen receptor alpha phosphorylation and its functional impact in human breast cancer. Mol Cell Endocrinol. 2015 Dec 15;418 Pt 3():264–72. doi: 10.1016/j.mce.2015.01.016. PMID: 25597633.; Li J, Liu Y, Yin Y. Inhibitory effects of Arhgap6 on cervical carcinoma cells. Tumour Biol. 2016 Feb;37(2):1411–25. doi: 10.1007/s13277-015-4502-z. PMID: 26628301.; Alexander SP, Davenport AP, Kelly E, Marrion N, Peters JA, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Southan C, Davies JA; CGTP Collaborators. The Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptors. Br J Pharmacol. 2015 Dec;172(24):5744–869. PMID: 26650439; PMCID: PMC4718210.; Dart AE, Box GM, Court W, Gale ME, Brown JP, Pinder SE, Eccles SA, Wells CM. PAK4 promotes kinase-independent stabilization of RhoU to modulate cell adhesion. J Cell Biol. 2015 Nov 23;211(4):863–79. PMID: 26598620; PMCID: PMC4657161.; Wang MT, Holderfield M, Galeas J, Delrosario R, To MD, Balmain A, McCormick F. K-Ras Promotes Tumorigenicity through Suppression of Non-canonical Wnt Signaling. Cell. 2015 Nov 19;163(5):1237–51. doi: 10.1016/j.cell.2015.10.041. PMID: 26590425.; Reshetnyak AV, Murray PB, Shi X, Mo ES, Mohanty J, Tome F, Bai H, Gunel M, Lax I, Schlessinger J. Augmentor a and ß (FAM150) are ligands of the receptor tyrosine kinases ALK and LTK: Hierarchy and specificity of ligand-receptor interactions. Proc Natl Acad Sci U S A. 2015 Dec 29;112(52):15862–7. PMID: 26630010; PMCID: PMC4702955.; Nederpelt I, Georgi V, Schiele F, Nowak-Reppel K, Fernández-Montalván AE, IJzerman AP, Heitman LH. Characterization of 12 GnRH peptide agonists – a kinetic perspective. British J Pharmacology. 2015 Nov 04;173(1):128–41. doi: 10.1111/bph.13342.; Kong R, Yi F, Wen P, Liu J, Chen X, Ren J, Li X, Shang Y, Nie Y, Wu K, Fan D, Zhu L, Feng W, Wu JY. Myo9b is a key player in SLIT/ROBO-mediated lung tumor suppression. J Clin Invest. 2015 Nov 03;125(12):4407–20. PMID: 26529257; PMCID: PMC4665778.; Hnit SST, Xie C, Yao M, Holst J, Bensoussan A, De Souza P, Li Z, Dong Q. p27Kip1 signaling: Transcriptional and post-translational regulation. The International Journal of Biochemistry & Cell Biology. 2015 Nov;68():9–14. doi: 10.1016/j.biocel.2015.08.005.; Bigal ME, Dodick DW, Rapoport AM, Silberstein SD, Ma Y, Yang R, Loupe PS, Burstein R, Newman LC, Lipton RB. Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study. Lancet Neurol. 2015 Nov;14(11):1081–90. doi: 10.1016/s1474-4422(15)00249-5. PMID: 26432182.; Busch M, Dünker N. Trefoil factor family peptides--friends or foes? Biomol Concepts. 2015 Dec;6(5-6):343–59. doi: 10.1515/bmc-2015-0020. PMID: 26479350.; Li R, Tan S, Yu M, Jundt MC, Zhang S, Wu M. Annexin A2 Regulates Autophagy in Pseudomonas aeruginosa Infection through the Akt1-mTOR-ULK1/2 Signaling Pathway. J Immunol. 2015 Oct 15;195(8):3901–11. PMID: 26371245; PMCID: PMC4592832.; Scherrer DZ, Zago VH, Parra ES, Avansini S, Panzoldo NB, Alexandre F, Baracat J, Nakandakare ER, Quintão EC, de Faria EC. Asymptomatic individuals with high HDL-C levels overexpress ABCA1 and ABCG1 and present miR-33a dysregulation in peripheral blood mononuclear cells. Gene. 2015 Oct 01;570(1):50–6. doi: 10.1016/j.gene.2015.05.074. PMID: 26051418.; Chastkofsky MI, Bie W, Ball-Kell SM, He Y, Tyner AL. Protein Tyrosine Kinase 6 Regulates UVB-Induced Signaling and Tumorigenesis in Mouse Skin. Journal of Investigative Dermatology. 2015 Oct;135(10):2492–501. doi: 10.1038/jid.2015.166.; Simões BM, O'Brien CS, Eyre R, Silva A, Yu L, Sarmiento-Castro A, Alférez DG, Spence K, Santiago-Gómez A, Chemi F, Acar A, Gandhi A, Howell A, Brennan K, Rydén L, Catalano S, Andó S, Gee J, Ucar A, Sims AH, Marangoni E, Farnie G, Landberg G, Howell SJ, Clarke RB. Anti-estrogen Resistance in Human Breast Tumors Is Driven by JAG1-NOTCH4-Dependent Cancer Stem Cell Activity. Cell Rep. 2015 Sep 29;12(12):1968–77. PMID: 26387946; PMCID: PMC4594158.; Salhiyyah K, Forster R, Senanayake E, Abdel-Hadi M, Booth A, Michaels JA. Pentoxifylline for intermittent claudication. Cochrane Database Syst Rev. 2015 Sep 29;9():CD005262. PMID: 26417854; PMCID: PMC6513423.; Guan J, Umapathy G, Yamazaki Y, Wolfstetter G, Mendoza P, Pfeifer K, Mohammed A, Hugosson F, Zhang H, Hsu AW, Halenbeck R, Hallberg B, Palmer RH. FAM150A and FAM150B are activating ligands for anaplastic lymphoma kinase. Elife. 2015 Sep 29;4():e09811. PMID: 26418745; PMCID: PMC4658194.; Peng SB, Henry JR, Kaufman MD, Lu WP, Smith BD, Vogeti S, Rutkoski TJ, Wise S, Chun L, Zhang Y, Van Horn RD, Yin T, Zhang X, Yadav V, Chen SH, Gong X, Ma X, Webster Y, Buchanan S, Mochalkin I, Huber L, Kays L, Donoho GP, Walgren J, McCann D, Patel P, Conti I, Plowman GD, Starling JJ, Flynn DL. Inhibition of RAF Isoforms and Active Dimers by LY3009120 Leads to Anti-tumor Activities in RAS or BRAF Mutant Cancers. Cancer Cell. 2015 Sep 14;28(3):384–98. doi: 10.1016/j.ccell.2015.08.002. PMID: 26343583.; Hu J, Qiu J, Zheng Y, Zhang T, Yin T, Xie X, Wang G. AAMP Regulates Endothelial Cell Migration and Angiogenesis Through RhoA/Rho Kinase Signaling. Annals of Biomedical Engineering. 2015 Sep 08;44(5):1462–74. doi: 10.1007/s10439-015-1442-0.; Nussinov R, Muratcioglu S, Tsai CJ, Jang H, Gursoy A, Keskin O. The Key Role of Calmodulin in KRAS-Driven Adenocarcinomas. Mol Cancer Res. 2015 Sep;13(9):1265–73. PMID: 26085527; PMCID: PMC4572916.; Beckenbach L, Baron JM, Merk HF, Löffler H, Amann PM. Retinoid treatment of skin diseases. European Journal of Dermatology. 2015 Sep;25(5):384–91. doi: 10.1684/ejd.2015.2544.; Kauh CY, Bursztyn LL. Positive Apraclonidine Test in Horner Syndrome Caused by Thalamic Hemorrhage. J Neuroophthalmol. 2015 Sep;35(3):287–8. doi: 10.1097/wno.0000000000000222. PMID: 25768246.; Richards M, Hetheridge C, Mellor H. The Formin FMNL3 Controls Early Apical Specification in Endothelial Cells by Regulating the Polarized Trafficking of Podocalyxin. Curr Biol. 2015 Aug 31;25(17):2325–31. doi: 10.1016/j.cub.2015.07.045. PMID: 26299518.; Yuan L, Lv Y, Li H, Gao H, Song S, Zhang Y, Xing G, Kong X, Wang L, Li Y, Zhou T, Gao D, Xiao ZX, Yin Y, Wei W, He F, Zhang L. Deubiquitylase OTUD3 regulates PTEN stability and suppresses tumorigenesis. Nat Cell Biol. 2015 Sep;17(9):1169–81. doi: 10.1038/ncb3218. PMID: 26280536.; Gelotte CK, Zimmerman BA. Pharmacokinetics, Safety, and Cardiovascular Tolerability of Phenylephrine HCl 10, 20, and 30 mg After a Single Oral Administration in Healthy Volunteers. Clinical Drug Investigation. 2015 Aug 13;35(9):547–58. doi: 10.1007/s40261-015-0311-9.; Hultberg A, Morello V, Huyghe L, De Jonge N, Blanchetot C, Hanssens V, De Boeck G, Silence K, Festjens E, Heukers R, Roux B, Lamballe F, Ginestier C, Charafe-Jauffret E, Maina F, Brouckaert P, Saunders M, Thibault A, Dreier T, de Haard H, Michieli P. Depleting MET-Expressing Tumor Cells by ADCC Provides a Therapeutic Advantage over Inhibiting HGF/MET Signaling. Cancer Res. 2015 Aug 15;75(16):3373–83. doi: 10.1158/0008-5472.can-15-0356. PMID: 26141862.; Tong GX, Mody K, Wang Z, Hamele-Bena D, Nikiforova MN, Nikiforov YE. Mutations of TSHR and TP53 Genes in an Aggressive Clear Cell Follicular Carcinoma of the Thyroid. Endocr Pathol. 2015 Dec;26(4):315–9. doi: 10.1007/s12022-015-9388-1. PMID: 26260781.; Peng M, Ball-Kell SM, Tyner AL. Protein tyrosine kinase 6 promotes ERBB2-induced mammary gland tumorigenesis in the mouse. Cell Death & Disease. 2015 Aug 06;6(8):e1848. doi: 10.1038/cddis.2015.210.; DiPilato LM, Ahmad F, Harms M, Seale P, Manganiello V, Birnbaum MJ. The Role of PDE3B Phosphorylation in the Inhibition of Lipolysis by Insulin. Molecular and Cellular Biology. 2015 Aug 01;35(16):2752–60. doi: 10.1128/mcb.00422-15.; Hennig A, Markwart R, Esparza-Franco MA, Ladds G, Rubio I. Ras activation revisited: role of GEF and GAP systems. Biol Chem. 2015 Aug;396(8):831–48. doi: 10.1515/hsz-2014-0257. PMID: 25781681.; Zhang CS, Liu Q, Li M, Lin SY, Peng Y, Wu D, Li TY, Fu Q, Jia W, Wang X, Ma T, Zong Y, Cui J, Pu C, Lian G, Guo H, Ye Z, Lin SC. RHOBTB3 promotes proteasomal degradation of HIFa through facilitating hydroxylation and suppresses the Warburg effect. Cell Res. 2015 Sep;25(9):1025–42. PMID: 26215701; PMCID: PMC4559813.; Paoletta S, Sabbadin D, von Kügelgen I, Hinz S, Katritch V, Hoffmann K, Abdelrahman A, Straßburger J, Baqi Y, Zhao Q, Stevens RC, Moro S, Müller CE, Jacobson KA. Modeling ligand recognition at the P2Y12 receptor in light of X-ray structural information. Journal of Computer-Aided Molecular Design. 2015 Jul 21;29(8):737–56. doi: 10.1007/s10822-015-9858-z.; Lee MS, Jeong MH, Lee HW, Han HJ, Ko A, Hewitt SM, Kim JH, Chun KH, Chung JY, Lee C, Cho H, Song J. PI3K/AKT activation induces PTEN ubiquitination and destabilization accelerating tumourigenesis. Nat Commun. 2015 Jul 17;6():7769. PMID: 26183061; PMCID: PMC4518267.; Mohammed H, Russell IA, Stark R, Rueda OM, Hickey TE, Tarulli GA, Serandour AA, Serandour AA, Birrell SN, Bruna A, Saadi A, Menon S, Hadfield J, Pugh M, Raj GV, Brown GD, D'Santos C, Robinson JL, Silva G, Launchbury R, Perou CM, Stingl J, Caldas C, Tilley WD, Carroll JS. Progesterone receptor modulates ERa action in breast cancer. Nature. 2015 Jul 16;523(7560):313–7. PMID: 26153859; PMCID: PMC4650274.; Abraham S, Scarcia M, Bagshaw RD, McMahon K, Grant G, Harvey T, Yeo M, Esteves FOG, Thygesen HH, Jones PF, Speirs V, Hanby AM, Selby PJ, Lorger M, Dear TN, Pawson T, Marshall CJ, Mavria G. A Rac/Cdc42 exchange factor complex promotes formation of lateral filopodia and blood vessel lumen morphogenesis. Nature Communications. 2015 Jul 01;6(1):7286. doi: 10.1038/ncomms8286.; Jung J, Genau HM, Behrends C. Amino Acid-Dependent mTORC1 Regulation by the Lysosomal Membrane Protein SLC38A9. Molecular and Cellular Biology. 2015 Jul 01;35(14):2479–94. doi: 10.1128/mcb.00125-15.; Panula P, Chazot PL, Cowart M, Gutzmer R, Leurs R, Liu WLS, Stark H, Thurmond RL, Haas HL. International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors. Pharmacological Reviews. 2015 Jul;67(3):601–55. doi: 10.1124/pr.114.010249.; Fan G, Aleem S, Yang M, Miller WT, Tonks NK. Protein-tyrosine Phosphatase and Kinase Specificity in Regulation of SRC and Breast Tumor Kinase*. Journal of Biological Chemistry. 2015 Jun;290(26):15934–47. doi: 10.1074/jbc.m115.651703.; Smith SA, Travers RJ, Morrissey JH. How it all starts: Initiation of the clotting cascade. Critical Reviews in Biochemistry and Molecular Biology. 2015 May 28;50(4):326–36. doi: 10.3109/10409238.2015.1050550.; Capala ME, Maat H, Bonardi F, van den Boom V, Kuipers J, Vellenga E, Giepmans BNG, Schuringa JJ. Mitochondrial Dysfunction in Human Leukemic Stem/Progenitor Cells upon Loss of RAC2. PLoS ONE. 2015 May 27;10(5):e0128585. doi: 10.1371/journal.pone.0128585.; Ruiz-Lafuente N, Alcaraz-García MJ, García-Serna AM, Sebastián-Ruiz S, Moya-Quiles MR, García-Alonso AM, Parrado A. Dock10, a Cdc42 and Rac1 GEF, induces loss of elongation, filopodia, and ruffles in cervical cancer epithelial HeLa cells. Biol Open. 2015 Apr 10;4(5):627–35. PMID: 25862245; PMCID: PMC4434814.; Kühn S, Erdmann C, Kage F, Block J, Schwenkmezger L, Steffen A, Rottner K, Geyer M. The structure of FMNL2–Cdc42 yields insights into the mechanism of lamellipodia and filopodia formation. Nature Communications. 2015 May 12;6(1):7088. doi: 10.1038/ncomms8088.; Henry JR, Kaufman MD, Peng S, Ahn YM, Caldwell TM, Vogeti L, Telikepalli H, Lu W, Hood MM, Rutkoski TJ, Smith BD, Vogeti S, Miller D, Wise SC, Chun L, Zhang X, Zhang Y, Kays L, Hipskind PA, Wrobleski AD, Lobb KL, Clay JM, Cohen JD, Walgren JL, McCann D, Patel P, Clawson DK, Guo S, Manglicmot D, Groshong C, Logan C, Starling JJ, Flynn DL. Discovery of 1-(3,3-Dimethylbutyl)-3-(2-fluoro-4-methyl-5-(7-methyl-2-(methylamino)pyrido[2,3-d]pyrimidin-6-yl)phenyl)urea (LY3009120) as a Pan-RAF Inhibitor with Minimal Paradoxical Activation and Activity against BRAF or RAS Mutant Tumor Cells. J. Med. Chem. 2015 May 12;58(10):4165–79. doi: 10.1021/acs.jmedchem.5b00067.; Farooq A. Structural and Functional Diversity of Estrogen Receptor Ligands. Curr Top Med Chem. 2015;15(14):1372–84. PMID: 25866274; PMCID: PMC4604006.; Myrum C, Baumann A, Bustad HJ, Flydal MI, Mariaule V, Alvira S, Cuéllar J, Haavik J, Soulé J, Valpuesta JM, Márquez JA, Martinez A, Bramham CR. Arc is a flexible modular protein capable of reversible self-oligomerization. Biochem J. 2015 May 15;468(1):145–58. PMID: 25748042; PMCID: PMC4422259.; Farzana F, Zalm R, Chen N, Li KW, Grant SGN, Smit AB, Toonen RF, Verhage M. Neurobeachin Regulates Glutamate- and GABA-Receptor Targeting to Synapses via Distinct Pathways. Molecular Neurobiology. 2015 May 02;53(4):2112–23. doi: 10.1007/s12035-015-9164-8.; Blom M, Reis K, Nehru V, Blom H, Gad AKB, Aspenström P. RhoD is a Golgi component with a role in anterograde protein transport from the ER to the plasma membrane. Exp Cell Res. 2015 May 01;333(2):208–19. doi: 10.1016/j.yexcr.2015.02.023. PMID: 25746724.; Patel P, Asbach B, Shteyn E, Gomez C, Coltoff A, Bhuyan S, Tyner AL, Wagner R, Blain SW. Brk/Protein Tyrosine Kinase 6 Phosphorylates p27 KIP1 , Regulating the Activity of Cyclin D–Cyclin-Dependent Kinase 4. Molecular and Cellular Biology. 2015 May 01;35(9):1506–22. doi: 10.1128/mcb.01206-14.; Lavoie H, Therrien M. Regulation of RAF protein kinases in ERK signalling. Nature Reviews Molecular Cell Biology. 2015 Apr 23;16(5):281–98. doi: 10.1038/nrm3979.; Makni-Maalej K, Marzaioli V, Boussetta T, Belambri SA, Gougerot-Pocidalo MA, Hurtado-Nedelec M, Dang PM, El-Benna J. TLR8, but not TLR7, induces the priming of the NADPH oxidase activation in human neutrophils. J Leukoc Biol. 2015 Jun;97(6):1081–7. doi: 10.1189/jlb.2a1214-623r. PMID: 25877926.; Wu D, Zhu X, Jimenez-Cowell K, Mold AJ, Sollecito CC, Lombana N, Jiao M, Wei Q. Identification of the GTPase-activating protein DEP domain containing 1B (DEPDC1B) as a transcriptional target of Pitx2. Experimental Cell Research. 2015 Apr;333(1):80–92. doi: 10.1016/j.yexcr.2015.02.008.; Jang H, Abraham SJ, Chavan TS, Hitchinson B, Khavrutskii L, Tarasova NI, Nussinov R, Gaponenko V. Mechanisms of Membrane Binding of Small GTPase K-Ras4B Farnesylated Hypervariable Region. Journal of Biological Chemistry. 2015 Apr;290(15):9465–77. doi: 10.1074/jbc.m114.620724.; Schmick M, Kraemer A, Bastiaens PI. Ras moves to stay in place. Trends Cell Biol. 2015 Apr;25(4):190–7. doi: 10.1016/j.tcb.2015.02.004. PMID: 25759176.; Papadopoulos T, Schemm R, Grubmüller H, Brose N. Lipid Binding Defects and Perturbed Synaptogenic Activity of a Collybistin R290H Mutant That Causes Epilepsy and Intellectual Disability. Journal of Biological Chemistry. 2015 Mar;290(13):8256–70. doi: 10.1074/jbc.m114.633024.; Florio M, Albert M, Taverna E, Namba T, Brandl H, Lewitus E, Haffner C, Sykes A, Wong FK, Peters J, Guhr E, Klemroth S, Prüfer K, Kelso J, Naumann R, Nüsslein I, Dahl A, Lachmann R, Pääbo S, Huttner WB. Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion. Science. 2015 Mar 27;347(6229):1465–70. doi: 10.1126/science.aaa1975. PMID: 25721503.; Sakai M, Martinez-Arguelles DB, Patterson NH, Chaurand P, Papadopoulos V. In Search of the Molecular Mechanisms Mediating the Inhibitory Effect of the GnRH Antagonist Degarelix on Human Prostate Cell Growth. PLoS ONE. 2015 Mar 26;10(3):e0120670. doi: 10.1371/journal.pone.0120670.; Yi P, Wang Z, Feng Q, Pintilie GD, Foulds CE, Lanz RB, Ludtke SJ, Schmid MF, Chiu W, O'Malley BW. Structure of a biologically active estrogen receptor-coactivator complex on DNA. Mol Cell. 2015 Mar 19;57(6):1047–58. PMID: 25728767; PMCID: PMC4369429.; Fan L, Yan H, Pellegrin S, Morigen, Mellor H. The Rif GTPase regulates cytoskeletal signaling from plexinA4 to promote neurite retraction. Neurosci Lett. 2015 Mar 17;590():178–83. doi: 10.1016/j.neulet.2015.02.010. PMID: 25668492.; Ramakrishnan G, Davaakhuu G, Chung WC, Zhu H, Rana A, Filipovic A, Green AR, Atfi A, Pannuti A, Miele L, Tzivion G. AKT and 14-3-3 Regulate Notch4 Nuclear Localization. Scientific Reports. 2015 Mar 05;5(1):8782. doi: 10.1038/srep08782.; Nold-Petry CA, Lo CY, Rudloff I, Elgass KD, Li S, Gantier MP, Lotz-Havla AS, Gersting SW, Cho SX, Lao JC, Ellisdon AM, Rotter B, Azam T, Mangan NE, Rossello FJ, Whisstock JC, Bufler P, Garlanda C, Mantovani A, Dinarello CA, Nold MF. IL-37 requires the receptors IL-18Ra and IL-1R8 (SIGIRR) to carry out its multifaceted anti-inflammatory program upon innate signal transduction. Nat Immunol. 2015 Apr;16(4):354–65. doi: 10.1038/ni.3103. PMID: 25729923.; Uygur B, Abramo K, Leikina E, Vary C, Liaw L, Wu WS. SLUG is a direct transcriptional repressor of PTEN tumor suppressor. Prostate. 2015 Jun 15;75(9):907–16. PMID: 25728608; PMCID: PMC4654464.; Antony J, Dasgupta T, Rhodes JM, McEwan MV, Print CG, O’Sullivan JM, Horsfield JA. Cohesin modulates transcription of estrogen-responsive genes. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 2015 Mar;1849(3):257–69. doi: 10.1016/j.bbagrm.2014.12.011.; Gagnon DM, Brophy MB, Bowman SE, Stich TA, Drennan CL, Britt RD, Nolan EM. Manganese binding properties of human calprotectin under conditions of high and low calcium: X-ray crystallographic and advanced electron paramagnetic resonance spectroscopic analysis. J Am Chem Soc. 2015 Mar 04;137(8):3004–16. PMID: 25597447; PMCID: PMC4354957.; Moon SM, Kim JS, Park BR, Kim DK, Kim SG, Kim HJ, Chun HS, Lee BK, Kim CS. Transcriptional regulation of the neuropeptide VGF by the neuron-restrictive silencer factor/neuron-restrictive silencer element. Neuroreport. 2015 Feb 11;26(3):144–51. doi: 10.1097/wnr.0000000000000316. PMID: 25569790.; Józwicki W, Brozyna AA, Siekiera J, Slominski AT. Expression of RCAS1 correlates with urothelial bladder cancer malignancy. Int J Mol Sci. 2015 Feb 10;16(2):3783–803. PMID: 25674852; PMCID: PMC4346926.; Golding JF, Gresty MA. Pathophysiology and treatment of motion sickness. Curr Opin Neurol. 2015 Feb;28(1):83–8. doi: 10.1097/wco.0000000000000163. PMID: 25502048.; Mathias TJ, Natarajan K, Shukla S, Doshi KA, Singh ZN, Ambudkar SV, Baer MR. The FLT3 and PDGFR inhibitor crenolanib is a substrate of the multidrug resistance protein ABCB1 but does not inhibit transport function at pharmacologically relevant concentrations. Investigational New Drugs. 2015 Jan 20;33(2):300–9. doi: 10.1007/s10637-015-0205-y.; Levin ER. Extranuclear steroid receptors are essential for steroid hormone actions. Annu Rev Med. 2015;66():271–80. doi: 10.1146/annurev-med-050913-021703. PMID: 25587652.; Wang S, Tsun ZY, Wolfson RL, Shen K, Wyant GA, Plovanich ME, Yuan ED, Jones TD, Chantranupong L, Comb W, Wang T, Bar-Peled L, Zoncu R, Straub C, Kim C, Park J, Sabatini BL, Sabatini DM. Metabolism. Lysosomal amino acid transporter SLC38A9 signals arginine sufficiency to mTORC1. Science. 2015 Jan 09;347(6218):188–94. PMID: 25567906; PMCID: PMC4295826.; Rebsamen M, Pochini L, Stasyk T, de Araújo ME, Galluccio M, Kandasamy RK, Snijder B, Fauster A, Rudashevskaya EL, Bruckner M, Scorzoni S, Filipek PA, Huber KV, Bigenzahn JW, Heinz LX, Kraft C, Bennett KL, Indiveri C, Huber LA, Superti-Furga G. SLC38A9 is a component of the lysosomal amino acid sensing machinery that controls mTORC1. Nature. 2015 Mar 26;519(7544):477–81. PMID: 25561175; PMCID: PMC4376665.; He H, Li W, Liyanarachchi S, Jendrzejewski J, Srinivas M, Davuluri RV, Nagy R, de la Chapelle A. Genetic predisposition to papillary thyroid carcinoma: involvement of FOXE1, TSHR, and a novel lincRNA gene, PTCSC2. J Clin Endocrinol Metab. 2015 Jan;100(1):E164–72. PMID: 25303483; PMCID: PMC4283026.; Morse EM, Sun X, Olberding JR, Ha BH, Boggon TJ, Calderwood DA. PAK6 targets to cell-cell adhesions through its N-terminus in a Cdc42-dependent manner to drive epithelial colony escape. J Cell Sci. 2016 Jan 15;129(2):380–93. PMID: 26598554; PMCID: PMC4732285.; Abiko H, Fujiwara S, Ohashi K, Hiatari R, Mashiko T, Sakamoto N, Sato M, Mizuno K. Rho guanine nucleotide exchange factors involved in cyclic-stretch-induced reorientation of vascular endothelial cells. J Cell Sci. 2015 May 01;128(9):1683–95. doi: 10.1242/jcs.157503. PMID: 25795300.; Baehr W. Membrane protein transport in photoreceptors: the function of PDEd: the Proctor lecture. Invest Ophthalmol Vis Sci. 2014 Dec 30;55(12):8653–66. PMID: 25550383; PMCID: PMC4541489.; Li N, Zhang Y, Han X, Liang K, Wang J, Feng L, Wang W, Songyang Z, Lin C, Yang L, Yu Y, Chen J. Poly-ADP ribosylation of PTEN by tankyrases promotes PTEN degradation and tumor growth. Genes Dev. 2015 Jan 15;29(2):157–70. PMID: 25547115; PMCID: PMC4298135.; William Tank A, Lee Wong D. Peripheral and Central Effects of Circulating Catecholamines. Comprehensive Physiology. 2015 Jan;5(1):1–15. doi: 10.1002/j.2040-4603.2015.tb00599.x.; Ikeda K, Horie-Inoue K, Inoue S. Identification of estrogen-responsive genes based on the DNA binding properties of estrogen receptors using high-throughput sequencing technology. Acta Pharmacologica Sinica. 2014 Dec 15;36(1):24–31. doi: 10.1038/aps.2014.123.; Santiago C, Bashaw GJ. Transcription factors and effectors that regulate neuronal morphology. Development. 2014 Dec;141(24):4667–80. PMID: 25468936; PMCID: PMC4299270.; Samatar AA, Poulikakos PI. Targeting RAS-ERK signalling in cancer: promises and challenges. Nat Rev Drug Discov. 2014 Dec;13(12):928–42. doi: 10.1038/nrd4281. PMID: 25435214.; Davari AS, Abnous K, Mehri S, Ghandadi M, Hadizadeh F. Synthesis and biological evaluation of novel pyridine derivatives as potential anticancer agents and phosphodiesterase-3 inhibitors. Bioorg Chem. 2014 Dec;57():83–9. doi: 10.1016/j.bioorg.2014.09.003. PMID: 25277835.; Gentry LR, Martin TD, Reiner DJ, Der CJ. Ral small GTPase signaling and oncogenesis: More than just 15minutes of fame. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 2014 Dec;1843(12):2976–88. doi: 10.1016/j.bbamcr.2014.09.004.; Liu L, Zeng W, Wortinger MA, Yan SB, Cornwell P, Peek VL, Stephens JR, Tetreault JW, Xia J, Manro JR, Credille KM, Ballard DW, Brown-Augsburger P, Wacheck V, Chow CK, Huang L, Wang Y, Denning I, Davies J, Tang Y, Vaillancourt P, Lu J. LY2875358, a neutralizing and internalizing anti-MET bivalent antibody, inhibits HGF-dependent and HGF-independent MET activation and tumor growth. Clin Cancer Res
Hydroxycarboxylic acid-binding receptors

Accession ID: Reactome:R-HSA-3296197
  • 10.1124/pr.110.003301
Offermanns S, Colletti SL, Lovenberg TW, Semple G, Wise A, IJzerman AP. International Union of Basic and Clinical Pharmacology. LXXXII: Nomenclature and Classification of Hydroxy-carboxylic Acid Receptors (GPR81, GPR109A, and GPR109B). Pharmacol Rev. 2011 Jun;63(2):269–90. doi: 10.1124/pr.110.003301. PMID: 21454438.
GPCR downstream signalling

Accession ID: Reactome:R-HSA-388396
  • 10.1002/14651858.cd005262.pub3
  • 10.1002/prp2.631
  • 10.1006/excr.1996.0045
  • 10.1006/geno.1993.1345
  • 10.1006/geno.1999.5992
  • 10.1007/s00018-005-4533-5
  • 10.1007/s00018-008-8006-5
  • 10.1007/s00408-004-2518-z
  • 10.1007/s10254-005-0004-0
  • 10.1007/s12033-008-9031-1
  • 10.1016/0002-9149(85)91036-7
  • 10.1016/0169-328x(94)90047-7
  • 10.1016/0896-6273(89)90261-4
  • 10.1016/0898-6568(95)02056-x
  • 10.1016/j.bioorg.2014.09.003
  • 10.1016/j.ejphar.2010.10.033
  • 10.1016/j.jaad.2019.06.1288
  • 10.1016/j.jsbmb.2017.05.005
  • 10.1016/j.lfs.2005.10.026
  • 10.1016/j.mce.2014.02.002
  • 10.1016/j.mce.2015.07.016
  • 10.1016/j.mehy.2020.109988
  • 10.1016/j.metabol.2020.154282
  • 10.1016/j.neuropharm.2016.07.003
  • 10.1016/j.pharmthera.2004.05.002
  • 10.1016/j.pharmthera.2005.09.008
  • 10.1016/j.pupt.2010.03.011
  • 10.1016/j.steroids.2009.11.005
  • 10.1016/j.yexcr.2017.10.032
  • 10.1016/s0006-2952(02)00924-3
  • 10.1016/s0014-2999(03)01855-7
  • 10.1016/s0021-9258(17)37451-3
  • 10.1016/s0021-9258(17)37574-9
  • 10.1016/s0021-9258(17)38404-1
  • 10.1016/s0021-9258(18)51471-x
  • 10.1016/s0021-9258(18)68692-2
  • 10.1016/s0021-9258(18)82304-3
  • 10.1016/s0021-9258(19)37125-x
  • 10.1016/s0021-9258(19)38697-1
  • 10.1016/s0092-8674(00)00086-6
  • 10.1016/s0378-1119(96)00456-8
  • 10.1017/s0033583506004306
  • 10.1021/bi952961+
  • 10.1024/0301-1526/a000845
  • 10.1038/12867
  • 10.1038/376781a0
  • 10.1038/nrd4228
  • 10.1038/nrd747
  • 10.1038/nrendo.2011.122
  • 10.1038/nrm2803
  • 10.1042/bj3210561
  • 10.1046/j.1463-1326.2002.0040s2s14.x
  • 10.1055/s-2007-996112
  • 10.1056/nejm198903163201101
  • 10.1073/pnas.0801508105
  • 10.1073/pnas.1936664100
  • 10.1073/pnas.83.9.2797
  • 10.1073/pnas.85.7.2081
  • 10.1073/pnas.91.21.9828
  • 10.1073/pnas.92.20.9284
  • 10.1074/jbc.271.32.19443
  • 10.1074/jbc.273.28.17469
  • 10.1074/jbc.274.47.33202
  • 10.1074/jbc.c000509200
  • 10.1074/jbc.m006478200
  • 10.1074/jbc.m114.566893
  • 10.1074/jbc.m115.697334
  • 10.1074/jbc.m116.765875
  • 10.1074/jbc.m203962200
  • 10.1074/jbc.m204753200
  • 10.1074/jbc.m305519200
  • 10.1074/jbc.m312786200
  • 10.1074/jbc.m513605200
  • 10.1093/cvr/18.5.302
  • 10.1093/eurheartj/10.suppl_c.25
  • 10.1093/nar/17.12.4887
  • 10.1096/fasebj.9.2.7781920
  • 10.1097/00005344-198205000-00023
  • 10.1097/md.0000000000009864
  • 10.1111/dth.13961
  • 10.1111/j.0022-202x.2004.12645.x
  • 10.1111/j.1523-1747.2003.12617.x
  • 10.1124/mol.108.049015
  • 10.1124/mol.113.090068
  • 10.1126/science.1071550
  • 10.1126/science.1106943
  • 10.1126/science.2163110
  • 10.1126/science.278.5345.1907
  • 10.1126/science.8327893
  • 10.1126/scisignal.125re5
  • 10.1126/scisignal.2001707
  • 10.1146/annurev.bi.56.070187.003151
  • 10.1152/ajpcell.00185.2009
  • 10.1159/000512234
  • 10.1177/1759720x19828669
  • 10.1186/s12931-019-1142-7
  • 10.1186/s12951-018-0364-z
  • 10.1210/en.2004-1064
  • 10.1210/en.2006-1605
  • 10.1210/en.2008-0269
  • 10.1210/en.2012-1061
  • 10.1210/er.2000-0026
  • 10.1210/me.14.10.1649
  • 10.1210/me.2005-0525
  • 10.1210/me.2008-0262
  • 10.1210/mend.16.1.0758
  • 10.1253/jcj.63.605
  • 10.1517/14656560903426189
  • 10.2165/0003495-200868002-00002
  • 10.2174/092986706778773040
  • 10.2741/1614
  • 10.3109/13813458409071165
  • 10.3389/fphar.2020.00259
  • 10.3390/ijms21155338
  • 10.7150/ijbs.1.51
Maldonado V, Loza-Mejía MA, Chávez-Alderete J. Repositioning of pentoxifylline as an immunomodulator and regulator of the renin-angiotensin system in the treatment of COVID-19. Medical Hypotheses. 2020 Nov;144():109988. doi: 10.1016/j.mehy.2020.109988.; Ghasemnejad-Berenji M, Pashapour S, Sadeghpour S. Pentoxifylline: A Drug with Antiviral and Anti-Inflammatory Effects to Be Considered in the Treatment of Coronavirus Disease 2019. Med Princ Pract. 2021;30(1):98–100. PMID: 33049737; PMCID: PMC7923888.; Dalamaga M, Karampela I, Mantzoros CS. Commentary: Phosphodiesterase 4 inhibitors as potential adjunct treatment targeting the cytokine storm in COVID-19. Metabolism. 2020 Aug;109():154282. doi: 10.1016/j.metabol.2020.154282.; Armesto S, González Vela C, Sánchez J, Illaro A, Mayorga J, López Sundh AE, Naharro Fernández C, Palmou N, Gómez-Fernández C, González López MA, González-Gay MA. Treating multidrug-resistant psoriasis with brodalumab, apremilast, methotrexate and prednisone combination therapy in the COVID-19 pandemic. Dermatol Ther. 2020 Nov;33(6):e14464. doi: 10.1111/dth.14464. PMID: 33112014.; Giorgi M, Cardarelli S, Ragusa F, Saliola M, Biagioni S, Poiana G, Naro F, Massimi M. Phosphodiesterase Inhibitors: Could They Be Beneficial for the Treatment of COVID-19? Int J Mol Sci. 2020 Jul 27;21(15). PMID: 32727145; PMCID: PMC7432892.; Hendry BM, Stafford N, Arnold AD, Sangwaiya A, Manglam V, Rosen SD, Arnold J. Hypothesis: Pentoxifylline is a potential cytokine modulator therapeutic in COVID-19 patients. Pharmacol Res Perspect. 2020 Aug;8(4):e00631. PMID: 32715661; PMCID: PMC7383088.; Farkas K, Kolossváry E, Járai Z. Simple assessment of quality of life and lower limb functional capacity during cilostazol treatment - results of the SHort-tERm cIlostazol eFFicacy and quality of life (SHERIFF) study. Vasa. 2020 Apr;49(3):235–42. doi: 10.1024/0301-1526/a000845. PMID: 31983287.; Phillips JE. Inhaled Phosphodiesterase 4 (PDE4) Inhibitors for Inflammatory Respiratory Diseases. Front. Pharmacol. 2020 Mar 12;11(). doi: 10.3389/fphar.2020.00259.; Hashim PW, Chima M, Kim HJ, Bares J, Yao CJ, Singer G, Chen T, Genece J, Baum D, Kimmel GW, Nia JK, Gagliotti M, Lebwohl MG. Crisaborole 2% ointment for the treatment of intertriginous, anogenital, and facial psoriasis: A double-blind, randomized, vehicle-controlled trial. Journal of the American Academy of Dermatology. 2020 Feb;82(2):360–5. doi: 10.1016/j.jaad.2019.06.1288.; Singh D, Beeh KM, Colgan B, Kornmann O, Leaker B, Watz H, Lucci G, Geraci S, Emirova A, Govoni M, Nandeuil MA. Effect of the inhaled PDE4 inhibitor CHF6001 on biomarkers of inflammation in COPD. Respiratory Research. 2019 Aug 09;20(1):180. doi: 10.1186/s12931-019-1142-7.; Kragstrup TW, Adams M, Lomholt S, Nielsen MA, Heftdal LD, Schafer P, Deleuran B. IL-12/IL-23p40 identified as a downstream target of apremilast in ex vivo models of arthritis. Therapeutic Advances in Musculoskeletal. 2019 Jan;11(). doi: 10.1177/1759720x19828669.; An R, Liu J, He J, Wang F, Zhang Q, Yu Q. PDE3A inhibitor anagrelide activates death signaling pathway genes and synergizes with cell death-inducing cytokines to selectively inhibit cancer cell growth. Am J Cancer Res. 2019;9(9):1905–21. PMID: 31598394; PMCID: PMC6780660.; Liu F, Yu H, Lin C, Elzoghby AO, Hwang T, Fang J. Use of cilomilast-loaded phosphatiosomes to suppress neutrophilic inflammation for attenuating acute lung injury: the effect of nanovesicular surface charge. Journal of Nanobiotechnology. 2018 Mar 30;16(1):35. doi: 10.1186/s12951-018-0364-z.; Filardo EJ. A role for G-protein coupled estrogen receptor (GPER) in estrogen-induced carcinogenesis: Dysregulated glandular homeostasis, survival and metastasis. The Journal of Steroid Biochemistry and Molecular Biology. 2018 Feb;176():38–48. doi: 10.1016/j.jsbmb.2017.05.005.; Liu DY, Wang ZG, Gao Y, Zhang HM, Zhang YX, Wang XJ, Peng D. Effect and safety of roflumilast for chronic obstructive pulmonary disease in Chinese patients. Medicine (Baltimore). 2018 Feb;97(7):e9864. PMID: 29443750; PMCID: PMC5839818.; Nazir M, Senkowski W, Nyberg F, Blom K, Edqvist PH, Jarvius M, Andersson C, Gustafsson MG, Nygren P, Larsson R, Fryknäs M. Targeting tumor cells based on Phosphodiesterase 3A expression. Exp Cell Res. 2017 Dec 15;361(2):308–15. doi: 10.1016/j.yexcr.2017.10.032. PMID: 29107068.; Gonzalez de Valdivia E, Broselid S, Kahn R, Olde B, Leeb-Lundberg LMF. G protein-coupled estrogen receptor 1 (GPER1)/GPR30 increases ERK1/2 activity through PDZ motif-dependent and -independent mechanisms. Journal of Biological Chemistry. 2017 Jun;292(24):9932–43. doi: 10.1074/jbc.m116.765875.; Alexander A, Irving AJ, Harvey J. Emerging roles for the novel estrogen-sensing receptor GPER1 in the CNS. Neuropharmacology. 2017 Feb;113(Pt B):652–60. doi: 10.1016/j.neuropharm.2016.07.003. PMID: 27392633.; Tran Q, Firkins R, Giles J, Francis S, Matnishian V, Tran P, VerMeer M, Jasurda J, Burgard MA, Gebert-Oberle B. Estrogen Enhances Linkage in the Vascular Endothelial Calmodulin Network via a Feedforward Mechanism at the G Protein-coupled Estrogen Receptor 1. Journal of Biological Chemistry. 2016 May;291(20):10805–23. doi: 10.1074/jbc.m115.697334.; Gaudet HM, Cheng SB, Christensen EM, Filardo EJ. The G-protein coupled estrogen receptor, GPER: The inside and inside-out story. Mol Cell Endocrinol. 2015 Dec 15;418 Pt 3():207–19. doi: 10.1016/j.mce.2015.07.016. PMID: 26190834.; Salhiyyah K, Forster R, Senanayake E, Abdel-Hadi M, Booth A, Michaels JA. Pentoxifylline for intermittent claudication. Cochrane Database Syst Rev. 2015 Sep 29;9():CD005262. PMID: 26417854; PMCID: PMC6513423.; Davari AS, Abnous K, Mehri S, Ghandadi M, Hadizadeh F. Synthesis and biological evaluation of novel pyridine derivatives as potential anticancer agents and phosphodiesterase-3 inhibitors. Bioorg Chem. 2014 Dec;57():83–9. doi: 10.1016/j.bioorg.2014.09.003. PMID: 25277835.; Broselid S, Berg KA, Chavera TA, Kahn R, Clarke WP, Olde B, Leeb-Lundberg LMF. G protein-coupled Receptor 30 (GPR30) Forms a Plasma Membrane Complex with Membrane-associated Guanylate Kinases (MAGUKs) and Protein Kinase A-anchoring Protein 5 (AKAP5) That Constitutively Inhibits cAMP Production. Journal of Biological Chemistry. 2014 Aug;289(32):22117–27. doi: 10.1074/jbc.m114.566893.; Prossnitz ER, Barton M: Estrogen biology: new insights into GPER function and clinical opportunities. Mol Cell Endocrinol. 2014 May 25;389(1-2):71-83. doi: 10.1016/j.mce.2014.02.002. Epub 2014 Feb 12.; Maurice DH, Ke H, Ahmad F, Wang Y, Chung J, Manganiello VC. Advances in targeting cyclic nucleotide phosphodiesterases. Nature Reviews Drug Discovery. 2014 Apr 01;13(4):290–314. doi: 10.1038/nrd4228.; Blumer JB, Lanier SM. Activators of G Protein Signaling Exhibit Broad Functionality and Define a Distinct Core Signaling Triad. Molecular Pharmacology. 2014 Mar;85(3):388–96. doi: 10.1124/mol.113.090068.; Filardo EJ, Thomas P. Minireview: G protein-coupled estrogen receptor-1, GPER-1: its mechanism of action and role in female reproductive cancer, renal and vascular physiology. Endocrinology. 2012 Jul;153(7):2953–62. PMID: 22495674; PMCID: PMC3380306.; Prossnitz ER, Barton M. The G-protein-coupled estrogen receptor GPER in health and disease. Nature Reviews Endocrinology. 2011 Aug 16;7(12):715–26. doi: 10.1038/nrendo.2011.122.; Nobles KN, Xiao K, Ahn S, Shukla AK, Lam CM, Rajagopal S, Strachan RT, Huang T, Bressler EA, Hara MR, Shenoy SK, Gygi SP, Lefkowitz RJ. Distinct Phosphorylation Sites on the ß 2 -Adrenergic Receptor Establish a Barcode That Encodes Differential Functions of ß-Arrestin. Sci. Signal. 2011 Aug 09;4(185). doi: 10.1126/scisignal.2001707.; Yamazaki T, Anraku T, Matsuzawa S: Ibudilast, a mixed PDE3/4 inhibitor, causes a selective and nitric oxide/cGMP-independent relaxation of the intracranial vertebrobasilar artery. Eur J Pharmacol. 2011 Jan 15;650(2-3):605-11. doi: 10.1016/j.ejphar.2010.10.033. Epub 2010 Oct 29.; Thomas P, Alyea R, Pang Y, Peyton C, Dong J, Berg AH. Conserved estrogen binding and signaling functions of the G protein-coupled estrogen receptor 1 (GPER) in mammals and fish. Steroids. 2010 Aug;75(8-9):595–602. doi: 10.1016/j.steroids.2009.11.005.; Hatzelmann A, Morcillo EJ, Lungarella G, Adnot S, Sanjar S, Beume R, Schudt C, Tenor H. The preclinical pharmacology of roflumilast – A selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease. Pulmonary Pharmacology & Therapeutics. 2010 Aug;23(4):235–56. doi: 10.1016/j.pupt.2010.03.011.; Ritter SL, Hall RA. Fine-tuning of GPCR activity by receptor-interacting proteins. Nature Reviews Molecular Cell Biology. 2009 Dec;10(12):819–30. doi: 10.1038/nrm2803.; Rolan P, Hutchinson M, Johnson K. Ibudilast: a review of its pharmacology, efficacy and safety in respiratory and neurological disease. Expert Opin Pharmacother. 2009 Dec;10(17):2897–904. doi: 10.1517/14656560903426189. PMID: 19929708.; Ding Q, Gros R, Limbird LE, Chorazyczewski J, Feldman RD. Estradiol-mediated ERK phosphorylation and apoptosis in vascular smooth muscle cells requires GPR 30. American Journal of Physiology-Cell Physiology. 2009 Nov;297(5):C1178–87. doi: 10.1152/ajpcell.00185.2009.; Nazarian R, Weinberg JM. AN-2728, a PDE4 inhibitor for the potential topical treatment of psoriasis and atopic dermatitis. Curr Opin Investig Drugs. 2009 Nov;10(11):1236–42. PMID: 19876791.; Quinn JA, Graeber CT, Frackelton AR, Kim M, Schwarzbauer JE, Filardo EJ. Coordinate regulation of estrogen-mediated fibronectin matrix assembly and epidermal growth factor receptor transactivation by the G protein-coupled receptor, GPR30. Mol Endocrinol. 2009 Jul;23(7):1052–64. PMID: 19342448; PMCID: PMC2703602.; Rennard S, Knobil K, Rabe KF, Morris A, Schachter N, Locantore N, Canonica WG, Zhu Y, Barnhart F. The efficacy and safety of cilomilast in COPD. Drugs. 2008;68 Suppl 2():3–57. doi: 10.2165/0003495-200868002-00002. PMID: 19105585.; Gurevich VV, Gurevich EV. Rich Tapestry of G Protein-Coupled Receptor Signaling and Regulatory Mechanisms. Molecular Pharmacology. 2008 Aug;74(2):312–6. doi: 10.1124/mol.108.049015.; Lambert NA. Dissociation of heterotrimeric g proteins in cells. Sci Signal. 2008 Jun 24;1(25):re5. doi: 10.1126/scisignal.125re5. PMID: 18577758.; Otto C, Rohde-Schulz B, Schwarz G, Fuchs I, Klewer M, Brittain D, Langer G, Bader B, Prelle K, Nubbemeyer R, Fritzemeier KH. G protein-coupled receptor 30 localizes to the endoplasmic reticulum and is not activated by estradiol. Endocrinology. 2008 Oct;149(10):4846–56. doi: 10.1210/en.2008-0269. PMID: 18566127.; Smrcka AV. G protein ß? subunits: Central mediators of G protein-coupled receptor signaling. Cellular and Molecular Life Sciences. 2008 May 19;65(14):2191–214. doi: 10.1007/s00018-008-8006-5.; Soundararajan M, Willard FS, Kimple AJ, Turnbull AP, Ball LJ, Schoch GA, Gileadi C, Fedorov OY, Dowler EF, Higman VA, Hutsell SQ, Sundström M, Doyle DA, Siderovski DP. Structural diversity in the RGS domain and its interaction with heterotrimeric G protein alpha-subunits. Proc Natl Acad Sci U S A. 2008 Apr 29;105(17):6457–62. PMID: 18434541; PMCID: PMC2359823.; Luttrell LM. Reviews in molecular biology and biotechnology: transmembrane signaling by G protein-coupled receptors. Mol Biotechnol. 2008 Jul;39(3):239–64. doi: 10.1007/s12033-008-9031-1. PMID: 18240029.; Filardo E, Quinn J, Pang Y, Graeber C, Shaw S, Dong J, Thomas P. Activation of the novel estrogen receptor G protein-coupled receptor 30 (GPR30) at the plasma membrane. Endocrinology. 2007 Jul;148(7):3236–45. doi: 10.1210/en.2006-1605. PMID: 17379646.; Boswell-Smith V, Spina D. PDE4 inhibitors as potential therapeutic agents in the treatment of COPD-focus on roflumilast. Int J Chron Obstruct Pulmon Dis. 2007;2(2):121–9. PMID: 18044684; PMCID: PMC2695611.; Huang Z, Mancini JA. Phosphodiesterase 4 inhibitors for the treatment of asthma and COPD. Curr Med Chem. 2006;13(27):3253–62. doi: 10.2174/092986706778773040. PMID: 17168849.; Pedram A, Razandi M, Levin ER. Nature of functional estrogen receptors at the plasma membrane. Mol Endocrinol. 2006 Sep;20(9):1996–2009. doi: 10.1210/me.2005-0525. PMID: 16645038.; Violin JD, Ren XR, Lefkowitz RJ. G-protein-coupled receptor kinase specificity for beta-arrestin recruitment to the beta2-adrenergic receptor revealed by fluorescence resonance energy transfer. J Biol Chem. 2006 Jul 21;281(29):20577–88. doi: 10.1074/jbc.m513605200. PMID: 16687412.; Gurevich VV, Gurevich EV. The structural basis of arrestin-mediated regulation of G-protein-coupled receptors. Pharmacology & Therapeutics. 2006 Jun;110(3):465–502. doi: 10.1016/j.pharmthera.2005.09.008.; Huang Z, Liu S, Zhang L, Salem M, Greig GM, Chan CC, Natsumeda Y, Noguchi K. Preferential inhibition of human phosphodiesterase 4 by ibudilast. Life Sci. 2006 May 01;78(23):2663–8. doi: 10.1016/j.lfs.2005.10.026. PMID: 16313925.; Oldham WM, Hamm HE. Structural basis of function in heterotrimeric G proteins. Q Rev Biophys. 2006 May;39(2):117–66. doi: 10.1017/s0033583506004306. PMID: 16923326.; Maurice DH. Cyclic nucleotide phosphodiesterase-mediated integration of cGMP and cAMP signaling in cells of the cardiovascular system. Front Biosci. 2005 May 01;10():1221–8. doi: 10.2741/1614. PMID: 15769620.; Jeon YH, Heo Y-, Kim CM, Hyun Y-, Lee TG, Ro S, Cho JM. Phosphodiesterase: overview of protein structures, potential therapeutic applications and recent progress in drug development. Cellular and Molecular Life Sciences. 2005 Mar 29;62(11):1198–220. doi: 10.1007/s00018-005-4533-5.; Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science. 2005 Mar 11;307(5715):1625–30. doi: 10.1126/science.1106943. PMID: 15705806.; Thomas P, Pang Y, Filardo EJ, Dong J. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology. 2005 Feb;146(2):624–32. doi: 10.1210/en.2004-1064. PMID: 15539556.; Siderovski DP, Willard FS. The GAPs, GEFs, and GDIs of heterotrimeric G-protein alpha subunits. Int J Biol Sci. 2005;1(2):51–66. PMID: 15951850; PMCID: PMC1142213.; Chen CK. The vertebrate phototransduction cascade: amplification and termination mechanisms. Rev Physiol Biochem Pharmacol. 2005;154():101–21. doi: 10.1007/s10254-005-0004-0. PMID: 16634148.; Beeh KM, Beier J, Lerch C, Schulz AK, Buhl R. Effects of piclamilast, a selective phosphodiesterase-4 inhibitor, on oxidative burst of sputum cells from mild asthmatics and stable COPD patients. Lung. 2004;182(6):369–77. doi: 10.1007/s00408-004-2518-z. PMID: 15765929.; Kanda N, Watanabe S. 17ß-Estradiol Stimulates the Growth of Human Keratinocytes by Inducing Cyclin D2 Expression. Journal of Investigative Dermatology. 2004 Aug;123(2):319–28. doi: 10.1111/j.0022-202x.2004.12645.x.; Kristiansen K. Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function. Pharmacol Ther. 2004 Jul;103(1):21–80. doi: 10.1016/j.pharmthera.2004.05.002. PMID: 15251227.; Cao X, Cismowski MJ, Sato M, Blumer JB, Lanier SM. Identification and characterization of AGS4: a protein containing three G-protein regulatory motifs that regulate the activation state of Gialpha. J Biol Chem. 2004 Jun 25;279(26):27567–74. doi: 10.1074/jbc.m312786200. PMID: 15096500.; Cabrera-Vera TM, Vanhauwe J, Thomas TO, Medkova M, Preininger A, Mazzoni MR, Hamm HE. Insights into G protein structure, function, and regulation. Endocr Rev. 2003 Dec;24(6):765–81. doi: 10.1210/er.2000-0026. PMID: 14671004.; Kanda N, Watanabe S. 17ß-Estradiol Inhibits Oxidative Stress-Induced Apoptosis in Keratinocytes by Promoting Bcl-2 Expression. Journal of Investigative Dermatology. 2003 Dec;121(6):1500–9. doi: 10.1111/j.1523-1747.2003.12617.x.; Wakasugi K, Nakano T, Morishima I. Oxidized human neuroglobin acts as a heterotrimeric Galpha protein guanine nucleotide dissociation inhibitor. J Biol Chem. 2003 Sep 19;278(38):36505–12. doi: 10.1074/jbc.m305519200. PMID: 12860983.; Azzi M, Charest PG, Angers S, Rousseau G, Kohout T, Bouvier M, Piñeyro G. Beta-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors. Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11406–11. PMID: 13679574; PMCID: PMC208770.; Zhang JY, Nawoschik S, Kowal D, Smith D, Spangler T, Ochalski R, Schechter L, Dunlop J. Characterization of the 5-HT6 receptor coupled to Ca2+ signaling using an enabling chimeric G-protein. Eur J Pharmacol. 2003 Jul 04;472(1-2):33–8. doi: 10.1016/s0014-2999(03)01855-7. PMID: 12860470.; Dessauer CW, Chen-Goodspeed M, Chen J. Mechanism of Galpha i-mediated inhibition of type V adenylyl cyclase. J Biol Chem. 2002 Aug 09;277(32):28823–9. doi: 10.1074/jbc.m203962200. PMID: 12058044.; Feldman DS, Zamah AM, Pierce KL, Miller WE, Kelly F, Rapacciuolo A, Rockman HA, Koch WJ, Luttrell LM. Selective inhibition of heterotrimeric Gs signaling. Targeting the receptor-G protein interface using a peptide minigene encoding the Galpha(s) carboxyl terminus. J Biol Chem. 2002 Aug 09;277(32):28631–40. doi: 10.1074/jbc.m204753200. PMID: 12036966.; Wenzel-Seifert K, Liu HY, Seifert R. Similarities and differences in the coupling of human beta1- and beta2-adrenoceptors to Gs(alpha) splice variants. Biochem Pharmacol. 2002 Jul 01;64(1):9–20. doi: 10.1016/s0006-2952(02)00924-3. PMID: 12106601.; Neves SR, Ram PT, Iyengar R. G protein pathways. Science. 2002 May 31;296(5573):1636–9. doi: 10.1126/science.1071550. PMID: 12040175.; Neubig RR, Siderovski DP. Regulators of G-protein signalling as new central nervous system drug targets. Nat Rev Drug Discov. 2002 Mar;1(3):187–97. doi: 10.1038/nrd747. PMID: 12120503.; Schrör K. The pharmacology of cilostazol. Diabetes Obes Metab. 2002 Mar;4 Suppl 2():S14–9. doi: 10.1046/j.1463-1326.2002.0040s2s14.x. PMID: 12180353.; Filardo EJ, Quinn JA, Frackelton AR, Bland KI. Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis. Mol Endocrinol. 2002 Jan;16(1):70–84. doi: 10.1210/mend.16.1.0758. PMID: 11773440.; Natochin M, Lester B, Peterson YK, Bernard ML, Lanier SM, Artemyev NO. AGS3 inhibits GDP dissociation from galpha subunits of the Gi family and rhodopsin-dependent activation of transducin. J Biol Chem. 2000 Dec 29;275(52):40981–5. doi: 10.1074/jbc.m006478200. PMID: 11024022.; Peterson YK, Bernard ML, Ma H, Hazard S, Graber SG, Lanier SM. Stabilization of the GDP-bound conformation of Gialpha by a peptide derived from the G-protein regulatory motif of AGS3. J Biol Chem. 2000 Oct 27;275(43):33193–6. doi: 10.1074/jbc.c000509200. PMID: 10969064.; Filardo EJ, Quinn JA, Bland KI, Frackelton AR. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol. 2000 Oct;14(10):1649–60. doi: 10.1210/mend.14.10.0532. PMID: 11043579.; Ma YC, Huang J, Ali S, Lowry W, Huang XY. Src tyrosine kinase is a novel direct effector of G proteins. Cell. 2000 Sep 01;102(5):635–46. doi: 10.1016/s0092-8674(00)00086-6. PMID: 11007482.; Qiao H, Saulnier R, Patryzkat A, Rahimi N, Raptis L, Rossiter J, Tremblay E, Elliott B. Cooperative effect of hepatocyte growth factor and fibronectin in anchorage-independent survival of mammary carcinoma cells: requirement for phosphatidylinositol 3-kinase activity. Cell Growth Differ. 2000 Feb;11(2):123–33. PMID: 10714768.; Downes GB, Gautam N. The G protein subunit gene families. Genomics. 1999 Dec 15;62(3):544–52. doi: 10.1006/geno.1999.5992. PMID: 10644457.; Takesono A, Cismowski MJ, Ribas C, Bernard M, Chung P, Hazard S, Duzic E, Lanier SM. Receptor-independent Activators of Heterotrimeric G-protein Signaling Pathways. Journal of Biological Chemistry. 1999 Nov;274(47):33202–5. doi: 10.1074/jbc.274.47.33202.; Cismowski MJ, Takesono A, Ma C, Lizano JS, Xie X, Fuernkranz H, Lanier SM, Duzic E. Genetic screens in yeast to identify mammalian nonreceptor modulators of G-protein signaling. Nat Biotechnol. 1999 Sep;17(9):878–83. doi: 10.1038/12867. PMID: 10471929.; Hamada Y, Kawachi K, Yamamoto T, Nakata T, Kashu Y, Sato M, Watanabe Y. Effects of single administration of a phosphodiesterase III inhibitor during cardiopulmonary bypass: comparison of milrinone and amrinone. Jpn Circ J. 1999 Aug;63(8):605–9. doi: 10.1253/jcj.63.605. PMID: 10478810.; Baker LP, Nielsen MD, Impey S, Metcalf MA, Poser SW, Chan G, Obrietan K, Hamblin MW, Storm DR. Stimulation of Type 1 and Type 8 Ca2+/Calmodulin-sensitive Adenylyl Cyclases by the Gs-coupled 5-Hydroxytryptamine Subtype 5-HT7AReceptor. Journal of Biological Chemistry. 1998 Jul;273(28):17469–76. doi: 10.1074/jbc.273.28.17469.; Tesmer JJ, Sunahara RK, Gilman AG, Sprang SR. Crystal structure of the catalytic domains of adenylyl cyclase in a complex with Gsalpha.GTPgammaS. Science. 1997 Dec 12;278(5345):1907–16. doi: 10.1126/science.278.5345.1907. PMID: 9417641.; Tefferi A, Silverstein MN, Petitt RM, Mesa RA, Solberg LA. Anagrelide as a new platelet-lowering agent in essential thrombocythemia: mechanism of actin, efficacy, toxicity, current indications. Semin Thromb Hemost. 1997;23(4):379–83. doi: 10.1055/s-2007-996112. PMID: 9263355.; Fields TA, Casey PJ. Signalling functions and biochemical properties of pertussis toxin-resistant G-proteins. Biochem J. 1997 Feb 01;321 ( Pt 3)():561–71. PMID: 9032437; PMCID: PMC1218106.; Mochizuki N, Cho G, Wen B, Insel PA. Identification and cDNA cloning of a novel human mosaic protein, LGN, based on interaction with G alpha i2. Gene. 1996 Nov 28;181(1-2):39–43. doi: 10.1016/s0378-1119(96)00456-8. PMID: 8973305.; Luttrell LM, Hawes BE, van Biesen T, Luttrell DK, Lansing TJ, Lefkowitz RJ. Role of c-Src tyrosine kinase in G protein-coupled receptor- and Gbetagamma subunit-mediated activation of mitogen-activated protein kinases. J Biol Chem. 1996 Aug 09;271(32):19443–50. doi: 10.1074/jbc.271.32.19443. PMID: 8702633.; Ono S, Ueda S, Sakuma T, Tanita T, Koika K, Fujimura S. Relaxation of human isolated pulmonary arteries by amrinone. J Cardiovasc Surg (Torino). 1996 Apr;37(2):177–81. PMID: 8675527.; Basi NS, Okuya S, Rebois RV. GTP binding to Gs does not promote subunit dissociation. Cell Signal. 1996 Mar;8(3):209–15. doi: 10.1016/0898-6568(95)02056-x. PMID: 8736705.; Saulnier R, Bhardwaj B, Klassen J, Leopold D, Rahimi N, Tremblay E, Mosher D, Elliott B. Fibronectin fibrils and growth factors stimulate anchorage-independent growth of a murine mammary carcinoma. Exp Cell Res. 1996 Feb 01;222(2):360–9. doi: 10.1006/excr.1996.0045. PMID: 8598224.; Ménard L, Ferguson SS, Barak LS, Bertrand L, Premont RT, Colapietro AM, Lefkowitz RJ, Caron MG. Members of the G protein-coupled receptor kinase family that phosphorylate the beta2-adrenergic receptor facilitate sequestration. Biochemistry. 1996 Apr 02;35(13):4155–60. doi: 10.1021/bi952961+. PMID: 8672451.; Touhara K, Hawes BE, van Biesen T, Lefkowitz RJ. G protein beta gamma subunits stimulate phosphorylation of Shc adapter protein. Proc. Natl. Acad. Sci. U.S.A. 1995 Sep 26;92(20):9284–7. doi: 10.1073/pnas.92.20.9284.; van Biesen T, Hawes BE, Luttrell DK, Krueger KM, Touhara K, Porfiri E, Sakaue M, Luttrell LM, Lefkowitz RJ. Receptor-tyrosine-kinase- and G beta gamma-mediated MAP kinase activation by a common signalling pathway. Nature. 1995 Aug 31;376(6543):781–4. doi: 10.1038/376781a0. PMID: 7651538.; Premont RT, Inglese J, Lefkowitz RJ. Protein kinases that phosphorylate activated G protein-coupled receptors. FASEB J. 1995 Feb;9(2):175–82. doi: 10.1096/fasebj.9.2.7781920. PMID: 7781920.; Kleuss C, Raw AS, Lee E, Sprang SR, Gilman AG. Mechanism of GTP hydrolysis by G-protein alpha subunits. Proc. Natl. Acad. Sci. U.S.A. 1994 Oct 11;91(21):9828–31. doi: 10.1073/pnas.91.21.9828.; Premont RT, Koch WJ, Inglese J, Lefkowitz RJ. Identification, purification, and characterization of GRK5, a member of the family of G protein-coupled receptor kinases. Journal of Biological Chemistry. 1994 Mar;269(9):6832–41. doi: 10.1016/s0021-9258(17)37451-3.; Takami S, Getchell TV, McLaughlin SK, Margolskee RF, Getchell ML. Human taste cells express the G protein alpha-gustducin and neuron-specific enolase. Brain Res Mol Brain Res. 1994 Mar;22(1-4):193–203. doi: 10.1016/0169-328x(94)90047-7. PMID: 8015379.; Taussig R, Tang WJ, Hepler JR, Gilman AG. Distinct patterns of bidirectional regulation of mammalian adenylyl cyclases. Journal of Biological Chemistry. 1994 Feb;269(8):6093–100. doi: 10.1016/s0021-9258(17)37574-9.; Morris TA, Fong SL. Characterization of the gene encoding human cone transducin alpha-subunit (GNAT2). Genomics. 1993 Aug;17(2):442–8. doi: 10.1006/geno.1993.1345. PMID: 8406495.; Sterne-Marr R, Gurevich VV, Goldsmith P, Bodine RC, Sanders C, Donoso LA, Benovic JL. Polypeptide variants of beta-arrestin and arrestin3. Journal of Biological Chemistry. 1993 Jul;268(21):15640–8. doi: 10.1016/s0021-9258(18)82304-3.; Taussig R, Iñiguez-Lluhi JA, Gilman AG. Inhibition of adenylyl cyclase by Gi alpha. Science. 1993 Jul 09;261(5118):218–21. doi: 10.1126/science.8327893. PMID: 8327893.; Richardson RM, Kim C, Benovic JL, Hosey MM. Phosphorylation and desensitization of human m2 muscarinic cholinergic receptors by two isoforms of the beta-adrenergic receptor kinase. Journal of Biological Chemistry. 1993 Jun;268(18):13650–6. doi: 10.1016/s0021-9258(19)38697-1.; Attramadal H, Arriza JL, Aoki C, Dawson TM, Codina J, Kwatra MM, Snyder SH, Caron MG, Lefkowitz RJ. Beta-arrestin2, a novel member of the arrestin/beta-arrestin gene family. Journal of Biological Chemistry. 1992 Sep;267(25):17882–90. doi: 10.1016/s0021-9258(19)37125-x.; Lohse MJ, Benovic JL, Codina J, Caron MG, Lefkowitz RJ. beta-Arrestin: a protein that regulates beta-adrenergic receptor function. Science. 1990 Jun 22;248(4962):1547–50. doi: 10.1126/science.2163110. PMID: 2163110.; Mitsuhashi M, Mitsuhashi T, Payan DG. Multiple signaling pathways of histamine H2 receptors. Identification of an H2 receptor-dependent Ca2+ mobilization pathway in human HL-60 promyelocytic leukemia cells. J Biol Chem. 1989 Nov 05;264(31):18356–62. PMID: 2553705.; Lerea CL, Bunt-Milam AH, Hurley JB. Alpha transducin is present in blue-, green-, and red-sensitive cone photoreceptors in the human retina. Neuron. 1989 Sep;3(3):367–76. doi: 10.1016/0896-6273(89)90261-4. PMID: 2534964.; Honerjäger P. Pharmacology of positive inotropic phosphodiesterase III inhibitors. Eur Heart J. 1989 Aug;10 Suppl C():25–31. doi: 10.1093/eurheartj/10.suppl_c.25. PMID: 2553411.; Van Dop C, Medynski DC, Apone LM. Nucleotide sequence for a cDNA encoding the alpha subunit of retinal transducin (GNAT1) isolated from the human eye. Nucleic Acids Res. 1989 Jun 26;17(12):4887. PMID: 2748346; PMCID: PMC318051.; DiBianco R, Shabetai R, Kostuk W, Moran J, Schlant RC, Wright R. A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure. N Engl J Med. 1989 Mar 16;320(11):677–83. doi: 10.1056/nejm198903163201101. PMID: 2646536.; Graziano MP, Freissmuth M, Gilman AG. Expression of Gs alpha in Escherichia coli. Purification and properties of two forms of the protein. J Biol Chem. 1989 Jan 05;264(1):409–18. PMID: 2491850.; Itoh H, Toyama R, Kozasa T, Tsukamoto T, Matsuoka M, Kaziro Y. Presence of three distinct molecular species of Gi protein alpha subunit. Structure of rat cDNAs and human genomic DNAs. Journal of Biological Chemistry. 1988 May;263(14):6656–64. doi: 10.1016/s0021-9258(18)68692-2.; Kozasa T, Itoh H, Tsukamoto T, Kaziro Y. Isolation and characterization of the human Gs alpha gene. Proc. Natl. Acad. Sci. U.S.A. 1988 Apr;85(7):2081–5. doi: 10.1073/pnas.85.7.2081.; Gilman AG. G proteins: transducers of receptor-generated signals. Annu Rev Biochem. 1987;56():615–49. doi: 10.1146/annurev.bi.56.070187.003151. PMID: 3113327.; Ferguson KM, Higashijima T, Smigel MD, Gilman AG. The influence of bound GDP on the kinetics of guanine nucleotide binding to G proteins. Journal of Biological Chemistry. 1986 Jun;261(16):7393–9. doi: 10.1016/s0021-9258(17)38404-1.; Benovic JL, Strasser RH, Caron MG, Lefkowitz RJ. Beta-adrenergic receptor kinase: identification of a novel protein kinase that phosphorylates the agonist-occupied form of the receptor. Proc. Natl. Acad. Sci. U.S.A. 1986 May;83(9):2797–801. doi: 10.1073/pnas.83.9.2797.; Weber KT, Janicki JS, Jain MC. Enoximone (MDL 17,043), a phosphodiesterase inhibitor, in the treatment of advanced, unstable chronic heart failure. J Heart Transplant. 1986 Mar;5(2):105–12. PMID: 2956397.; Alousi AA, Johnson DC. Pharmacology of the bipyridines: amrinone and milrinone. Circulation. 1986 Mar;73(3 Pt 2):III10–24. PMID: 2417744.; Benotti JR, Lesko LJ, McCue JE, Alpert JS. Pharmacokinetics and pharmacodynamics of milrinone in chronic congestive heart failure. The American Journal of Cardiology. 1985 Oct;56(10):685–9. doi: 10.1016/0002-9149(85)91036-7.; Wilmshurst PT, Walker JM, Fry CH, Mounsey JP, Twort CH, Williams BT, Davies MJ, Webb-Peploe MM. Inotropic and vasodilator effects of amrinone on isolated human tissue. Cardiovasc Res. 1984 May;18(5):302–9. doi: 10.1093/cvr/18.5.302. PMID: 6733734.; Allaf DE, D'orio V, Carlier J. The new inotropic phosphodiesterase inhibitors. Archives Internationales de Physiologie et de Biochimie. 1984 Jan;92(4):S69–79. doi: 10.3109/13813458409071165.; Dage RC, Roebel LE, Hsieh CP, Weiner DL, Woodward JK. Cardiovascular properties of a new cardiotonic agent: MDL 17,043 (1.3-dihydro-4-methyl-5-[4-(methylthio)-benzoyl]-2H-imidazol-2-one). J Cardiovasc Pharmacol. 1982 May;4(3):500–8. PMID: 6177949.
Transport of small molecules

Accession ID: Reactome:R-MMU-382551
-
SLC-mediated transmembrane transport

Accession ID: Reactome:R-MMU-425407
  • 10.1006/abbi.1999.1213
  • 10.1007/s00424-003-1064-5
  • 10.1007/s00424-003-1089-9
  • 10.1007/s00424-003-1168-y
  • 10.1007/s00424-003-1192-y
  • 10.1007/s00424-005-1487-2
  • 10.1016/j.febslet.2015.03.012
  • 10.1016/j.mam.2012.07.010
  • 10.1016/s0021-9258(18)31744-7
  • 10.1073/pnas.94.7.2897
  • 10.1079/bjn2002763
  • 10.1097/mnh.0b013e3282e7d7d0
  • 10.1111/j.1471-4159.2004.02962.x
  • 10.1152/physiol.00037.2007
  • 10.1152/physrev.00044.2006
  • 10.1177/0960327107070573
  • 10.1186/1479-7364-3-2-195
  • 10.1208/s12248-008-9035-6
  • 10.1590/s0100-879x2006000900002
Schneider S. Inositol transport proteins. FEBS Lett. 2015 Apr 28;589(10):1049–58. doi: 10.1016/j.febslet.2015.03.012. PMID: 25819438.; Anderson CM, Stahl A. SLC27 fatty acid transport proteins. Molecular Aspects of Medicine. 2013 Apr;34(2-3):516–28. doi: 10.1016/j.mam.2012.07.010.; He L, Vasiliou K, Nebert DW. Analysis and update of the human solute carrier (SLC) gene superfamily. Hum Genomics. 2009 Jan;3(2):195–206. PMID: 19164095; PMCID: PMC2752037.; Morris ME, Felmlee MA. Overview of the Proton-coupled MCT (SLC16A) Family of Transporters: Characterization, Function and Role in the Transport of the Drug of Abuse ?-Hydroxybutyric Acid. The AAPS Journal. 2008 Jun 04;10(2):311. doi: 10.1208/s12248-008-9035-6.; Dorwart MR, Shcheynikov N, Yang D, Muallem S. The solute carrier 26 family of proteins in epithelial ion transport. Physiology (Bethesda). 2008 Apr;23():104–14. doi: 10.1152/physiol.00037.2007. PMID: 18400693.; Ashmore J. Cochlear outer hair cell motility. Physiol Rev. 2008 Jan;88(1):173–210. doi: 10.1152/physrev.00044.2006. PMID: 18195086.; Sindic A, Chang MH, Mount DB, Romero MF. Renal physiology of SLC26 anion exchangers. Curr Opin Nephrol Hypertens. 2007 Sep;16(5):484–90. doi: 10.1097/mnh.0b013e3282e7d7d0. PMID: 17693766.; Bressler JP, Olivi L, Cheong JH, Kim Y, Maerten A, Bannon D. Metal transporters in intestine and brain: their involvement in metal-associated neurotoxicities. Hum Exp Toxicol. 2007 Mar;26(3):221–9. doi: 10.1177/0960327107070573. PMID: 17439925.; Handford M, Rodriguez-Furlán C, Orellana A. Nucleotide-sugar transporters: structure, function and roles in vivo. Braz J Med Biol Res. 2006 Sep;39(9):1149–58. doi: 10.1590/s0100-879x2006000900002. PMID: 16981043.; Pajor AM. Molecular properties of the SLC13 family of dicarboxylate and sulfate transporters. Pflügers Archiv - European Journal of Physiology. 2005 Oct 07;451(5):597–605. doi: 10.1007/s00424-005-1487-2.; Traiffort E, Ruat M, O'Regan S, Meunier FM. Molecular characterization of the family of choline transporter-like proteins and their splice variants. Journal of Neurochemistry. 2005 Feb 04;92(5):1116–25. doi: 10.1111/j.1471-4159.2004.02962.x.; Koepsell H, Endou H. The SLC22 drug transporter family. Pflügers Archiv - European Journal of Physiology. 2003 Jul 19;447(5):666–76. doi: 10.1007/s00424-003-1089-9.; Hediger MA, Romero MF, Peng J, Rolfs A, Takanaga H, Bruford EA. The ABCs of solute carriers: physiological, pathological and therapeutic implications of human membrane transport proteins. Pflügers Archiv - European Journal of Physiology. 2003 Nov 18;447(5):465–8. doi: 10.1007/s00424-003-1192-y.; Hagenbuch B, Meier PJ. Organic anion transporting polypeptides of the OATP/ SLC21 family: phylogenetic classification as OATP/ SLCO superfamily, new nomenclature and molecular/functional properties. Pfl?gers Archiv European Journal of Physiology. 2004 Feb 01;447(5):653–65. doi: 10.1007/s00424-003-1168-y.; Chen N, Reith MEA, Quick MW. Synaptic uptake and beyond: the sodium- and chloride-dependent neurotransmitter transporter family SLC6. Pflügers Archiv - European Journal of Physiology. 2003 Apr 29;447(5):519–31. doi: 10.1007/s00424-003-1064-5.; Wood IS, Trayhurn P. Glucose transporters (GLUT and SGLT): expanded families of sugar transport proteins. Br J Nutr. 2003 Jan;89(1):3–9. doi: 10.1079/bjn2002763. PMID: 12568659.; Prasad PD, Wang H, Huang W, Fei YJ, Leibach FH, Devoe LD, Ganapathy V. Molecular and functional characterization of the intestinal Na+-dependent multivitamin transporter. Arch Biochem Biophys. 1999 Jun 01;366(1):95–106. doi: 10.1006/abbi.1999.1213. PMID: 10334869.; Kanamori A, Nakayama J, Fukuda MN, Stallcup WB, Sasaki K, Fukuda M, Hirabayashi Y. Expression cloning and characterization of a cDNA encoding a novel membrane protein required for the formation of O -acetylated ganglioside: A putative acetyl-CoA transporter. Proc. Natl. Acad. Sci. U.S.A. 1997 Apr;94(7):2897–902. doi: 10.1073/pnas.94.7.2897.; Olives B, Neau P, Bailly P, Hediger MA, Rousselet G, Cartron JP, Ripoche P. Cloning and functional expression of a urea transporter from human bone marrow cells. Journal of Biological Chemistry. 1994 Dec;269(50):31649–52. doi: 10.1016/s0021-9258(18)31744-7.